,Epitope,Number of results,Allele,Serotype,Class,MHC species,Category,Swiss Prot Ref,Journal Ref
0,AAAAAAAAR,1.0,n/a,HLA-A68,CLASS-I,HUMAN,VIRAL,P21433,JOURNAL OF IMMUNOLOGY 1999 162 331-337
1,AAAENAEAA,2.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
2,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
3,AAAKAAAAV,3.0,A*0205,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
4,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
5,,,A*0202,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
6,AAAPRTLLA,1.0,n/a,Qa-1b,CLASS-Ib,MOUSE,VIRAL,P31614,JOURNAL OF IMMUNOLOGY 1997 158 3244-3251
7,AAAPRTLLL,1.0,n/a,Qa-1b,CLASS-Ib,MOUSE,VIRAL,P31614,JOURNAL OF IMMUNOLOGY 1997 158 3244-3251
8,AACRAAGL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26664,JOURNAL OF VIROLOGY 1995 69 2462-2470
9,AADKAAAAAY,5.0,A*2401,HLA-A24,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
10,,,n/a,HLA-A1,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
11,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
12,,,A*1101,HLA-A11,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
13,,,A*0301,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
14,AADKAAAAY,5.0,n/a,HLA-A1,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
15,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
16,,,A*1101,HLA-A11,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
17,,,A*2401,HLA-A24,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
18,,,A*0301,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
19,AAENAEAA,2.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
20,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
21,AAEPAAAAY,1.0,n/a,HLA-A1,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 620-631
22,AAFQSSMTK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
23,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
24,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
25,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
26,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
27,AAGIGILT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
28,AAGIGILTV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
29,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,IMMUNOLOGICAL REVIEWS 2002 188 136-146
30,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
31,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1995 154 3961-3968
32,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1995 154 2257-2265
33,AAGIGILTVI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1995 154 3961-3968
34,AAGLQDCT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF VIROLOGY 1995 69 2462-2470
35,AAGLQDCTM,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF VIROLOGY 1995 69 2462-2470
36,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF VIROLOGY 1995 69 2462-2470
37,AAGLQDCTML,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF VIROLOGY 1995 69 2462-2470
38,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF VIROLOGY 1995 69 2462-2470
39,AAGLQDCTMLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF VIROLOGY 1995 69 2462-2470
40,AAHEFGHAL,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P57748,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
41,AAKDASIPTATIRRH,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01404,JOURNAL OF HEPATOLOGY 2001 34 321-329
42,AALFYTHRENASGCS,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
43,AAMIDTVVFK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,BACTERIAL,P95068,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
44,,,A*0301,HLA-A3,CLASS-I,HUMAN,BACTERIAL,P95068,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
45,AANDPIFVV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
46,AAPPKQEFL,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P25785,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
47,AAPPVAPA,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
48,,,A*0202,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
49,,,A*0203,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
50,,,A*0206,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
51,,,A*6802,HLA-A68,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
52,AAPTSAPV,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05885,JOURNAL OF VIROLOGY 2001 75 738-749
53,AAPYDINQML,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
54,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
55,AARDRFPGL,1.0,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P03188,JOURNAL OF MEDICAL VIROLOGY 2004 72 635-645
56,AARPATSTL,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,Q04637,JOURNAL OF IMMUNOLOGY 2003 171 22-26
57,AARPDDPTL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
58,AASKERGSVSL,6.0,A*0101,HLA-A1,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 1995 154 247-259
59,,,n/a,HLA-B7,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 1995 154 247-259
60,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 1995 154 247-259
61,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 1995 154 247-259
62,,,B*2705,HLA-B27,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 1995 154 247-259
63,,,B*0801,HLA-B8,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 1995 154 247-259
64,AASKERSGVSL,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P16403,JOURNAL OF IMMUNOLOGY 2003 171 22-26
65,AAWGFFPYL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 47320-47328
66,ACSANNSHHYI,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
67,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
68,ADAKAAAAV,3.0,A*0205,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
69,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
70,,,A*0202,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
71,ADHPFIFL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P19324,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
72,ADLFNAQPGL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271Â 
73,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
74,ADLMGYIPLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P29846,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
75,ADLVGFLLLK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
76,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
77,ADMIMHTPGCVPCVR,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26662,JOURNAL OF HEPATOLOGY 2001 34 321-329
78,AEDTNVSLI,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SYNTHETIC,P23700,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
79,AEMGKGSFY,1.0,n/a,Mamu-A*11,CLASS-I,RHESUS,SELF PEPTIDE,Q05639,JOURNAL OF IMMUNOLOGY 2000 164 283-291
80,AENENMRTM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P26065,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
81,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P26065,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
82,AESKSVII,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,PARASITE,P13664,INFECTION AND IMMUNITY 1999 67 6358-6363
83,AESTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
84,AFDERRNKY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03467,IMMUNOGENETICS 1997 45 249-258
85,AFHHVAREL,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20867,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
86,AFLDWHRLF,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,SELF PEPTIDE,P14679,IMMUNOGENETICS 1996 44 233-241
87,AFLDWHRLFL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,SELF PEPTIDE,P14679,IMMUNOGENETICS 1996 44 233-241
88,AFPYDINQML,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
89,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
90,AFSPEVIPM,3.0,A*2601,HLA-A26,CLASS-I,HUMAN,VIRAL,P05888,TISSUE ANTIGENS 1999 54 325-332
91,,,A*2602,HLA-A26,CLASS-I,HUMAN,VIRAL,P05888,TISSUE ANTIGENS 1999 54 325-332
92,,,A*2603,HLA-A26,CLASS-I,HUMAN,VIRAL,P05888,TISSUE ANTIGENS 1999 54 325-332
93,AGAVVGLSPGEQEY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
94,AGLAYYSMVGNWAKV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
95,AGNSAYEYV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P13201,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
96,AGPFGMSRI,1.0,H-2Dd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
97,AGVEAIIRILQQLL,7.0,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P05927,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
98,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P05927,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
99,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P05927,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
100,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P05927,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
101,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P05927,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
102,,,n/a,HLA-DR13,CLASS-I,HUMAN,VIRAL,P05927,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
103,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P05927,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
104,AHLPLWGRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
105,AHLPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
106,AHRPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
107,AHYNIVTF,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03129,IMMUNOLOGY LETTERS 1995 47 1-8
108,AHYNIVTFC,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03129,IMMUNOLOGY LETTERS 1995 47 1-8
109,AIAKAAAAV,3.0,A*0205,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
110,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
111,,,A*0202,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
112,AIAQSSMTK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
113,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
114,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
115,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
116,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
117,AIAWGAWGEV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q02251,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
118,AIEAQQHLL,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20871,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
119,AIFASSMTK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
120,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
121,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
122,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
123,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
124,AIFQASMTK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
125,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
126,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
127,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
128,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
129,AIFQCSMTK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
130,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
131,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
132,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
133,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
134,AIFQRSMTR,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
135,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
136,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
137,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
138,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
139,AIFQSAMTK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
140,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
141,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
142,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
143,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
144,AIFQSSATK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
145,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
146,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
147,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
148,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
149,AIFQSSMAK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
150,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
151,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
152,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
153,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
154,AIFQSSMTA,4.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
155,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
156,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
157,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
158,AIFQSSMTK,12.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
159,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
160,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
161,,,A*1101,HLA-A11,CLASS-I,HUMAN,n/a,not applicable,TISSUE ANTIGENS 2002 59 251-258
162,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
163,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
164,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
165,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
166,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
167,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
168,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
169,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
170,AIFQSSMTKI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
171,AIFQSSMTR,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
172,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
173,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
174,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
175,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
176,AIFQSSMTT,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
177,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
178,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
179,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
180,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
181,AIFQSSMTY,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
182,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
183,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
184,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
185,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
186,AIHNVVHAI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,ALLERGEN,P04721,JOURNAL OF IMMUNOLOGY 2003 170 2719-2726
187,AIIAKFAAL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1999 162 3388-3394
188,AIIDPLIYA,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
189,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
190,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
191,AIIKFAAL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1999 162 3388-3394
192,AIIRILQQL,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05954,JOURNAL OF VIROLOGY 2001 75 1301-1311
193,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P05954,JOURNAL OF VIROLOGY 2001 75 1301-1311
194,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P05954,JOURNAL OF VIROLOGY 2001 75 1301-1311
195,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P05954,JOURNAL OF VIROLOGY 2001 75 1301-1311
196,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P05954,JOURNAL OF VIROLOGY 2001 75 1301-1311
197,AIKKKDSTK,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P04589,HUMAN IMMUNOLOGY 2003 64 245-255
198,AIKKKDSTKW,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
199,AILQSSMTR,4.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
200,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
201,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
202,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
203,AIMDKNIIL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03496,INTERNATIONAL IMMUNOLOGY 1995 7 597-605
204,AIMDKNIML,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03495,INTERNATIONAL IMMUNOLOGY 1995 7 597-605
205,AIMKFHSM,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
206,AIMPRFYPK,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P24024,TISSUE ANTIGENS 2002 59 251-258
207,AIPPSRSM,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
208,AIPPSRSML,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
209,AIYHPQQFV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P17944,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
210,AKFQSSMTK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
211,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
212,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
213,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
214,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
215,AKPYDINQML,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
216,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
217,ALAAAAAAAK,5.0,A*0101,HLA-A1,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
218,,,n/a,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
219,,,n/a,HLA-A11,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
220,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
221,,,A*2401,HLA-A24,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
222,ALAAAAAAK,5.0,A*0101,HLA-A1,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
223,,,n/a,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
224,,,n/a,HLA-A11,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
225,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
226,,,A*2401,HLA-A24,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
227,ALAALITPK,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20877,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
228,ALADAVKVT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P06806,EURO.JOURNAL OF IMMUNOLOGY 2001 31 3602-3611
229,ALAETSYVK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
230,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
231,ALAETSYVKV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
232,ALAHGVRVL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27954,JOURNAL OF HEPATOLOGY 2001 34 321-329
233,ALAIAALEL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
234,ALAIAALELL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
235,ALAKAAAAA,3.0,A*0205,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
236,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
237,,,A*0202,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
238,ALAKAAAAAV,5.0,A*0101,HLA-A1,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
239,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
240,,,A*1101,HLA-A11,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
241,,,A*2401,HLA-A24,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
242,,,A*0301,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
243,ALAKAAAAI,3.0,A*0205,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
244,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
245,,,A*0202,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
246,ALAKAAAAL,3.0,A*0205,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
247,,,A*0201,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
248,,,A*0202,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
249,ALAKAAAAM,3.0,A*0205,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
250,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
251,,,A*0202,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
252,ALAKAAAAN,3.0,A*0205,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
253,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
254,,,A*0202,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
255,ALAKAAAAR,3.0,A*0205,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
256,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
257,,,A*0202,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
258,ALAKAAAAV,8.0,A*0205,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
259,,,A*0101,HLA-A1,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
260,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
261,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
262,,,A*0202,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
263,,,A*1101,HLA-A11,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
264,,,A*2401,HLA-A24,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
265,,,A*0301,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
266,ALCRWGLLL,7.0,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
267,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,INTERNATIONAL JOURNAL OF CANCER 1998 78 202-208
268,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
269,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
270,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
271,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
272,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
273,ALCRWGLLLA,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,INTERNATIONAL JOURNAL OF CANCER 1998 78 202-208
274,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
275,ALDGGNKHFL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802
276,ALDLAKKRV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
277,ALELLPREL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
278,ALFCGCGHEAL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
279,ALFFFDIDL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
280,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
281,ALFFIIFNK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
282,,,A*0301,HLA-A3,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
283,,,A*3101,HLA-A31,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
284,,,A*3301,HLA-A33,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
285,,,A*6801,HLA-A68,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
286,ALFGYPVYV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03409,PROC.NATL.ACAD.SCI. USA 1995 92 4036-4040
287,ALGIIQAQ,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20875,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
288,ALGIIQAQPD,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
289,ALGLVCVQA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
290,ALGLVCVQM,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
291,ALGSTAPPV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P15941,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
292,ALGSTTPPA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P15941,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
293,ALIHHNTHL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,INTERNATIONAL JOURNAL OF CANCER 1998 78 202-208
294,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
295,ALIICNAII,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
296,ALISFLLL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
297,ALLACAGLAY,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
298,,,A*0301,HLA-A3,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
299,,,A*3101,HLA-A31,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
300,,,A*3301,HLA-A33,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
301,,,A*6801,HLA-A68,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
302,ALLAGLVSL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
303,ALLAGLVSLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
304,ALLAVGATK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
305,,,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
306,,,A*3101,HLA-A31,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
307,,,A*3301,HLA-A33,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
308,,,A*6801,HLA-A68,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
309,ALLERASAT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
310,ALLERASATL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
311,ALLGFFPYL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,Q9NPA0,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 47320-47328
312,ALLPSLSHC,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
313,ALLSDWLPA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P46533,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
314,ALMDKSLHV,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
315,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
316,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1995 154 2257-2265
317,ALMPLYACI,9.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03159,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 1047-1058
318,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
319,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
320,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
321,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
322,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
323,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
324,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
325,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
326,ALNFPGSQK,6.0,A*1101,HLA-A11,CLASS-I,HUMAN,n/a,not applicable,TISSUE ANTIGENS 2002 59 251-258
327,,,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
328,,,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
329,,,A*3101,HLA-A31,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
330,,,A*3301,HLA-A33,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
331,,,A*6801,HLA-A68,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
332,ALNKMFBQV,5.0,,,,,,,
333,,,,,,,,,
334,,,,,,,,,
335,,,,,,,,,
336,,,,,,,,,
337,ALNKMFCQL,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
338,,,A*0202,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
339,,,A*0203,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
340,,,A*0206,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
341,,,A*6802,HLA-A68,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
342,ALPGFFPVL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,Q9NPA0,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 47320-47328
343,ALPGFFPYL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,Q9NPA0,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 47320-47328
344,ALPPVAPV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
345,,,A*0202,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
346,,,A*0203,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
347,,,A*0206,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
348,,,A*6802,HLA-A68,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
349,ALPYWNFAT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
350,ALQNAASIAGL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P06806,EURO.JOURNAL OF IMMUNOLOGY 2001 31 3602-3611
351,ALQSLLQHL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
352,ALQSLLQHLI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
353,ALREEEEGV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
354,ALSPFPFDL,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
355,,,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 2001 167 4207-4214
356,ALSTGLIHL,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
357,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF VIROLOGY 1995 69 2462-2470
358,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
359,ALTGTEKL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
360,ALTGTEKLI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
361,ALTPYDGGK,1.0,n/a,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
362,ALTVVWLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
363,ALTVVWLLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
364,ALVARAAVL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
365,ALVEGLRNV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P06806,EURO.JOURNAL OF IMMUNOLOGY 2001 31 3602-3611
366,ALVEICTEM,5.0,*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
367,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
368,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
369,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
370,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
371,ALVEMGHHA,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20882,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
372,ALVGLFVLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
373,ALVLLMLPV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,O86345,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
374,ALVLLMLPVV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,O86345,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
375,ALWGFFPVL,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,Q9NPA0,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 47320-47328
376,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,Q9NPA0,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 47320-47328
377,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,Q9NPA0,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 47320-47328
378,ALWGFVPVL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,Q9NPA0,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 47320-47328
379,ALWGVFPVL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,Q9NPA0,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 47320-47328
380,ALYGALLLA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
381,ALYLLDGLRA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q05861,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
382,ALYVDSLFFL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
383,AMAARTLLL,1.0,n/a,Qa-1b,CLASS-Ib,MOUSE,VIRAL,P31614,JOURNAL OF IMMUNOLOGY 1997 158 3244-3251
384,AMALLRLPLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,O07214,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
385,AMAPATLLL,1.0,n/a,Qa-1b,CLASS-Ib,MOUSE,VIRAL,P31614,JOURNAL OF IMMUNOLOGY 1997 158 3244-3251
386,AMAPRALLL,1.0,n/a,Qa-1b,CLASS-Ib,MOUSE,VIRAL,P31614,JOURNAL OF IMMUNOLOGY 1997 158 3244-3251
387,AMAPRTALL,1.0,n/a,Qa-1b,CLASS-Ib,MOUSE,VIRAL,P31614,JOURNAL OF IMMUNOLOGY 1997 158 3244-3251
388,AMAPRTLAL,1.0,n/a,Qa-1b,CLASS-Ib,MOUSE,VIRAL,P31614,JOURNAL OF IMMUNOLOGY 1997 158 3244-3251
389,AMAPRTLLA,1.0,n/a,Qa-1b,CLASS-Ib,MOUSE,VIRAL,P31614,JOURNAL OF IMMUNOLOGY 1997 158 3244-3251
390,AMFQDPQER,11.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,HUMAN IMMUNOLOGY 1995 44 189-198
391,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,HUMAN IMMUNOLOGY 1995 44 189-198
392,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
393,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
394,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
395,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
396,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
397,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1995 154 5934-5943
398,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
399,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03126,HUMAN IMMUNOLOGY 1995 44 189-198
400,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
401,AMGPRTLLL,1.0,n/a,Qa-1b,CLASS-Ib,MOUSE,VIRAL,P31614,JOURNAL OF IMMUNOLOGY 1997 158 3244-3251
402,AMIENLEYM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
403,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
404,AMKADIQHV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P31953,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
405,AMLGTHTMEV,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,CELLULAR IMMUNOLOGY 2000 204 29-37
406,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
407,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802
408,AMLQDMAIL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P06806,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
409,AMPAYNWMTV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P46533,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
410,AMPMQDIKMI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
411,AMSAARSSR,3.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03126,HUMAN IMMUNOLOGY 1995 44 189-198
412,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03126,HUMAN IMMUNOLOGY 1995 44 189-198
413,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
414,AMVGAVLTA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
415,AMVQAWPFT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
416,AMVQAWPFTC,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
417,AMYPRTLLL,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P14426,JOURNAL OF IMMUNOLOGY 1997 158 3244-3251
418,,,n/a,Qa-1b,CLASS-I,MOUSE,SELF PEPTIDE,P14426,JOURNAL OF IMMUNOLOGY 1997 158 3244-3251
419,ANEGYDAL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,P31681,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
420,ANFQSSMTK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
421,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
422,,,*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
423,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
424,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
425,APAYSRAL,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P04792,JOURNAL OF IMMUNOLOGY 2003 171 22-26
426,APDTRPAPG,4.0,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P15941,JOURNAL OF IMMUNOLOGY 1995 155 4766-4774
427,,,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P15941,JOURNAL OF IMMUNOLOGY 1995 155 4766-4774
428,,,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P15941,JOURNAL OF IMMUNOLOGY 1995 155 4766-4774
429,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P15941,JOURNAL OF IMMUNOLOGY 1995 155 4766-4774
430,APGNYPAL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P04857,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
431,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P04857,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
432,APIFYPPVL,1.0,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P03203,JOURNAL OF MEDICAL VIROLOGY 2004 72 635-645
433,APKRPPSAF,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P26583,JOURNAL OF IMMUNOLOGY 2003 171 22-26
434,APKTPDACL,1.0,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P03222,JOURNAL OF MEDICAL VIROLOGY 2004 72 635-645
435,APPEESFRF,3.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1998 47 256-263
436,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1999 49 819-822
437,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1999 49 819-822
438,APPPSWDQM,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P31634,IMMUNOGENETICS 1999 49 819-822
439,APPSWDQM,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663http://us.expasy.org/cgi-bin/get-sprot-entry,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
440,APPYDINQML,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
441,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
442,APQAPWM,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P01897,JOURNAL OF IMMUNOLOGY 2000 165 5656-5663
443,APQKAGGFL,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P09411,MOLECULAR IMMUNOLOGY 1997 34 273-281
444,APRASRPSL,10.0,A*0101,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
445,,,B*3502,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
446,,,n/a,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
447,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
448,,,A*0302,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
449,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
450,,,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
451,,,B*3503,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
452,,,B*5401,HLA-B54,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
453,,,B*0801,HLA-B8,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
454,APRAWISSL,1.0,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P03184,JOURNAL OF MEDICAL VIROLOGY 2004 72 635-645
455,APRLPDDPI,1.0,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P03203,JOURNAL OF MEDICAL VIROLOGY 2004 72 635-645
456,APRQWPMPL,1.0,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P03203,JOURNAL OF MEDICAL VIROLOGY 2004 72 635-645
457,APRTLVYLL,12.0,A*0101,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P30450,JOURNAL OF IMMUNOLOGY 1995 154 247-259
458,,,B*3502,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P30450,JOURNAL OF IMMUNOLOGY 1995 154 247-259
459,,,n/a,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P30450,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
460,,,n/a,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P30450,JOURNAL OF IMMUNOLOGY 1995 154 247-259
461,,,n/a,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P30450,JOURNAL OF IMMUNOLOGY 1995 154 247-259
462,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P30450,JOURNAL OF IMMUNOLOGY 1995 154 247-259
463,,,A*0302,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P30450,JOURNAL OF IMMUNOLOGY 1995 154 247-259
464,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P30450,JOURNAL OF IMMUNOLOGY 1995 154 247-259
465,,,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P30450,JOURNAL OF IMMUNOLOGY 1995 154 247-259
466,,,B*3503,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P30450,JOURNAL OF IMMUNOLOGY 1995 154 247-259
467,,,B*5401,HLA-B54,CLASS-I,HUMAN,SELF PEPTIDE,P30450,JOURNAL OF IMMUNOLOGY 1995 154 247-259
468,,,B*0801,HLA-B8,CLASS-I,HUMAN,SELF PEPTIDE,P30450,JOURNAL OF IMMUNOLOGY 1995 154 247-259
469,APRTVALTA,12.0,A*0101,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P04440,JOURNAL OF IMMUNOLOGY 1995 154 247-259
470,,,B*3502,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P04440,JOURNAL OF IMMUNOLOGY 1995 154 247-259
471,,,n/a,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P04440,JOURNAL OF IMMUNOLOGY 1995 154 247-259
472,,,n/a,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P04440,JOURNAL OF IMMUNOLOGY 1995 154 247-259
473,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04440,INTERNATIONAL IMMUNOLOGY 1994 7 597-605
474,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04440,JOURNAL OF IMMUNOLOGY 1995 154 247-259
475,,,A*0302,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P04440,JOURNAL OF IMMUNOLOGY 1995 154 247-259
476,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P04440,JOURNAL OF IMMUNOLOGY 1995 154 247-259
477,,,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P04440,JOURNAL OF IMMUNOLOGY 1995 154 247-259
478,,,B*3503,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P04440,JOURNAL OF IMMUNOLOGY 1995 154 247-259
479,,,B*5401,HLA-B54,CLASS-I,HUMAN,SELF PEPTIDE,P04440,JOURNAL OF IMMUNOLOGY 1995 154 247-259
480,,,B*0801,HLA-B8,CLASS-I,HUMAN,SELF PEPTIDE,P04440,JOURNAL OF IMMUNOLOGY 1995 154 247-259
481,APRTVALTAL,5.0,B*3502,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P04440,JOURNAL OF IMMUNOLOGY 1995 154 247-259
482,,,n/a,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P04440,JOURNAL OF IMMUNOLOGY 1995 154 247-259
483,,,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P04440,JOURNAL OF IMMUNOLOGY 1995 154 247-259
484,,,B*3503,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P04440,JOURNAL OF IMMUNOLOGY 1995 154 247-259
485,,,B*5401,HLA-B54,CLASS-I,HUMAN,SELF PEPTIDE,P04440,JOURNAL OF IMMUNOLOGY 1995 154 247-259
486,APTAGAFFF,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P19902,MOLECULAR IMMUNOLOGY 1997 34 273-281
487,APTLWARMI,3.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P26664,IMMUNOGENETICS 1996 43 268-276
488,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P26664,IMMUNOGENETICS 1996 43 268-276
489,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P26664,IMMUNOGENETICS 1996 43 268-276
490,APTYRWGENETDVLL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
491,APVPPPEPL,1.0,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P03197,JOURNAL OF MEDICAL VIROLOGY 2004 72 635-645
492,APYLGWLVF,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P19473,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
493,,,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P19473,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
494,AQPQNGQFI,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
495,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09992,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
496,AQPYDINQML,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
497,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
498,ARDETEFYL,1.0,B*3909,HLA-B39,CLASS-I,HUMAN,SELF PEPTIDE,P18077,TISSUE ANTIGENS 1999 53 227-236
499,ARFFPYYV,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
500,ARFGGVKRI,2.0,B*2704,HLA-B27,CLASS-I,HUMAN,CILIATE,P23750,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 16744-16749
501,,,B*2706,HLA-B27,CLASS-I,HUMAN,CILIATE,P23750,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 16744-16749
502,ARFPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
503,ARLFGIRAK,5.0,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P26373,TISSUE ANTIGENS 1996 48 509-518
504,,,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P26373,JOURNAL OF IMMUNOLOGY 1992 149 1896-1904
505,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P26373,TISSUE ANTIGENS 1996 48 509-518
506,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P25120,ARTHRITIS & RHEUMATISM 1999 42 175-181
507,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P26373,TISSUE ANTIGENS 1996 48 509-518
508,ARLQTALL,2.0,B*3901,HLA-B39,CLASS-I,HUMAN,SELF PEPTIDE,O00626,ARTHRITIS & RHEUMATISM 1999 42 175-181
509,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,O00626http://www.expasy.ch/cgi-bin/get-sprot-entry,ARTHRITIS & RHEUMATISM 1999 42 175-181
510,ARLYGIRAK,11.0,A*0101,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P26373,JOURNAL OF IMMUNOLOGY 1995 154 247-259
511,,,A*0101,HLA-A1,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1994 31 813-822
512,,,n/a,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P26373,JOURNAL OF IMMUNOLOGY 1995 154 247-259
513,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1994 31 813-822
514,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P26373,JOURNAL OF IMMUNOLOGY 1995 154 247-259
515,,,A*0302,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
516,,,A*1101,HLA-A11,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1994 31 813-822
517,,,A*2401,HLA-A24,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1994 31 813-822
518,,,A*0301,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1994 31 813-822
519,,,B*2705,HLA-B27,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
520,,,B*0801,HLA-B8,CLASS-I,HUMAN,SELF PEPTIDE,P26373,JOURNAL OF IMMUNOLOGY 1995 154 247-259
521,ARRGGVKRI,2.0,B*2704,HLA-B27,CLASS-I,HUMAN,CILIATE,P23750,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 16744-16749
522,,,B*2706,HLA-B27,CLASS-I,HUMAN,CILIATE,P23750,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 16744-16749
523,ARRHRIL,1.0,n/a,Mamu-B*03,CLASS-I,RHESUS,VIRAL,P11262,JOURNAL OF IMMUNOLOGY 2000 164 283-291
524,ARRHRILD,1.0,n/a,Mamu-B*03,CLASS-I,RHESUS,VIRAL,P11262,JOURNAL OF IMMUNOLOGY 2000 164 283-291
525,ARRHRILDM,1.0,n/a,Mamu-B*03,CLASS-I,RHESUS,VIRAL,P11262,JOURNAL OF IMMUNOLOGY 2000 164 283-291
526,ARRHRILDMY,1.0,n/a,Mamu-B*03,CLASS-I,RHESUS,VIRAL,P11262,JOURNAL OF IMMUNOLOGY 2000 164 283-291
527,ARRHRILDMYL,1.0,n/a,Mamu-B*03,CLASS-I,RHESUS,VIRAL,P11262,JOURNAL OF IMMUNOLOGY 2000 164 283-291
528,ARRHRILDMYLE,1.0,n/a,Mamu-B*03,CLASS-I,RHESUS,VIRAL,P11262,JOURNAL OF IMMUNOLOGY 2000 164 283-291
529,ARVGGVKRI,2.0,B*2704,HLA-B27,CLASS-I,HUMAN,CILIATE,P23750,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 16744-16749
530,,,B*2706,HLA-B27,CLASS-I,HUMAN,CILIATE,P23750,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 16744-16749
531,ARYWAIRTR,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
532,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
533,ASADKPYSY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,Q06379,IMMUNOGENETICS 1997 45 249-258
534,ASARFSWL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
535,ASFDKAKLK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,P13472,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
536,,,A*0301,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P13472,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
537,ASGVYMGNL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09992,VIROLOGY 1998 240 158-167
538,ASNEDMDTM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,Q07531,JOURNAL OF EXPERIMENTAL MEDICINE 2000 191 1853-1867
539,,,H-2Dd,H-2d,CLASS-I,MOUSE,VIRAL,Q07531,JOURNAL OF EXPERIMENTAL MEDICINE 2000 191 1853-1867
540,ASNENIDTM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,Q07531,JOURNAL OF EXPERIMENTAL MEDICINE 2000 191 1853-1867
541,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,Q07531,JOURNAL OF EXPERIMENTAL MEDICINE 2000 191 1853-1867
542,ASNENMDTM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,Q07531,JOURNAL OF EXPERIMENTAL MEDICINE 2000 191 1853-1867
543,,,H-2Dd,H-2d,CLASS-I,MOUSE,VIRAL,Q07531,JOURNAL OF EXPERIMENTAL MEDICINE 2000 191 1853-1867
544,ASNENMDTT,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,Q07531,JOURNAL OF EXPERIMENTAL MEDICINE 2000 191 1853-1867
545,ASNENMETI,1.0,H-2Dd,H-2d,CLASS-I,MOUSE,VIRAL,P15673,JOURNAL OF IMMUNOLOGICAL METHODS 1994 177 261-268
546,ASNENMETM,8.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P03467,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
547,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P03467,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
548,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P03467,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
549,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P26065,VIROLOGY 1999 256 246-257
550,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
551,,,H-2Dd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,JOURNAL OF IMMUNOLOGICAL METHODS 1994 177 261-268
552,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P03467,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
553,,,n/a,H-2b,CLASS-I,MOUSE,VIRAL,P18277,JOURNAL OF BIOLOGICAL CHEMISTRY 2003 278 46 45135-45144
554,ASNENMRTM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P26065,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
555,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P26065,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
556,ASNENTDTM,1.0,H-2Dd,H-2d,CLASS-I,MOUSE,VIRAL,Q07531,JOURNAL OF EXPERIMENTAL MEDICINE 2000 191 1853-1867
557,ASNESMDTM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,Q07531,JOURNAL OF EXPERIMENTAL MEDICINE 2000 191 1853-1867
558,,,H-2Dd,H-2d,CLASS-I,MOUSE,VIRAL,Q07531,JOURNAL OF EXPERIMENTAL MEDICINE 2000 191 1853-1867
559,ASNETMDTM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,Q07531,JOURNAL OF EXPERIMENTAL MEDICINE 2000 191 1853-1867
560,,,H-2Dd,H-2d,CLASS-I,MOUSE,VIRAL,Q07531,JOURNAL OF EXPERIMENTAL MEDICINE 2000 191 1853-1867
561,ASPFPFDL,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 2001 167 4207-4214
562,ASPPSRSM,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
563,ASPPSRSML,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
564,ASQIYAGIK,2.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
565,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P18802,TISSUE ANTIGENS 2002 59 251-258
566,ASSFSTTINY,1.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43356,PROC.NATL.ACAD.SCI. USA 1994 91 2105-2109
567,ASSLPTTMNY,1.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43357,PROC.NATL.ACAD.SCI. USA 1994 91 2105-2109
568,ASTPESANL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
569,ATAAAAAAAK,5.0,A*0101,HLA-A1,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
570,,,n/a,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
571,,,n/a,HLA-A11,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
572,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
573,,,A*2401,HLA-A24,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
574,ATAAAAAAK,5.0,A*0101,HLA-A1,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
575,,,n/a,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
576,,,n/a,HLA-A11,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
577,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
578,,,A*2401,HLA-A24,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
579,ATAAAAAAR,1.0,n/a,HLA-A68,CLASS-I,HUMAN,VIRAL,P21433,JOURNAL OF IMMUNOLOGY 1999 162 331-337
580,ATAAAIAAR,1.0,n/a,HLA-A68,CLASS-I,HUMAN,VIRAL,P21433,JOURNAL OF IMMUNOLOGY 1999 162 331-337
581,ATAGDGIIELRK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,P35232,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
582,,,A*0301,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P35232,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
583,ATAGDGILELRK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,P35232,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
584,,,A*0301,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P35232,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
585,ATAGDGLIELRK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,P35232,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
586,,,A*0301,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P35232,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
587,ATAGDGLLELRK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,P35232,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
588,,,A*0301,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P35232,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
589,ATAKAAAAAY,5.0,n/a,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
590,,,n/a,HLA-A11,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
591,,,n/a,HLA-A1,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
592,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
593,,,A*2401,HLA-A24,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
594,ATAKAAAAF,1.0,n/a,HLA-A24,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
595,ATAKAAAAY,5.0,n/a,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
596,,,n/a,HLA-A11,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
597,,,n/a,HLA-A1,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
598,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
599,,,A*2401,HLA-A24,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
600,ATAYDINQML,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
601,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
602,ATDFKFAMY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P30279,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
603,ATDKAAAAAY,5.0,n/a,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
604,,,n/a,HLA-A11,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
605,,,n/a,HLA-A1,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
606,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
607,,,A*2401,HLA-A24,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
608,ATDKAAAAY,5.0,n/a,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
609,,,n/a,HLA-A11,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
610,,,n/a,HLA-A1,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
611,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
612,,,A*2401,HLA-A24,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
613,ATEIRASVGK,1.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P15663,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
614,ATFYDINQML,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
615,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
616,ATGFKQSSK,2.0,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P11274,BLOOD 1995 85 2680-2684
617,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P11274,BLOOD 1995 85 2680-2684
618,ATGFKQSSKAL,2.0,n/a,HLA-B8,CLASS-I,HUMAN,CANCER,P11274,BLOOD 1995 85 2680-2684
619,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P11274,BLOOD 1995 85 2680-2684
620,ATGNLPGCSFSIFL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27954,JOURNAL OF HEPATOLOGY 2001 34 321-329
621,ATGRNECDV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
622,ATIGTAMYK,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,TISSUE ANTIGENS 2002 59 251-258
623,ATKYDINQML,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
624,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
625,ATLEEMMTA,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20873,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
626,ATLPLWGRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
627,ATLPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
628,ATLQDIVLH,1.0,A*1102,HLA-A11,CLASS-I,HUMAN,VIRAL,P06788,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
629,ATNADCAWL,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20867,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
630,ATPKDINQML,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
631,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
632,ATPQDLNTM,3.0,A*2601,HLA-A26,CLASS-I,HUMAN,VIRAL,P05888,TISSUE ANTIGENS 1999 54 325-332
633,,,A*2602,HLA-A26,CLASS-I,HUMAN,VIRAL,P05888,TISSUE ANTIGENS 1999 54 325-332
634,,,A*2603,HLA-A26,CLASS-I,HUMAN,VIRAL,P05888,TISSUE ANTIGENS 1999 54 325-332
635,ATPYDIKQML,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
636,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
637,ATPYDINAML,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
638,ATPYDINFML,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
639,ATPYDINIML,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
640,ATPYDINKML,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
641,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
642,ATPYDINNML,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
643,ATPYDINQKL,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
644,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
645,ATPYDINQMA,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
646,ATPYDINQMF,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
647,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
648,ATPYDINQMI,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
649,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
650,ATPYDINQMK,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
651,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
652,ATPYDINQML,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
653,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
654,ATPYDINQMM,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
655,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
656,ATPYDINQMQ,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
657,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
658,ATPYDINQMT,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
659,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
660,ATPYDKNQML,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
661,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
662,ATPYKINQML,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
663,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
664,ATQIPSYKK,1.0,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
665,ATQYDINQML,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
666,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
667,ATRKTTSERQPRGR,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
668,ATRPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
669,ATTYDINQML,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
670,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
671,ATVGIMIGV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
672,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
673,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
674,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
675,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
676,ATVYDINQML,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
677,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
678,ATWGQYWQV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1997 70 302-309
679,ATWIPEWEFV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
680,ATYDKGILTV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P30223,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
681,AVAAVAARR,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,TISSUE ANTIGENS 2002 59 251-258
682,AVAKAAAAV,3.0,A*0205,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
683,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
684,,,A*0202,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 685-693
685,AVCDKCLK,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
686,AVCTRGVAK,2.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
687,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
688,AVDLSHFLK,6.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03405,MOLECULAR IMMUNOLOGY 1994 31 813-822
689,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03405,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
690,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03405,MOLECULAR IMMUNOLOGY 1994 31 813-822
691,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03405,MOLECULAR IMMUNOLOGY 1994 31 813-822
692,,,A*2401,HLA-A24,CLASS-I,HUMAN,VIRAL,P03405,MOLECULAR IMMUNOLOGY 1994 31 813-822
693,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03405,MOLECULAR IMMUNOLOGY 1994 31 813-822
694,AVFDRKSDAK,5.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03203,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
695,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03203,HUMAN IMMUNOLOGY 2000 61 972-984
696,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03203,HUMAN IMMUNOLOGY 2000 61 972-984
697,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03203,HUMAN IMMUNOLOGY 2000 61 972-984
698,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03203,HUMAN IMMUNOLOGY 2000 61 972-984
699,AVFIHNFKP,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P04589,HUMAN IMMUNOLOGY 2003 64 245-255
700,AVFIHNFKR,8.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
701,,,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P04586,HUMAN IMMUNOLOGY 1996 45 79-93
702,,,n/a,HLA-A31,CLASS-I,HUMAN,VIRAL,P04586,HUMAN IMMUNOLOGY 1996 45 79-93
703,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P04586,HUMAN IMMUNOLOGY 1996 45 79-93
704,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P04586,TISSUE ANTIGENS 2002 59 251-258
705,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P04586,HUMAN IMMUNOLOGY 1996 45 79-93
706,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
707,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P04586,HUMAN IMMUNOLOGY 1996 45 79-93
708,AVFIHNFKRK,1.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
709,AVHDTLFYCV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P30234,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
710,AVIGALLAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
711,AVLDGLDVL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
712,AVLDGLDVLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
713,AVLPLWGRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
714,AVLPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
715,AVLPLWVRMG,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
716,AVMDPFIYA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01718,CANCER RESEARCH 1997 57 4348-4355
717,AVMPPILYKK,3.0,A*0301,HLA-A3,CLASS-I,HUMAN,n/a,not applicable,EURO.JOURNAL OF IMMUNOLOGY 2001 31 2986-2996
718,,,A*3101,HLA-A31,CLASS-I,HUMAN,n/a,not applicable,EURO.JOURNAL OF IMMUNOLOGY 2001 31 2986-2996
719,,,A*1101,HLA-A11,CLASS-I,HUMAN,n/a,not applicable,EURO.JOURNAL OF IMMUNOLOGY 2001 31 2986-2996
720,AVNHYFKTR,7.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P12933,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
721,,,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 1996 45 79-93
722,,,n/a,HLA-A31,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 1996 45 79-93
723,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P12933,TISSUE ANTIGENS 2002 59 251-258
724,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 1996 45 79-93
725,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 1996 45 79-93
726,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 1996 45 79-93
727,AVPYDINQML,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
728,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
729,AVRPLWGRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
730,AVRPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
731,AVRPLWVRMG,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
732,AVVLASLIYR,3.0,n/a,HLA-A3,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
733,,,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
734,,,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
735,AVYFCAAGK,2.0,n/a,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
736,,,n/a,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
737,AVYNFAT,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1997 234 62-73
738,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1997 234 62-73
739,AVYNFATC,4.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
740,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1997 234 62-73
741,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
742,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1997 234 62-73
743,AVYNFATCG,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1997 234 62-73
744,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1997 234 62-73
745,AVYNFATCGI,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1997 234 62-73
746,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1997 234 62-73
747,AWCWFGGKW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2002 168 210-219
748,AWVPAHKGIG,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
749,AYADFVYAY,2.0,Cw*0401,HLA-Cw4,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
750,,,Cw*0702,HLA-Cw7,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
751,AYAKAAAAAF,1.0,n/a,HLA-A24,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
752,AYAKAAAAAK,4.0,A*0101,HLA-A1,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
753,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
754,,,A*1101,HLA-A11,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
755,,,A*0301,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
756,AYAKAAAAF,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
757,AYAKAAAAK,3.0,A*0101,HLA-A1,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
758,,,A*1101,HLA-A11,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
759,,,A*0301,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
760,AYFLLKLAGR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
761,AYFQSSMTK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
762,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
763,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
764,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
765,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
766,AYFSVPLDK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03368,TISSUE ANTIGENS 2000 55 296-302
767,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03368,TISSUE ANTIGENS 2000 55 296-302
768,AYFSVPLDKDF,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
769,AYLVSIFLHL,3.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
770,,,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,P09991,IMMUNOGENETICS 2003 54 830-841
771,,,A*2402,HLA-A24,CLASS-I,HUMAN,BACTERIAL,P09991,IMMUNOGENETICS 2003 54 830-841
772,AYQRTRALV,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,FEBS LETTERS 1993 317 49-52
773,AYRAILHI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
774,AYSLTLQGL,1.0,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P04626,BRITISH JOURNAL OF CANCER 2001 84 94-99
775,AYVHMVTHF,1.0,A*2401,HLA-A24,CLASS-I,HUMAN,SELF PEPTIDE,P55061,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
776,BLLWSFQTSA,1.0,,,,,,,
777,CALPFTSAR,6.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,O43504,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
778,,,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P03166,HUMAN IMMUNOLOGY 1996 45 79-93
779,,,n/a,HLA-A31,CLASS-I,HUMAN,VIRAL,P03166,HUMAN IMMUNOLOGY 1996 45 79-93
780,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03166,HUMAN IMMUNOLOGY 1996 45 79-93
781,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03166,HUMAN IMMUNOLOGY 1996 45 79-93
782,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03166,HUMAN IMMUNOLOGY 1996 45 79-93
783,CAPPGYAL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05885,JOURNAL OF VIROLOGY 2001 75 738-749
784,CAPPGYALL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05885,JOURNAL OF VIROLOGY 2001 75 738-749
785,CATKNRDTW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2002 168 210-219
786,CDFNNGITI,3.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
787,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
788,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
789,CGGPPCNIGGVGNNT,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
790,CGIVPALQVCGPVYC,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26662,JOURNAL OF HEPATOLOGY 2001 34 321-329
791,CHIRQIINTW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2002 168 210-219
792,CIDFYSRIR,3.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
793,,,A*1102,HLA-A11,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
794,,,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
795,CKGVNKEYL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P03070,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
796,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P03070,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
797,CLAAGDILAL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16790,CANCER RESEARCH 1999 59 5554-5559
798,CLALSDLLV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
799,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
800,CLERDLQRL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
801,CLGGLLTMV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P13285,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
802,CLIFLLVL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
803,CLQALYVDSL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
804,CLTFGRETV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,CELL 1993 74 929-937
805,CLTSTVQLV,6.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
806,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
807,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
808,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
809,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
810,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
811,CLVGAPFASLC,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
812,CMHLLLEAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,not applicable,CANCER RESEARCH 2000 60 6448-6456
813,CMTWNQMNL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P19544,IMMUNOGENETICS 2000 51 99-107
814,,,A*2402,HLA-A24,CLASS-I,HUMAN,CANCER,P19544,CANCER IMMUNOLOGY IMMUNOTHERAPY 2002 51 614-620
815,CNIGGVGNNTLICPT,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26662,JOURNAL OF HEPATOLOGY 2001 34 321-329
816,CPGYRWMCL,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
817,CPHCGDRTFY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P78395,HUMAN IMMUNOLOGY 2003 64 245-255
818,CPIGENSPL,1.0,n/a,HLA-B7,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
819,CPKDGQPSL,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
820,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
821,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
822,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
823,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
824,CPKVSFEPI,10.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1996 43 268-276
825,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1996 43 268-276
826,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
827,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,HUMAN IMMUNOLOGY 1999 60 177-186
828,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
829,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1996 43 268-276
830,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
831,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
832,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
833,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P12490,HUMAN IMMUNOLOGY 2003 64 211-223
834,CPKVSFEPIPI,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,HUMAN IMMUNOLOGY 1999 60 177-186
835,CPLERFAEL,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
836,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
837,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
838,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
839,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
840,CPSGHAVGI,4.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P26664,IMMUNOGENETICS 1996 43 268-276
841,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P26664,IMMUNOGENETICS 1996 43 268-276
842,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,Q00269http://us.expasy.org/cgi-bin/get-sprot-entry,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
843,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P26664,IMMUNOGENETICS 1996 43 268-276
844,CQLAKTCPV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
845,,,A*0202,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
846,,,A*0203,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
847,,,A*0206,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
848,,,A*6802,HLA-A68,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
849,CRAPRRQGCW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05893,JOURNAL OF IMMUNOLOGY 2002 168 210-219
850,CRFPRAHKY,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05902,JOURNAL OF IMMUNOLOGY 2002 168 210-219
851,CRPIDQFDQGWGPIT,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01404,JOURNAL OF HEPATOLOGY 2001 34 321-329
852,CSAMYVGDLCGSVFL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
853,CSANNSHHYI,3.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
854,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
855,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
856,CSNDKSLVY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P46081,IMMUNOGENETICS 1997 45 249-258
857,CSNSSIVYETADMIM,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26662,JOURNAL OF HEPATOLOGY 2001 34 321-329
858,CSSRRYPNAVYL,2.0,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P26032,VACCINE 2002 20 249-261
859,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P26032,VACCINE 2002 20 249-261
860,CTCGSSDLY,2.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 1997 45 249-258
861,,,n/a,HLA-A1,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
862,CTELKLSDY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P26077,IMMUNOGENETICS 1997 45 249-258
863,CTEMEKEGKI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
864,CTLNFPISPI,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
865,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
866,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
867,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
868,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
869,CTPYDINQ,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
870,CTPYDINQM,3.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
871,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF VIROLOGY 2001 75 738-749
872,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27972,JOURNAL OF VIROLOGY 2001 75 2462-2467
873,CTPYDINQML,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
874,CTPYDINQMLN,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
875,CTWKLPTLA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
876,CVHQRIDVK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P04594,TISSUE ANTIGENS 2000 55 296-302
877,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P04594,TISSUE ANTIGENS 2000 55 296-302
878,CYDAGCAWY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 1997 45 249-258
879,CYSLYGTTL,1.0,A*2401,HLA-A24,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
880,CYTWNQMNL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,CANCER,P19544,CANCER IMMUNOLOGY IMMUNOTHERAPY 2002 51 614-620
881,DADPTGHSY,1.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 10227-10234
882,DAEKEVLVWR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20867,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
883,DAKIRIFDL,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P27635,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
884,DAPPIGGQI,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1997 46 245-248
885,DARAYDTEV,5.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1996 43 268-276
886,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1996 43 268-276
887,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1997 46 245-248
888,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,HUMAN IMMUNOLOGY 1999 60 177-186
889,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1996 43 268-276
890,DAYFSVPL,2.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,HUMAN IMMUNOLOGY 1999 60 177-186
891,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1999 49 819-822
892,DCFRKHPEATYTKCG,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
893,DCKTILKAL,6.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1995 154 247-259
894,,,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1995 154 247-259
895,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1995 154 247-259
896,,,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1995 154 247-259
897,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1995 154 247-259
898,,,B*0801,HLA-B8,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1995 154 247-259
899,DDEEYVIL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,P31682,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
900,DDHRAGKI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,SELF PEPTIDE,P39027,JOURNAL OF IMMUNOLOGY 1994 153 3079-3092
901,DDLLEAR,2.0,n/a,HLA-B8,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 169 3131-3136
902,,,n/a,HLA-B14,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 169 3131-3136
903,DERTVRKI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,SELF PEPTIDE,O14818,JOURNAL OF IMMUNOLOGY 1994 153 3079-3092
904,DESTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
905,DEVINIVII,4.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
906,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
907,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
908,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1999 256 246-257
909,DFAFRDLA,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03126,IMMUNOLOGY LETTERS 1995 47 1-8
910,DFLPSDFFPSV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P17391,JOURNAL OF IMMUNOLOGY 2003 170 2977-2984
911,DFNLPPVVAK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 2000 55 296-302
912,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 2000 55 296-302
913,DFRELNKR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
914,DGLLLKLV,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,SYNTHETIC,not applicable,TISSUE ANTIGENS 2001 57 405-414
915,DGPKVKQWPL,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
916,DGVNYATGNLPGCS,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27954,JOURNAL OF HEPATOLOGY 2001 34 321-329
917,DGYVYQGL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
918,DIAGTTSTL,3.0,A*2601,HLA-A26,CLASS-I,HUMAN,VIRAL,P18800,TISSUE ANTIGENS 1999 54 325-332
919,,,A*2602,HLA-A26,CLASS-I,HUMAN,VIRAL,P18800,TISSUE ANTIGENS 1999 54 325-332
920,,,A*2603,HLA-A26,CLASS-I,HUMAN,VIRAL,P18800,TISSUE ANTIGENS 1999 54 325-332
921,DIEITCVYC,3.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
922,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
923,,,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
924,DIILECVYCK,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
925,DIKMILKMV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
926,DIQTKELQK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 2000 55 296-302
927,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 2000 55 296-302
928,DIRQGPKEPFR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
929,DIYRIFAEL,3.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1994 152 163-175
930,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
931,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
932,DLAARNVLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,CELL 1993 74 929-937
933,DLAFLQGKAR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
934,DLDSTVVAL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,not applicable,CANCER RESEARCH 2000 60 6448-6456
935,DLEIGQHRTK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
936,DLEVTCTWKL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
937,DLFLKEGAC,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
938,DLFVVYRDS,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
939,DLLVGAAAF,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
940,DLLVSGSNV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
941,DLMGYIPLV,8.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
942,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
943,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF VIROLOGY 1995 69 2462-2470
944,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
945,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
946,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
947,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
948,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
949,DLNLGNLNV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
950,DLVFDECGI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
951,DLVFDECGIT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
952,DLVGFLLLK,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
953,DLVGFLLLKY,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
954,DMIVDAIPY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,Q60393,IMMUNOGENETICS 1997 45 249-258
955,DMWEHAFYL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P46728,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
956,DNPKNTLFL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P01783,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
957,,,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P01783,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
958,DPALNMENI,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P17397,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
959,DPCRIKQII,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1997 46 245-248
960,DPCSLQCPY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03383,IMMUNOGENETICS 1998 47 256-263
961,DPDSFQDYI,5.0,n/a,HLA-B51,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
962,,,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
963,,,B*5301,HLA-B53,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
964,,,B*5401,HLA-B54,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
965,,,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
966,DPEIVMHSF,3.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03383,IMMUNOGENETICS 1999 49 819-822
967,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P12490,IMMUNOGENETICS 1998 47 256-263
968,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03383,IMMUNOGENETICS 1999 49 819-822
969,DPEMADVTY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,Q59599,IMMUNOGENETICS 1997 45 249-258
970,DPIFLLHHA,5.0,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
971,,,B*5101,HLA-B51,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
972,,,B*5301,HLA-B53,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
973,,,B*5401,HLA-B54,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
974,,,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
975,DPKVKQWPL,14.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1995 154 247-259
976,,,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1995 154 685-693
977,,,B*3502,HLA-B35,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1995 154 247-259
978,,,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1995 154 247-259
979,,,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1995 154 247-259
980,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1995 154 247-259
981,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1995 154 685-693
982,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1995 154 685-693
983,,,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1995 154 247-259
984,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1995 154 247-259
985,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1995 154 247-259
986,,,B*3503,HLA-B35,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1995 154 247-259
987,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1995 154 247-259
988,,,B*0801,HLA-B8,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1995 154 247-259
989,DPNPQEVVL,2.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1998 47 256-263
990,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1999 49 819-822
991,DPPTDTPLDL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
992,DPPTNTPEAL,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
993,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27971,JOURNAL OF VIROLOGY 2001 75 738-749
994,DPSRGRLGL,6.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P03156 ,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
995,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03156 ,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
996,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03156 ,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
997,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03156 ,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
998,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24024 ,IMMUNOGENETICS 2003 54 830-841
999,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03156 ,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
1000,DPYEVSYRI,5.0,B*3502,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P78543 ,JOURNAL OF IMMUNOLOGY 1995 154 247-259
1001,,,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P78543 ,JOURNAL OF IMMUNOLOGY 1995 154 247-259
1002,,,B*3503,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P78543 ,JOURNAL OF IMMUNOLOGY 1995 154 247-259
1003,,,B*5401,HLA-B54,CLASS-I,HUMAN,SELF PEPTIDE,P78543 ,JOURNAL OF IMMUNOLOGY 1995 154 247-259
1004,,,B*5401,HLA-B54,CLASS-I,HUMAN,SELF PEPTIDE,P78543 ,JOURNAL OF IMMUNOLOGY 1995 154 247-259
1005,DRAHYNIV,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03129 ,IMMUNOLOGY LETTERS 1995 47 1-8
1006,DRAHYNIVT,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03129 ,IMMUNOLOGY LETTERS 1995 47 1-8
1007,DRAHYNIVTF,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03129 ,IMMUNOLOGY LETTERS 1995 47 1-8
1008,DRAHYNIVTFC,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03129 ,IMMUNOLOGY LETTERS 1995 47 1-8
1009,DRNPYENI,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991 ,VIROLOGY 1998 240 158-167
1010,DRNPYENIL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991 ,VIROLOGY 1998 240 158-167
1011,DRYWAIRTR,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277 ,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
1012,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277 ,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
1013,DSDGSFFLY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P01857 ,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
1014,DSGLEVNIVT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
1015,DSTKWRKLVD,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
1016,DTGADDTVL,3.0,A*2601,HLA-A26,CLASS-I,HUMAN,VIRAL,P20892 ,TISSUE ANTIGENS 1999 54 325-332
1017,,,A*2602,HLA-A26,CLASS-I,HUMAN,VIRAL,P20892 ,TISSUE ANTIGENS 1999 54 325-332
1018,,,A*2603,HLA-A26,CLASS-I,HUMAN,VIRAL,P20892 ,TISSUE ANTIGENS 1999 54 325-332
1019,DVKDTKEAL,3.0,A*2601,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349 ,TISSUE ANTIGENS 1999 54 325-332
1020,,,A*2602,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349 ,TISSUE ANTIGENS 1999 54 325-332
1021,,,A*2603,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349 ,TISSUE ANTIGENS 1999 54 325-332
1022,DVRLVHRDL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,CANCER,P04626 ,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427
1023,DYKLVEI,1.0,n/a,Mamu-A*11,CLASS-I,RHESUS,VIRAL,P05885 ,JOURNAL OF IMMUNOLOGY 2000 164 283-291
1024,DYVDRFYKTL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P05888 ,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
1025,DYVDRFYKTLR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873 ,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
1026,EAAGIGIL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655 ,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
1027,EAAGIGILTV,5.0,n/a,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655 ,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427
1028,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655 ,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
1029,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655 ,JOURNAL OF IMMUNOLOGY 1995 154 3961-3968
1030,,,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,Q16655 ,JOURNAL OF IMMUNOLOGY 2003 171 6283-6289
1031,,,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,Q16655 ,JOURNAL OF IMMUNOLOGY 2003 171 6283-6289
1032,EAAGIGILTY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,Q16655 ,JOURNAL OF IMMUNOLOGY 2003 171 6283-6289
1033,EADPTGHSY,10.0,A*0101,HLA-A1,CLASS-I,HUMAN,CANCER,P43355 ,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
1034,,,A*0101,HLA-A1,CLASS-I,HUMAN,CANCER,P43355 ,MOLECULAR IMMUNOLOGY 1994 31 813-822
1035,,,A*0205,HLA-A2,CLASS-I,HUMAN,CANCER,P43355 ,JOURNAL OF IMMUNOLOGY 1995 154 685-693
1036,,,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43355 ,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
1037,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355 ,JOURNAL OF IMMUNOLOGY 1995 154 685-693
1038,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355 ,MOLECULAR IMMUNOLOGY 1994 31 813-822
1039,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P43355 ,JOURNAL OF IMMUNOLOGY 1995 154 685-693
1040,,,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355 ,MOLECULAR IMMUNOLOGY 1994 31 813-822
1041,,,A*2401,HLA-A24,CLASS-I,HUMAN,CANCER,P43355 ,MOLECULAR IMMUNOLOGY 1994 31 813-822
1042,,,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P43355 ,MOLECULAR IMMUNOLOGY 1994 31 813-822
1043,EALQRPVASDF,1.0,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P00519 ,BLOOD 1995 85 2680-2684
1044,EAPQFPHGSSA,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27973 ,JOURNAL OF VIROLOGY 2001 75 738-749
1045,EAQAPWM,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P01897 ,JOURNAL OF IMMUNOLOGY 2000 165 5656-5663
1046,EAYLGKKV,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,SELF PEPTIDE,P11021 ,JOURNAL OF IMMUNOLOGY 1994 153 3079-3092
1047,EEDPVKKV,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,SELF PEPTIDE,Q99020 ,JOURNAL OF IMMUNOLOGY 1994 153 3079-3092
1048,EESTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1049,EFCEMLRL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991 ,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
1050,EFDMSHLNL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991 ,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
1051,EFLWGPRAL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,CANCER,P43357 ,INTERNATIONAL JOURNAL OF CANCER 1999 81 387-394
1052,EFSSEQTR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875 ,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
1053,EGNSSRCWVALTPTL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26662 ,JOURNAL OF HEPATOLOGY 2001 34 321-329
1054,EGRFNDPVEI,3.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991 ,VIROLOGY 1998 240 158-167
1055,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991 ,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
1056,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991 ,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
1057,EIDGPAGQA,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03129 ,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
1058,EIKDTKEAL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888 ,JOURNAL OF IMMUNOLOGY 1994 152 163-175
1059,EILGFVFTK,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429 ,JOURNAL OF IMMUNOLOGY 1994 152 163-175
1060,EILKEPVHGV,2.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P12499 ,JOURNAL OF IMMUNOLOGY 1995 154 567-576
1061,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
1062,EIYKRWIIL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888 ,JOURNAL OF IMMUNOLOGY 1994 152 163-175
1063,EKEVVPDFY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,Q59599 ,IMMUNOGENETICS 1997 45 249-258
1064,ELAENREIL,3.0,A*2601,HLA-A26,CLASS-I,HUMAN,VIRAL,P20892 ,TISSUE ANTIGENS 1999 54 325-332
1065,,,A*2602,HLA-A26,CLASS-I,HUMAN,VIRAL,P20892 ,TISSUE ANTIGENS 1999 54 325-332
1066,,,A*2603,HLA-A26,CLASS-I,HUMAN,VIRAL,P20892 ,TISSUE ANTIGENS 1999 54 325-332
1067,ELAENREILK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
1068,ELAGIGILTV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655 ,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427
1069,ELCCQHLWQI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,ALLERGEN,P04721 ,JOURNAL OF IMMUNOLOGY 2003 170 2719-2726
1070,ELDAPNSHY,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P03469 ,JOURNAL OF IMMUNOLOGY 1994 152 163-175
1071,ELDKWEKIR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873 ,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
1072,ELDKWEKIRLR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873 ,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
1073,ELELAENREI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
1074,ELFPPLFMA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395 ,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
1075,ELFSYLIEKV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395 ,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
1076,ELGRPSMVWL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395 ,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
1077,ELHPDKWTV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05959 ,CELL 1993 74 929-937
1078,ELKKIIGQVR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875 ,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
1079,ELKSKYWAI,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P03467 ,JOURNAL OF IMMUNOLOGY 1994 152 163-175
1080,ELKVKNLEL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P30622 ,JOURNAL OF IMMUNOLOGY 1994 152 163-175
1081,ELLGFQLPPL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16790 ,CANCER RESEARCH 1999 59 5554-5559
1082,ELRHYSDSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06463 ,CELL 1993 74 929-937
1083,ELRQHILLR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875 ,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
1084,ELRRTLKEV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726 ,CANCER RESEARCH 1997 57 4348-4355
1085,ELRSLYNTV,2.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888 ,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
1086,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888 ,JOURNAL OF IMMUNOLOGY 1994 152 163-175
1087,ELRSRYWAI,12.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03467 ,JOURNAL OF IMMUNOLOGY 1995 154 247-259
1088,,,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03467 ,MOLECULAR IMMUNOLOGY 1994 31 813-822
1089,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P03467 ,JOURNAL OF IMMUNOLOGY 1994 152 163-175
1090,,,n/a,HLA-B27,CLASS-I,HUMAN,VIRAL,P03467 ,JOURNAL OF IMMUNOLOGY 1995 154 247-259
1091,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03467 ,MOLECULAR IMMUNOLOGY 1994 31 813-822
1092,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03467 ,JOURNAL OF IMMUNOLOGY 1995 154 247-259
1093,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03467 ,MOLECULAR IMMUNOLOGY 1994 31 813-822
1094,,,A*2401,HLA-A24,CLASS-I,HUMAN,VIRAL,P03467 ,MOLECULAR IMMUNOLOGY 1994 31 813-822
1095,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03467 ,MOLECULAR IMMUNOLOGY 1994 31 813-822
1096,,,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P03467 ,JOURNAL OF IMMUNOLOGY 1995 154 247-259
1097,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P03467 ,JOURNAL OF IMMUNOLOGY 1995 154 247-259
1098,,,B*0801,HLA-B8,CLASS-I,HUMAN,VIRAL,P03467 ,JOURNAL OF IMMUNOLOGY 1995 154 247-259
1099,ELTEVFEFA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06463 ,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
1100,ELVNQIIEQL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
1101,ELVSEFSRV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,CANCER,P04626 ,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427
1102,ELYPLTSLR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873 ,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
1103,EMEKEGKISK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
1104,EMMTACQGV,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20873 ,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
1105,ENILYKVCL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991 ,VIROLOGY 1998 240 158-167
1106,ENITSGFL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P17397 ,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
1107,EPAAPWM,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P01897 ,JOURNAL OF IMMUNOLOGY 2000 165 5656-5663
1108,EPAGIGILTV,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,Q16655 ,JOURNAL OF IMMUNOLOGY 2003 171 6283-6289
1109,EPAGIGILTY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,Q16655 ,JOURNAL OF IMMUNOLOGY 2003 171 6283-6289
1110,EPEPDVAVL,2.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663 ,IMMUNOGENETICS 1998 47 256-263
1111,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663 ,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
1112,EPFKNLKTGKY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P05959 ,AIDS 1996 10 1075-1083
1113,EPFRDYVDRFY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P05888 ,AIDS 1996 10 1075-1083
1114,EPGPVTAQV,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1115,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1116,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1117,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1118,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1119,EPIDKELY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P05888 ,AIDS 1996 10 1075-1083
1120,EPILCPCFM,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P78395 ,HUMAN IMMUNOLOGY 2003 64 245-255
1121,EPILRSLAY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03383 ,IMMUNOGENETICS 1998 47 256-263
1122,EPIVGAETF,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03368 ,IMMUNOGENETICS 1999 49 819-822
1123,EPIVGAETFY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03368 ,IMMUNOGENETICS 1999 49 819-822
1124,EPLDLPQII,4.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P26663 ,IMMUNOGENETICS 1996 43 268-276
1125,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P26663 ,IMMUNOGENETICS 1996 43 268-276
1126,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663 ,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
1127,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P26663 ,IMMUNOGENETICS 1996 43 268-276
1128,EPPFLWMGY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P05959 ,AIDS 1996 10 1075-1083
1129,EPQAAWM,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P01897 ,JOURNAL OF IMMUNOLOGY 2000 165 5656-5663
1130,EPQAPAM,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P01897 ,JOURNAL OF IMMUNOLOGY 2000 165 5656-5663
1131,EPQAPWA,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P01897 ,JOURNAL OF IMMUNOLOGY 2000 165 5656-5663
1132,EPQAPWM,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P01897 ,JOURNAL OF IMMUNOLOGY 2000 165 5656-5663
1133,EPQAPWME,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P01897 ,JOURNAL OF IMMUNOLOGY 2000 165 5656-5663
1134,EPQAPWMEQ,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P01897 ,JOURNAL OF IMMUNOLOGY 2000 165 5656-5663
1135,EPQAPWMEQE,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P01897 ,JOURNAL OF IMMUNOLOGY 2000 165 5656-5663
1136,EPQARWM,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P01897 ,JOURNAL OF IMMUNOLOGY 2000 165 5656-5663
1137,EPRAPWM,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P01897 ,JOURNAL OF IMMUNOLOGY 2000 165 5656-5663
1138,EPRDLDQRPY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,Q00269http://us.expasy.org/cgi-bin/get-sprot-entry ,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
1139,EPRYTYWQL,1.0,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P03227 ,JOURNAL OF MEDICAL VIROLOGY 2004 72 635-645
1140,EPVHEVYY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03369 ,AIDS 1996 10 1075-1083
1141,EPYTTGGTHGRAAHG,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,O72264 ,JOURNAL OF HEPATOLOGY 2001 34 321-329
1142,ERMASCRPIDQFDQG,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01404 ,JOURNAL OF HEPATOLOGY 2001 34 321-329
1143,ERYLKDQQL,2.0,n/a,Gogo-B*0101,CLASS-I,GORILLA,VIRAL,P20871 ,JOURNAL OF IMMUNOLOGY 2001 166 3334-3344
1144,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P20871 ,JOURNAL OF IMMUNOLOGY 1994 152 163-175
1145,ERYWAIRTR,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277 ,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
1146,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277 ,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
1147,ESEDFSSL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P35689 ,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
1148,ESLFRAVITK,9.0,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P43355 ,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
1149,,,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355 ,TISSUE ANTIGENS 2002 59 251-258
1150,,,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355 ,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
1151,,,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355 ,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
1152,,,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P43355 ,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
1153,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355 ,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
1154,,,A*3101,HLA-A31,CLASS-I,HUMAN,CANCER,P43355 ,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
1155,,,A*3301,HLA-A33,CLASS-I,HUMAN,CANCER,P43355 ,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
1156,,,A*6801,HLA-A68,CLASS-I,HUMAN,CANCER,P43355 ,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
1157,ETDIIIDRSEY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
1158,ETDIILDRSEY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
1159,ETDILIDRSEY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
1160,ETDILLDRSEY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
1161,ETDLIIDRSEY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
1162,ETDLILDRSEY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
1163,ETDLLIDRSEY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
1164,ETDLLLDRSEY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
1165,ETFKAVLDGL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395 ,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
1166,ETFSGVYKK,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,n/a,not applicable,TISSUE ANTIGENS 2002 59 251-258
1167,ETIIPDWSY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
1168,ETILPDWSY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
1169,ETKLGKAGY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P05961 ,IMMUNOGENETICS 1997 45 249-258
1170,ETKLGKAGYV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
1171,ETLEEITGY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,CANCER,P04626 ,IMMUNOGENETICS 1997 45 249-258
1172,ETLIPDWSY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
1173,ETLSITNCRL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395 ,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
1174,ETLSPTCTY,2.0,n/a,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P01781 ,CANCER RESEARCH 2001 61 5145-5152
1175,,,n/a,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P01781 ,CANCER RESEARCH 2001 61 5145-5152
1176,ETPGIRYQY,4.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03368 ,IMMUNOGENETICS 1997 45 249-258
1177,,,A*2601,HLA-A26,CLASS-I,HUMAN,VIRAL,P03368 ,TISSUE ANTIGENS 1999 54 325-332
1178,,,A*2602,HLA-A26,CLASS-I,HUMAN,VIRAL,P03368 ,TISSUE ANTIGENS 1999 54 325-332
1179,,,A*2603,HLA-A26,CLASS-I,HUMAN,VIRAL,P03368 ,TISSUE ANTIGENS 1999 54 325-332
1180,ETSYVKVLEY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,CANCER,P43355 ,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
1181,ETTDLYCY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03129 ,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
1182,ETWETWWTEY,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
1183,EVAPPEYHR,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q9UBU8 ,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
1184,EVAPPEYHRK,1.0,n/a,HLA-A68,CLASS-I,HUMAN,VIRAL,P21433 ,JOURNAL OF IMMUNOLOGY 1999 162 331-337
1185,EVDPIGHLY,2.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43357 ,PROC.NATL.ACAD.SCI. USA 1994 91 2105-2109
1186,,,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P43357 ,JOURNAL OF IMMUNOLOGY 2003 171 6283-6289
1187,EVDPIGHVY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P43360 ,JOURNAL OF IMMUNOLOGY 2003 171 6283-6289
1188,EVFCVQPEK,1.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958 ,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
1189,EVIPMFSAL,3.0,A*2601,HLA-A26,CLASS-I,HUMAN,VIRAL,P03350 ,TISSUE ANTIGENS 1999 54 325-332
1190,,,A*2602,HLA-A26,CLASS-I,HUMAN,VIRAL,P03350 ,TISSUE ANTIGENS 1999 54 325-332
1191,,,A*2603,HLA-A26,CLASS-I,HUMAN,VIRAL,P03350 ,TISSUE ANTIGENS 1999 54 325-332
1192,EVNIVTDSQY,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
1193,EVYDFAFR,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03126 ,IMMUNOLOGY LETTERS 1995 47 1-8
1194,EVYDFAFRD,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03126 ,IMMUNOLOGY LETTERS 1995 47 1-8
1195,EVYDFAFRDL,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03126 ,IMMUNOLOGY LETTERS 1995 47 1-8
1196,EVYDFAFRDLA,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03126 ,IMMUNOLOGY LETTERS 1995 47 1-8
1197,EWFRNVLSI,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P26121 ,MOLECULAR IMMUNOLOGY 1996 33 1323-1333
1198,EYLQLVFGI,1.0,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P43356 ,CLINICAL CANCER RESEARCH 1999 5 2236-2241
1199,EYWQATWI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368 ,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
1200,EYWQATWIPE,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
1201,FAAPQFSLW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05897 ,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1202,FACSAVPVYI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905 ,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
1203,FAFGFFPVL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 47320-47328
1204,FAFGFFPYL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 47320-47328
1205,FAFKDLFVV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06463 ,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
1206,FAFKYAAAF,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1207,FAFPGELL,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,SYNTHETIC,not applicable,TISSUE ANTIGENS 2001 57 405-414
1208,FAFRDLCIV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126 ,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
1209,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126 ,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
1210,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126 ,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
1211,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126 ,JOURNAL OF IMMUNOLOGY 1995 154 5934-5943
1212,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126 ,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
1213,FAFWAFVV,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,SYNTHETIC,not applicable,TISSUE ANTIGENS 2001 57 405-414
1214,FALGFFPYL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 47320-47328
1215,FALISFLL,1.0,H-2Dd,H-2d,CLASS-I,MOUSE,VIRAL,P09991 ,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
1216,FAMPNFQTL,2.0,Cw*0401,HLA-Cw4,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
1217,,,Cw*0702,HLA-Cw7,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
1218,FAPGFFPYL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,Q9NPA0 ,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 47320-47328
1219,,,A*0201,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 47320-47328
1220,FAPGKYPAL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P04857 ,JOURNAL OF IMMUNOLOGY 1999 162 3388-3394
1221,FAPGNYPAL,13.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P04857 ,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
1222,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P04857 ,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
1223,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P04857 ,BIOCHEMISTRY 1998 37 3001-3012
1224,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P04857 ,BIOCHEMISTRY 1998 37 3001-3012
1225,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P04857 ,BIOCHEMISTRY 1998 37 3001-3012
1226,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P04857 ,BIOCHEMISTRY 1998 37 3001-3012
1227,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P04857 ,EURO.JOURNAL OF IMMUNOLOGY 2001 31 2986-2996
1228,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P06161 ,IMMUNITY 2001 14 231-242
1229,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P06161 ,IMMUNITY 2001 14 231-242
1230,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P04857 ,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
1231,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P04857 ,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
1232,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P04857 ,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
1233,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P06161 ,IMMUNITY 2001 14 231-242
1234,FAPQNGQFI,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991 ,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1235,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09992 ,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1236,FASTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1237,FATCLGLSY,1.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43357 ,PROC.NATL.ACAD.SCI. USA 1994 91 2105-2109
1238,FAVDGAANR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03366 ,TISSUE ANTIGENS 2000 55 296-302
1239,FAVRPQVPL,6.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P03405 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1240,,,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1241,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1242,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1243,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1244,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1245,FAVRPQVPM,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03405 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1246,FAVRPQVPV,1.0,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03405 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1247,FAVRPQVPW,1.0,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03405 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1248,FAWGFFPVL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 47320-47328
1249,FAWGFFPYL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 47320-47328
1250,FCGVNSDTV,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P03468 ,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
1251,FDEKNQDKY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,Q06379 ,IMMUNOGENETICS 1997 45 249-258
1252,FDFKYAAAF,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1253,FDPSDYFPSV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495 ,HUMAN IMMUNOLOGY 1997 58 12-20
1254,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495 ,HUMAN IMMUNOLOGY 1997 58 12-20
1255,FDSTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1256,FDVDGAANR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P04589 ,TISSUE ANTIGENS 2000 55 296-302
1257,FDVRPQVPL,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1258,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1259,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1260,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1261,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1262,FEANGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03452 ,JOURNAL OF IMMUNOLOGY 1994 153 3079-3092
1263,FEATGNLN,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1264,FEDPTRRPY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03126 ,IMMUNOGENETICS 1997 45 249-258
1265,FEDTGNLN,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1266,FEETGNLN,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1267,FEFTGNLN,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1268,FEGTGNLN,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1269,FEHTGNLN,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1270,FEITGNLN,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1271,FEKTGNLN,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1272,FELRFKQYL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P98083 ,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
1273,FELTGNLN,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1274,FEMTGNLN,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1275,FENTGNLN,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1276,FEPTGNLN,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1277,FEQTGNLN,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1278,FERTGNLN,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1279,FESAGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1280,FESDGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1281,FESEGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1282,FESFGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1283,FESGGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1284,FESHGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1285,FESIGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1286,FESKGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1287,FESLGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1288,FESMGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1289,FESNGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1290,FESPGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1291,FESQGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1292,FESRGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1293,FESSGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1294,FESTANLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1295,FESTDNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1296,FESTENLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1297,FESTFNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1298,FESTGALI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1299,FESTGDLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1300,FESTGELI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1301,FESTGFLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1302,FESTGGLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1303,FESTGHLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1304,FESTGILI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1305,FESTGKLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1306,FESTGLLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1307,FESTGMLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1308,FESTGNAI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1309,FESTGNDI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1310,FESTGNEI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1311,FESTGNFI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1312,FESTGNGI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1313,FESTGNHI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1314,FESTGNII,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1315,FESTGNKI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1316,FESTGNLA,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1317,FESTGNLD,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1318,FESTGNLE,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1319,FESTGNLF,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1320,FESTGNLG,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1321,FESTGNLH,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1322,FESTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1323,FESTGNLK,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1324,FESTGNLL,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1325,FESTGNLM,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1326,FESTGNLN,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1327,FESTGNLP,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1328,FESTGNLQ,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1329,FESTGNLR,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1330,FESTGNLS,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1331,FESTGNLT,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1332,FESTGNLV,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1333,FESTGNLW,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1334,FESTGNLY,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1335,FESTGNMI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1336,FESTGNNI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1337,FESTGNPI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1338,FESTGNQI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1339,FESTGNRI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1340,FESTGNSI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1341,FESTGNTI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1342,FESTGNVI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1343,FESTGNWI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1344,FESTGNYI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1345,FESTGPLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1346,FESTGQLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1347,FESTGRLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1348,FESTGSLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1349,FESTGTLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1350,FESTGVLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1351,FESTGWLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1352,FESTGYLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1353,FESTHNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1354,FESTINLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1355,FESTKNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1356,FESTLNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1357,FESTMNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1358,FESTNNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1359,FESTPNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1360,FESTQNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1361,FESTRNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1362,FESTSNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1363,FESTTNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1364,FESTVNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1365,FESTWNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1366,FESTYNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1367,FESVGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1368,FESWGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1369,FESYGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1370,FETTGNLN,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1371,FEVTGNLN,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1372,FEWTGNLN,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1373,FEYTGNLN,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1374,FFPSDYFPSV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1375,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1376,FFSTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1377,FFVDGAANR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03366,TISSUE ANTIGENS 2000 55 296-302
1378,FFVRPQVPL,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1379,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1380,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1381,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1382,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1383,FGIDNFEFI,2.0,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P23298,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1384,,,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P23298,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1385,FGPQDIDEL,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P54279,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
1386,FGPSNWHFM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,CANCER,P25118,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1387,,,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P25118,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1388,FGSTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1389,FGVRPQVPL,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1390,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1391,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1392,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1393,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1394,FHEAVQAVW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1395,FHFKYAAAF,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1396,FHLPVEKDVW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05897,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1397,FHSTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1398,FIAGNSAYE,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P13201,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
1399,FIDSYICQV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,IMMUNITY 1997 6 273-281
1400,FIFQSSMTK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
1401,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
1402,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
1403,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
1404,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
1405,FIIFLFIL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
1406,FILLLCLIFL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
1407,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q02317,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
1408,FILVNLLIFH,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
1409,,,A*0301,HLA-A3,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
1410,,,A*3101,HLA-A31,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
1411,,,A*3301,HLA-A33,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
1412,,,A*6801,HLA-A68,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
1413,FIMIVGGLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P19550,AIDS RESEARCH HUMAN RETROVIRUSES 1998 14 1669-1678
1414,FIPSDYFPSV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1415,,,*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1416,FIPVEVLVDL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
1417,FISTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1418,FIYAGSLSA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P31952,JOURNAL OF IMMUNOLOGY 2000 165 6463-6471
1419,FIYAGSLSAL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P31952,JOURNAL OF IMMUNOLOGY 2000 165 6463-6471
1420,FKDLFVVYR,4.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
1421,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
1422,,,A*1102,HLA-A11,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
1423,,,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
1424,FKFKYAAAF,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1425,FKPSDYFPSV,10.0,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1426,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1427,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1428,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1429,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1430,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1431,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1432,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1433,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1434,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1435,FKQSSKALQR,2.0,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P11274,BLOOD 1995 85 2680-2684
1436,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P11274,BLOOD 1995 85 2680-2684
1437,FKSTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1438,FKVRPQVPL,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1439,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1440,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1441,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1442,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1443,FLAGALLLA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
1444,FLALIICNA,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
1445,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
1446,FLAMLVLMA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
1447,FLCKQYLNL,4.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03155,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
1448,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03155,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
1449,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
1450,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
1451,FLCWGPFFL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
1452,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
1453,FLDEVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,CANCER IMMUNOLOGY IMMUNOTHERAPY 2003 52 199-206
1454,FLDPRPLTV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,Q16678,BLOOD 2003 102 3287-3294
1455,FLDQVPFSV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,CANCER IMMUNOLOGY IMMUNOTHERAPY 2003 52 199-206
1456,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
1457,FLDQWWTEY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P46081,IMMUNOGENETICS 1997 45 249-258
1458,FLENFVRSSNL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P31952,JOURNAL OF IMMUNOLOGY 2000 165 6463-6471
1459,FLEPGPVTA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
1460,FLFESLAFL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04626,CANCER IMMUNOLOGY IMMUNOTHER 2004 53 307-314
1461,FLFEVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,CANCER IMMUNOLOGY IMMUNOTHERAPY 2003 52 199-206
1462,FLFGSLAFL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04626,CANCER IMMUNOLOGY IMMUNOTHER 2004 53 307-314
1463,FLGGTPVCL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
1464,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P17399,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
1465,FLGKIWPS,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20873,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
1466,FLGKIWPSY,3.0,A*2601,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
1467,,,A*2602,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
1468,,,A*2603,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
1469,FLHLTLIVL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
1470,FLHPSMPV,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,Q8XBW0,TISSUE ANTIGENS 2001 57 405-414
1471,FLIFFDLFLV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
1472,,,A*0202,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
1473,,,A*0203,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
1474,,,A*0206,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
1475,,,A*6802,HLA-A68,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
1476,FLIIVLVMIA,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
1477,FLKEGACDEL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
1478,FLKENKLNK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
1479,,,A*0301,HLA-A3,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
1480,,,A*3101,HLA-A31,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
1481,,,A*3301,HLA-A33,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
1482,,,A*6801,HLA-A68,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
1483,FLKSDYFPSV,8.0,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1484,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1485,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1486,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1487,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1488,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1489,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1490,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1491,FLLADERVRV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P46401,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
1492,FLLAQFTSAI,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03159,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 1047-1058
1493,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
1494,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
1495,FLLFFEFLLV,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z7H7,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
1496,FLLLADARV,8.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
1497,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
1498,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF VIROLOGY 1995 69 2462-2470
1499,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
1500,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
1501,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
1502,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
1503,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
1504,FLLLGLWGFA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,P18269,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
1505,FLLMWITQV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78358,JOURNAL OF IMMUNOTHERAPY 2001 24 1-9
1506,FLLPDAQSI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P15712,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
1507,FLLRWEQEI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
1508,FLLSLGIHL,12.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03159,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 1047-1058
1509,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
1510,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
1511,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
1512,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
1513,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
1514,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
1515,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
1516,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
1517,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
1518,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
1519,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
1520,FLLTRILTI,7.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P17397,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
1521,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P17397,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
1522,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
1523,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P17397,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
1524,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03140,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
1525,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03138,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
1526,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03140,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
1527,FLMPVEDVFI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P31501,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
1528,FLNTLSFVC,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06788,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
1529,FLPADFFPSI,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24023,JOURNAL OF EXPERIMENTAL MEDICINE 1994 180 933-943
1530,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,NATURE 1994 369 6479 407-410
1531,FLPADFFPSV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24023,JOURNAL OF EXPERIMENTAL MEDICINE 1994 180 933-943
1532,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,NATURE 1994 369 6479 407-410
1533,FLPKDYFPSV,8.0,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1534,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1535,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1536,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1537,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1538,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1539,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1540,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1541,FLPNDFFPSA,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24023,JOURNAL OF EXPERIMENTAL MEDICINE 1994 180 933-943
1542,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,NATURE 1994 369 6479 407-410
1543,FLPNDFFPSV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24023,JOURNAL OF EXPERIMENTAL MEDICINE 1994 180 933-943
1544,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,NATURE 1994 369 6479 407-410
1545,FLPRHRDTGI,1.0,*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P02686,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
1546,FLPRHRDTGIL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
1547,FLPSDCFPSV,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,CANCER RESEARCH 1999 59 5554-5559
1548,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF IMMUNOLOGICAL METHODS 1997 200 89-97
1549,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,CANCER RESEARCH 2000 60 6995-7001
1550,FLPSDDFPSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
1551,FLPSDFFP,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24023,MOLECULAR IMMUNOLOGY 1994 31 813-822
1552,FLPSDFFPEV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,JOURNAL OF IMMUNOLOGY 1999 162 3915-3925
1553,FLPSDFFPS,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24023,MOLECULAR IMMUNOLOGY 1994 31 813-822
1554,FLPSDFFPSA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24023,JOURNAL OF EXPERIMENTAL MEDICINE 1994 180 933-943
1555,FLPSDFFPSI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24023,JOURNAL OF EXPERIMENTAL MEDICINE 1994 180 933-943
1556,FLPSDFFPSV,34.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P24023,MOLECULAR IMMUNOLOGY 1994 31 813-822
1557,,,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF IMMUNOLOGY 1995 154 685-693
1558,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P17391,JOURNAL OF IMMUNOLOGY 2003 170 2977-2984
1559,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24023,MOLECULAR IMMUNOLOGY 1994 31 813-822
1560,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 1995 44 189-198
1561,,,*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146http://www.expasy.ch/cgi-bin/get-sprot-entry,HUMAN IMMUNOLOGY 1995 44 189-198
1562,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,CANCER RESEARCH 2000 60 6448-6456
1563,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 1047-1058
1564,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24023,MOLECULAR IMMUNOLOGY 1994 31 813-822
1565,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1999 60 1013-1017
1566,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
1567,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24023,JOURNAL OF EXPERIMENTAL MEDICINE 1994 180 933-943
1568,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,NATURE 1994 369 6479 407-410
1569,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,JOURNAL OF IMMUNOLOGY 1995 154 685-693
1570,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
1571,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
1572,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
1573,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
1574,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
1575,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
1576,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
1577,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,JOURNAL OF IMMUNOLOGY 1995 154 685-693
1578,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1999 60 1013-1017
1579,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
1580,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1999 60 1013-1017
1581,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P24023,MOLECULAR IMMUNOLOGY 1994 31 813-822
1582,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
1583,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1999 60 1013-1017
1584,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1999 60 1013-1017
1585,,,A*2401,HLA-A24,CLASS-I,HUMAN,VIRAL,P24023,MOLECULAR IMMUNOLOGY 1994 31 813-822
1586,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P24023,MOLECULAR IMMUNOLOGY 1994 31 813-822
1587,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1999 60 1013-1017
1588,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
1589,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
1590,FLPSDFFPSVR,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24023,MOLECULAR IMMUNOLOGY 1994 31 813-822
1591,FLPSDFFPSVRD,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24023,MOLECULAR IMMUNOLOGY 1994 31 813-822
1592,FLPSDKFPSV,8.0,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1593,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1594,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1595,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1596,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1597,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1598,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1599,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1600,FLPSDYFKSV,8.0,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1601,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1602,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1603,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1604,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1605,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1606,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1607,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1608,FLPSDYFPKV,8.0,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1609,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1610,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1611,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1612,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1613,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1614,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1615,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1616,FLPSDYFPSD,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1617,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 1997 58 12-20
1618,FLPSDYFPSF,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1619,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1620,FLPSDYFPSI,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 1997 58 12-20
1621,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1622,FLPSDYFPSK,10.0,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1623,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 1997 58 12-20
1624,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1625,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1626,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1627,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1628,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1629,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1630,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 1997 58 12-20
1631,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1632,FLPSDYFPSL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1633,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1634,FLPSDYFPSP,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1635,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1636,FLPSDYFPSQ,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1637,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1638,FLPSDYFPST,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1639,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1640,FLPSDYFPSV,11.0,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1641,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P17391,EURO.JOURNAL OF IMMUNOLOGY 2001 31 2986-2996
1642,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1643,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1644,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
1645,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1646,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1647,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1648,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1649,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1650,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
1651,FLPSDYKPSV,8.0,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1652,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1653,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1654,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1655,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1656,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1657,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1658,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1659,FLPSKYFPSV,8.0,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1660,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1661,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1662,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1663,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1664,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1665,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1666,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
1667,FLPVDFFPSI,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24023,JOURNAL OF EXPERIMENTAL MEDICINE 1994 180 933-943
1668,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,NATURE 1994 369 6479 407-410
1669,FLPVDFFPSV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24023,JOURNAL OF EXPERIMENTAL MEDICINE 1994 180 933-943
1670,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,NATURE 1994 369 6479 407-410
1671,FLPWHRLFL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
1672,FLPWHRLFLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
1673,FLRGRAYGI,6.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P12977,JOURNAL OF IMMUNOLOGY 1995 154 247-259
1674,,,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P12977,JOURNAL OF IMMUNOLOGY 1995 154 247-259
1675,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P12977,JOURNAL OF IMMUNOLOGY 1995 154 247-259
1676,,,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P12977,JOURNAL OF IMMUNOLOGY 1995 154 247-259
1677,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P12977,JOURNAL OF IMMUNOLOGY 1995 154 247-259
1678,,,B*0801,HLA-B8,CLASS-I,HUMAN,VIRAL,P12977,JOURNAL OF IMMUNOLOGY 1995 154 247-259
1679,FLRGRLDQL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
1680,FLRGRLDQLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
1681,FLRNQPLTFA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
1682,FLSFHISNL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P15941,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
1683,FLSLGLVSL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
1684,FLSLQCLQA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
1685,FLSLQCLQAL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
1686,FLSTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1687,FLTCDANLAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q02251,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
1688,FLTSELPQWL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P31952,JOURNAL OF IMMUNOLOGY 2000 165 6463-6471
1689,FLVRPQVPL,5.0,n/a,HLA-B541,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1690,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1691,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1692,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1693,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1694,FLWGFFPVL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,Q9NPA0,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 47320-47328
1695,FLWGFFPYL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,Q9NPA0,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 47320-47328
1696,FLWGPRALA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
1697,FLWGPRALV,7.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
1698,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
1699,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
1700,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
1701,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
1702,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
1703,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
1704,FLWGPRLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF MOLECULAR BIOLOGY 2001 310 1167-1176
1705,FLYAALLLA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
1706,FLYGAALLA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
1707,FLYGALALA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
1708,FLYGALLAA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
1709,FLYGALLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
1710,FLYGALLLA,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
1711,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
1712,FLYGALRLA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
1713,FLYGALVLA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
1714,FLYGALYLA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
1715,FLYGGLLLA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
1716,FLYNRPLSV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,not applicable,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
1717,,,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,P18269,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
1718,FMDGTMSQV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,MOUSE,P11344,IMMUNOLOGICAL REVIEWS 2002 188 136-146
1719,,,A*0201,HLA-A2,CLASS-I,HUMAN,MOUSE,P11344,JOURNAL OF EXPERIMENTAL MEDICINE 2000 191 1221-1231
1720,FMGAGSKAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,not applicable,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
1721,FMIAATYNFAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
1722,FMPHFFKL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P22777,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
1723,FMSLAGFVRM,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q06861,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
1724,FMSTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1725,FMVDGAANR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03366,TISSUE ANTIGENS 2000 55 296-302
1726,FNDPGPGTY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,Q60393,IMMUNOGENETICS 1997 45 249-258
1727,FNSTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1728,FNVRPQVPL,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1729,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1730,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1731,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1732,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1733,FPASFFIKL,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1734,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1735,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1736,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1737,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1738,FPBRPQVPL,1.0,,,,,,,
1739,FPFCLAFSY,4.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1740,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1741,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1742,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1743,FPFDYAAAF,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1744,FPFKKAAAF,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1745,FPFKYAAAA,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1746,FPFKYAAAD,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1747,FPFKYAAAF,5.0,H-2Ld,H-2d,CLASS-I,MOUSE,n/a,not applicable,IMMUNOGENETICS 2003 54 830-841
1748,,,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1749,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
1750,,,B*0702,HLA-B7,CLASS-I,HUMAN,n/a,not applicable,IMMUNOGENETICS 2003 54 830-841
1751,,,B*0702,HLA-B7,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
1752,FPFKYAAAK,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1753,FPFKYAAAP,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1754,FPFKYAAAQ,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1755,FPFKYAAAT,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1756,FPFKYAAAV,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1757,FPFKYAAKA,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1758,FPFKYAKAF,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1759,FPFKYKAAF,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1760,FPFVLAAII,5.0,n/a,HLA-B51,CLASS-I,HUMAN,PARASITE,O13332,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1761,,,B*3501,HLA-B35,CLASS-I,HUMAN,PARASITE,O13332,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1762,,,B*5301,HLA-B53,CLASS-I,HUMAN,PARASITE,O13332,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1763,,,B*5401,HLA-B54,CLASS-I,HUMAN,PARASITE,O13332,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1764,,,B*0702,HLA-B7,CLASS-I,HUMAN,PARASITE,O13332,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1765,FPGCSFSIF,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P27955,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1766,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P27955,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1767,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P27955,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1768,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P27955,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1769,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P27955,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1770,FPHCLAFSI,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1771,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1772,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1773,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1774,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1775,FPHCLAFSY,7.0,B*1301,HLA-B13,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
1776,,,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1777,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1778,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1779,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1780,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
1781,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1782,FPHCLAFSYM,11.0,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 2003 64 211-223
1783,,,B*1301,HLA-B13,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
1784,,,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
1785,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P12933,IMMUNOGENETICS 2003 54 830-841
1786,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
1787,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
1788,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
1789,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
1790,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P12933,IMMUNOGENETICS 2003 54 830-841
1791,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
1792,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
1793,FPIPSSWAF,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1794,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1795,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1796,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1797,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1798,FPISHLYIL,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1799,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1800,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1801,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1802,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1803,FPISPIETV,9.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 43 268-276
1804,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 43 268-276
1805,,,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1806,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1807,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 43 268-276
1808,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,HUMAN IMMUNOLOGY 1999 60 177-186
1809,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1810,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1811,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1812,FPKAGLLII,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1813,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1814,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1815,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1816,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1817,FPKKYAAAF,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1818,FPPEGVSIW,4.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1819,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1820,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1821,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1822,FPPLFMAAF,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P78395,HUMAN IMMUNOLOGY 2003 64 245-255
1823,FPPSDYFPSV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1824,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
1825,FPRFKFVWV,5.0,n/a,HLA-B51,CLASS-I,HUMAN,PARASITE,O13332,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1826,,,B*3501,HLA-B35,CLASS-I,HUMAN,PARASITE,O13332,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1827,,,B*5301,HLA-B53,CLASS-I,HUMAN,PARASITE,O13332,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1828,,,B*5401,HLA-B54,CLASS-I,HUMAN,PARASITE,O13332,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1829,,,B*0702,HLA-B7,CLASS-I,HUMAN,PARASITE,O13332,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1830,FPRPWLHGL,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20883,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
1831,FPSDSWCYF,5.0,B*3501,HLA-B35,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
1832,,,B*3501,HLA-B35,CLASS-I,HUMAN,n/a,not applicable,JOURNAL OF IMMUNOLOGY 2000 164 4130-4134
1833,,,B*3503,HLA-B35,CLASS-I,HUMAN,CANCER,not applicable,JOURNAL OF IMMUNOLOGY 2000 164 4130-4134
1834,,,B*3503,HLA-B35,CLASS-I,HUMAN,n/a,not applicable,JOURNAL OF IMMUNOLOGY 2000 164 4130-4134
1835,,,B*3503,HLA-B35,CLASS-I,HUMAN,n/a,not applicable,J.EXP.MED 2001 193 1189-1198
1836,FPSTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1837,FPVRPQVPA,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1838,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1839,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1840,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1841,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1842,FPVRPQVPC,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1843,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1844,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1845,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1846,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1847,FPVRPQVPD,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1848,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1849,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1850,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1851,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1852,FPVRPQVPF,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1853,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1854,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1855,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1856,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1857,FPVRPQVPH,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1858,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1859,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1860,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1861,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1862,FPVRPQVPI,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1863,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1864,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1865,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1866,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1867,FPVRPQVPK,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1868,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1869,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1870,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1871,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1872,FPVRPQVPL,29.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P03405,IMMUNOGENETICS 1996 43 268-276
1873,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P03405,IMMUNOGENETICS 1996 43 268-276
1874,,,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P03405,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1875,,,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1876,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P12478,IMMUNOGENETICS 2003 54 830-841
1877,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03405,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
1878,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1879,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1880,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P04604,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1881,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,IMMUNOGENETICS 1999 49 819-822
1882,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03407,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
1883,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03405,HUMAN IMMUNOLOGY 1999 60 177-186
1884,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03405,IMMUNOGENETICS 1996 43 268-276
1885,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03407,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
1886,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03407,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
1887,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1888,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1889,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03405,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1890,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03405,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1891,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1892,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1893,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03407,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
1894,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1895,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1896,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P12478,HUMAN IMMUNOLOGY 2003 64 211-223
1897,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03407,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
1898,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P12478,IMMUNOGENETICS 2003 54 830-841
1899,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03405,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1900,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03405,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
1901,FPVRPQVPM,5.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1902,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1903,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1904,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1905,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1906,FPVRPQVPN,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1907,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1908,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1909,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1910,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1911,FPVRPQVPQ,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1912,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1913,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1914,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1915,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1916,FPVRPQVPT,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1917,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1918,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1919,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1920,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1921,FPVRPQVPV,5.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1922,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1923,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1924,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1925,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1926,FPVRPQVPW,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1927,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1928,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1929,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1930,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1931,FPVRPQVPY,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1932,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1933,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1934,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1935,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1936,FPVTPRVPL,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P05860,JOURNAL OF INFECTIOUS DISEASES 2001 183 928-934
1937,FPYLVAYQA,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P29846,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1938,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P29846,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1939,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P29846,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1940,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P29846,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1941,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P29846,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1942,FQAQNGQFI,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1943,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09992,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1944,FQDPQERPRK,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
1945,FQFKYAAAF,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1946,FQLCNSYDL,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z752,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
1947,FQPANGQFI,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1948,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09992,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1949,FQPQAGQFI,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1950,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09992,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1951,FQPQNAQFI,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1952,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09992,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1953,FQPQNGAFI,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1954,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09992,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1955,FQPQNGQAI,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1956,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09992,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1957,FQPQNGQF,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
1958,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
1959,FQPQNGQFA,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1960,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09992,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1961,FQPQNGQFI,14.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
1962,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09992,VIROLOGY 1998 240 158-167
1963,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
1964,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
1965,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
1966,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
1967,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1998 161 5087-5096
1968,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1999 256 246-257
1969,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1970,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1971,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09992,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1972,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09992,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
1973,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09992,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
1974,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1998 161 5087-5096
1975,FQPQNGQFIH,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
1976,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
1977,FQPQNGQFIHF,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
1978,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
1979,FQPQNGQFIHFY,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
1980,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
1981,FQQLFLNTL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06788,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
1982,FQSTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1983,FQVRPQVPL,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1984,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1985,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1986,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1987,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
1988,FQWMGYELW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05897,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1989,FRDYVDRFY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P05888,AIDS 1996 10 1075-1083
1990,FRFKYAAAF,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1991,FRFPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
1992,FRGPNVVTL,3.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09992,VIROLOGY 1998 240 158-167
1993,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
1994,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
1995,FRSTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
1996,FRVDGAANR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,SYNTHETIC,not applicable,TISSUE ANTIGENS 2000 55 296-302
1997,FRYNGLIHR,12.0,A*0101,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P08526,JOURNAL OF IMMUNOLOGY 1995 154 247-259
1998,,,B*2703,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P46779,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
1999,,,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P46779,TISSUE ANTIGENS 1996 48 509-518
2000,,,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P08526,JOURNAL OF IMMUNOLOGY 1992 149 1896-1904
2001,,,n/a,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P08526,JOURNAL OF IMMUNOLOGY 1995 154 247-259
2002,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P08526,JOURNAL OF IMMUNOLOGY 1995 154 247-259
2003,,,A*0302,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P08526,JOURNAL OF IMMUNOLOGY 1995 154 247-259
2004,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P46779,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
2005,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P46779,TISSUE ANTIGENS 1996 48 509-518
2006,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P08526,JOURNAL OF IMMUNOLOGY 1995 154 247-259
2007,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P46779,TISSUE ANTIGENS 1996 48 509-518
2008,,,B*0801,HLA-B8,CLASS-I,HUMAN,SELF PEPTIDE,P08526,JOURNAL OF IMMUNOLOGY 1995 154 247-259
2009,FRYWAIRTR,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
2010,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
2011,FSIPLDEEF,1.0,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05897,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
2012,FSSTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
2013,FSVDGAANR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03366,TISSUE ANTIGENS 2000 55 296-302
2014,FSVIKDRL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P08278,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
2015,FSVPLDEDFR,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
2016,FSVRPQVPL,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2017,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2018,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2019,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2020,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2021,FTAGEVRRAI,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
2022,FTCLPLGVL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
2023,FTDQVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
2024,FTDVNSIIRY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
2025,FTDVNSILRY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
2026,FTDVNSLIRY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
2027,FTDVNSLLRY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
2028,FTDYYIHWV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
2029,FTEVSIRKY,1.0,n/a,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 620-631
2030,FTFKYAAAF,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2031,FTIFKIRMY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P29846,IMMUNOGENETICS 1997 45 249-258
2032,FTIPSINNET,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
2033,FTPGEVRRAI,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
2034,FTPSDYFPSV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
2035,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
2036,FTPSPVVVGTTDRFG,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
2037,FTSTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
2038,FTVRPQVPL,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2039,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2040,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2041,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2042,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24741,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2043,FVDYNFTIV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,P18269,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
2044,FVEDPNGKY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,Q60393,IMMUNOGENETICS 1997 45 249-258
2045,FVFKYAAAF,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2046,FVNHDFTVV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,not applicable,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
2047,FVNHRFTLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,not applicable,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
2048,FVNTPPLV,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20875,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
2049,FVPSDYFPSV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
2050,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
2051,FVQWFVGL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
2052,FVSTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
2053,FVTWHRYHL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
2054,FVVALIPLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,O86345,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
2055,FVVDGAANR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03366,TISSUE ANTIGENS 2000 55 296-302
2056,FVWLHYYSV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
2057,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
2058,FWEVQLGI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P04589,HUMAN IMMUNOLOGY 2003 64 245-255
2059,FWSTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
2060,FWVDGAANR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03366,TISSUE ANTIGENS 2000 55 296-302
2061,FYCKMNWFL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P27757,JOURNAL OF IMMUNOLOGY 2001 167 655-666
2062,FYCNTTQL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
2063,FYCNTTQLF,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
2064,FYDPMFKYHL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,Q04609,CLINICAL CANCER RESEARCH 2002 8 3885-3892
2065,FYNVDISYL,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P10605,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
2066,FYSRIREL,1.0,A*2401,HLA-A24,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
2067,FYSTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
2068,FYVDGAAND,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03366,TISSUE ANTIGENS 2000 55 296-302
2069,FYVDGAANI,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03366,TISSUE ANTIGENS 2000 55 296-302
2070,FYVDGAANK,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03366,TISSUE ANTIGENS 2000 55 296-302
2071,FYVDGAANR,2.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03366,TISSUE ANTIGENS 2000 55 296-302
2072,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
2073,GAAAFCSAMYVGDLC,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27954,JOURNAL OF HEPATOLOGY 2001 34 321-329
2074,GAARALAHGVRVLR,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27954,JOURNAL OF HEPATOLOGY 2001 34 321-329
2075,GACDELFSYL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
2076,GAFGGVGGV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 163-175
2077,GAPLGGAARALAHG,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27954,JOURNAL OF HEPATOLOGY 2001 34 321-329
2078,GAQGQFPRV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
2079,GCGWAGWLLSPRGS,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27961,JOURNAL OF HEPATOLOGY 2001 34 321-329
2080,GDARLVITTYWGL,7.0,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,Q70623,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
2081,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,Q70623,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
2082,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,Q70623,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
2083,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q70623,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
2084,,,n/a,HLA-DR13,CLASS-I,HUMAN,VIRAL,Q70623,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
2085,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q70623,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
2086,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q70623,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
2087,GDYKLVEI,1.0,n/a,Mamu-A*11,CLASS-I,RHESUS,VIRAL,P05885,JOURNAL OF IMMUNOLOGY 2000 164 283-291
2088,GEFPNKNYL,1.0,n/a,Mamu-A*11,CLASS-I,RHESUS,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2000 164 283-291
2089,GEIYKRWII,7.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1995 154 247-259
2090,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1994 152 163-175
2091,,,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1995 154 247-259
2092,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1995 154 247-259
2093,,,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1995 154 247-259
2094,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1995 154 247-259
2095,,,B*0801,HLA-B8,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1995 154 247-259
2096,GERQNATEI,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P26065,MOLECULAR IMMUNOLOGY 1996 33 1323-1333
2097,GESTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
2098,GEVKNLMEI,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,Q66282,MOLECULAR IMMUNOLOGY 1996 33 1323-1333
2099,GFAILKCNNK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03383,TISSUE ANTIGENS 2000 55 296-302
2100,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03383,TISSUE ANTIGENS 2000 55 296-302
2101,GFKQSSKAL,1.0,n/a,HLA-B8,CLASS-I,HUMAN,CANCER,P11274,BLOOD 1995 85 2680-2684
2102,GFKQSSKALQR,2.0,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P11274,BLOOD 1995 85 2680-2684
2103,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P11274,BLOOD 1995 85 2680-2684
2104,GFKSNFNKI,2.0,H-2Db,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z7H7,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
2105,,,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z7H7,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
2106,GFTKTCGGPPCNIGG,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
2107,GGGFGGGGV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
2108,GGTHGRAAHGLTSLF,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P29846,JOURNAL OF HEPATOLOGY 2001 34 321-329
2109,GIDPNAPTWI,4.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
2110,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
2111,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
2112,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1999 256 246-257
2113,GIFGGGGGA,1.0,n/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
2114,GIFGGGGGV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 163-175
2115,GIFGGVGGV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 163-175
2116,GIFQSSMTK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
2117,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
2118,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
2119,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
2120,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
2121,GIGFGGGGL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
2122,GIGGFGGGL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
2123,GIGGGFGGL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
2124,GIGGGGFGL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
2125,GIGGGGGFL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
2126,GIGGGGGGL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
2127,GIGILTVI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
2128,GIGILTVIL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
2129,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1995 154 2257-2265
2130,GIIQAQPDK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03383,TISSUE ANTIGENS 2000 55 296-302
2131,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03383,TISSUE ANTIGENS 2000 55 296-302
2132,GIKVRQLCKL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
2133,GILGFVFT,1.0,n/a,HLA-B27,CLASS-I,HUMAN,VIRAL,P21429,JOURNAL OF IMMUNOLOGY 1992 149 1896-1904
2134,GILGFVFTE,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429,JOURNAL OF IMMUNOLOGY 1994 152 163-175
2135,GILGFVFTK,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429,JOURNAL OF IMMUNOLOGY 1994 152 163-175
2136,GILGFVFTL,15.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P21429,MOLECULAR IMMUNOLOGY 1994 31 813-822
2137,,,n/a,HLA-B27,CLASS-I,HUMAN,VIRAL,P21429,JOURNAL OF IMMUNOLOGY 1992 149 1896-1904
2138,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429,IMMUNOGENETICS 1998 48 98-107
2139,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429,CANCER RESEARCH 2001 61 5145-5152
2140,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
2141,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429,MOLECULAR IMMUNOLOGY 1994 31 813-822
2142,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
2143,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
2144,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429,JOURNAL OF MOLECULAR BIOLOGY 2001 310 1167-1176
2145,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
2146,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429,INTERNATIONAL IMMUNOLOGY 1995 7 597-605
2147,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
2148,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P21429,MOLECULAR IMMUNOLOGY 1994 31 813-822
2149,,,A*2401,HLA-A24,CLASS-I,HUMAN,VIRAL,P21429,MOLECULAR IMMUNOLOGY 1994 31 813-822
2150,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P21429,MOLECULAR IMMUNOLOGY 1994 31 813-822
2151,GILGFVFTLTV,1.0,n/a,HLA-B27,CLASS-I,HUMAN,VIRAL,P21429,JOURNAL OF IMMUNOLOGY 1992 149 1896-1904
2152,GILLFVFTL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429,HUMAN IMMUNOLOGY 1995 44 189-198
2153,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429,HUMAN IMMUNOLOGY 1995 44 189-198
2154,GILTVILGV,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
2155,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
2156,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1995 154 2257-2265
2157,GILTVILGVL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
2158,GILTVILGVLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
2159,GIPHPAGLK,2.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
2160,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P04589,HUMAN IMMUNOLOGY 2003 64 245-255
2161,GIPHPAGLKK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
2162,GIRFPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,RHESUS,VIRAL,P11262,JOURNAL OF IMMUNOLOGY 2000 164 283-291
2163,GIRPYEILA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,not applicable,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
2164,GITDDQLLA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
2165,GITDDQLLAL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
2166,GIVCPICSQK,2.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
2167,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
2168,GIVSGILLSI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q50097,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
2169,GKDLYYKNY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P09790,IMMUNOGENETICS 1997 45 249-258
2170,GKTPKFKLPI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
2171,GLAANQTGA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
2172,GLACHQLCA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
2173,GLADQLIHL,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20877,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
2174,GLADQLIHM,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20877,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
2175,GLAGTVLRFV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q9CCI3,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
2176,GLAVLAAFL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16790,CANCER RESEARCH 1999 59 5554-5559
2177,GLCFFGVAL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
2178,GLDQRPYCWHYAPQP,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q00269,JOURNAL OF HEPATOLOGY 2001 34 321-329
2179,GLDVLLAQEV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
2180,GLDVLTAKV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P18206,JOURNAL OF EXPERIMENTAL MEDICINE 1996 183 2509-2516
2181,GLEGLIWSQRR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20867,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
2182,GLFGGGGGA,1.0,n/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 163-175
2183,GLFLSLGLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
2184,GLFLTTEAV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P06806,EURO.JOURNAL OF IMMUNOLOGY 2001 31 3602-3611
2185,,,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P06806,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
2186,GLFLTTEAVV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P06806,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
2187,GLFVLLAFL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
2188,GLGFGGGGG,1.0,n/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
2189,GLGGGFGGV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 163-175
2190,GLGGGGFGV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 163-175
2191,GLGGGGGGL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
2192,GLGGGGGGV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
2193,GLGGGVGGV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 163-175
2194,GLGGLGLFFA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q02251,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
2195,GLGQVPLIV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802
2196,GLIMVLSFL,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,P05691,IMMUNITY 1997 7 97-112
2197,,,A*0202,HLA-A2,CLASS-I,HUMAN,PARASITE,P05691,IMMUNITY 1997 7 97-112
2198,,,A*0203,HLA-A2,CLASS-I,HUMAN,PARASITE,P05691,IMMUNITY 1997 7 97-112
2199,,,A*0206,HLA-A2,CLASS-I,HUMAN,PARASITE,P05691,IMMUNITY 1997 7 97-112
2200,,,A*6802,HLA-A68,CLASS-I,HUMAN,PARASITE,P05691,IMMUNITY 1997 7 97-112
2201,GLKGAVTLT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
2202,GLKKKKSVTV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
2203,GLLECCARCLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
2204,GLLETSEGCR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
2205,GLLFAVTSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16790,CANCER RESEARCH 1999 59 5554-5559
2206,GLLGDNQIM,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
2207,GLLGGGGGV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 163-175
2208,GLLGGGVGV,1.0,/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 163-175
2209,GLLGNVSTV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
2210,,,A*0202,HLA-A2,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
2211,,,A*0203,HLA-A2,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
2212,,,A*0206,HLA-A2,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
2213,,,A*6801,HLA-A68,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
2214,GLLGWSPQA,7.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2215,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2216,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2217,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2218,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2219,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2220,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2221,GLMTAVYLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,O86345,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
2222,GLNKIVRMY,3.0,A*2601,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
2223,,,A*2602,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
2224,,,A*2603,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
2225,GLPVEYLQV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P31952,JOURNAL OF IMMUNOLOGY 2000 165 6463-6471
2226,GLPVGGNEK,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P16507,JOURNAL OF IMMUNOLOGY 1994 152 163-175
2227,GLQDCTMLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF VIROLOGY 1995 69 2462-2470
2228,GLRDLAVAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26664,CELL 1993 74 929-937
2229,GLSISGNLL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
2230,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
2231,GLSIVMPV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P31952,JOURNAL OF IMMUNOLOGY 2000 165 6463-6471
2232,GLSNLTHVL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
2233,GLSPTVWLSV,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P31869,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
2234,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P30019,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2235,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2236,GLSRYVARL,11.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03159,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 1047-1058
2237,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03158,JOURNAL OF EXPERIMENTAL MEDICINE 2001 194 833-846
2238,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2239,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2240,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1999 162 3915-3925
2241,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
2242,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
2243,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2244,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2245,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2246,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2247,GLSRYVPRL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03158,JOURNAL OF EXPERIMENTAL MEDICINE 2001 194 833-846
2248,GLTSLFTPG,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01404,JOURNAL OF HEPATOLOGY 2001 34 321-329
2249,GLVCVQAAT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
2250,GLVDFVKHI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q9L7L3,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
2251,GLVSLVENA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
2252,GLYDGMEHL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43363,JOURNAL OF MOLECULAR BIOLOGY 2001 310 1167-1176
2253,GLYGAQYDV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P31848,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
2254,GLYLSQIAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q06861,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
2255,GLYNLLIRC,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
2256,,,A*1102,HLA-A11,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
2257,,,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
2258,GLYRQWALA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P46401,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
2259,GLYSSTVPV,6.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
2260,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
2261,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
2262,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2263,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2264,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
2265,GLYYLTTEV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P47769,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
2266,GMAPRTLLL,1.0,n/a,Qa-1b,CLASS-Ib,MOUSE,VIRAL,P31614,JOURNAL OF IMMUNOLOGY 1997 158 3244-3251
2267,GMGPSLIGL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P31952,JOURNAL OF IMMUNOLOGY 2000 165 6463-6471
2268,GMGSPQILV,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20869,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
2269,GMQNIYIKY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,Q60393,IMMUNOGENETICS 1997 45 249-258
2270,GMQWNSTAF,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P17101,JOURNAL OF IMMUNOLOGY 1994 152 163-175
2271,GMRQNATEI,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P26065,MOLECULAR IMMUNOLOGY 1996 33 1323-1333
2272,GNSNYKAV,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
2273,GPAATLEEM,2.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1998 47 256-263
2274,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P05888,AIDS 1996 10 1075-1083
2275,GPDIYKGV,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
2276,GPKVKQWPI,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P04589,HUMAN IMMUNOLOGY 2003 64 211-223
2277,GPLLVLQAGF,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P31873,IMMUNOGENETICS 2003 54 830-841
2278,GPPPPPPGL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27976,JOURNAL OF VIROLOGY 2001 75 738-749
2279,GPPPPPPPGL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27976,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
2280,GPQFPFTGV,5.0,n/a,HLA-B51,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2281,,,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2282,,,B*5301,HLA-B53,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2283,,,B*5401,HLA-B54,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2284,,,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2285,GPRTAALGLL,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,Q14257,JOURNAL OF IMMUNOLOGY 2003 171 22-26
2286,GPSLYSIL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P17397,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
2287,GPTLIGANA,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2288,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2289,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2290,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2291,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2292,GPVTAQVVL,5.0,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2293,,,B*5101,HLA-B51,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2294,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2295,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2296,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2297,GPVYCFTPSPVVVGT,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01404,JOURNAL OF HEPATOLOGY 2001 34 321-329
2298,GQCHSCCNR,1.0,A*1102,HLA-A11,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
2299,GQYGNPLNK,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,TISSUE ANTIGENS 2002 59 251-258
2300,GRAFVTIGI,2.0,n/a,HLA-B27,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 18472-18477
2301,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P04582,JOURNAL OF IMMUNOLOGICAL METHODS 2001 255 57-66
2302,GRAFVTIGK,3.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1992 149 1896-1904
2303,,,n/a,HLA-B27,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 18472-18477
2304,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P04582,JOURNAL OF IMMUNOLOGICAL METHODS 2001 255 57-66
2305,GRAFVTIGS,2.0,n/a,HLA-B27,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 18472-18477
2306,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P04582,JOURNAL OF IMMUNOLOGICAL METHODS 2001 255 57-66
2307,GRFFVTIGK,2.0,n/a,HLA-B27,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 18472-18477
2308,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P04582,JOURNAL OF IMMUNOLOGICAL METHODS 2001 255 57-66
2309,GRFGTKGLAITF,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q13838,JOURNAL OF IMMUNOLOGY 2001 166 1016-1027
2310,GRFKLIVLY,2.0,n/a,Mamu-B*03,CLASS-I,RHESUS,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2000 164 283-291
2311,,,n/a,Gogo-B*0101,CLASS-I,GORILLA,MISCELLANEOUS,P22237,JOURNAL OF IMMUNOLOGY 2001 166 3334-3344
2312,GRFYGLIGL,2.0,B*2704,HLA-B27,CLASS-I,HUMAN,NEMATODE,Q9UG63,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 16744-16749
2313,,,B*2706,HLA-B27,CLASS-I,HUMAN,NEMATODE,Q9UG63,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 16744-16749
2314,GRHGVFLEL,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q13200,JOURNAL OF IMMUNOLOGY 2001 166 1016-1027
2315,GRIDKPILK,7.0,B*2703,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P25120,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
2316,,,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P25120,TISSUE ANTIGENS 1996 48 509-518
2317,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P25120,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
2318,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P25120,ARTHRITIS & RHEUMATISM 1999 42 175-181
2319,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P25120,JOURNAL OF IMMUNOLOGY 2001 166 1016-1027
2320,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P25120,TISSUE ANTIGENS 1996 48 509-518
2321,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P25120,TISSUE ANTIGENS 1996 48 509-518
2322,GRILSGVVTK,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P04643,JOURNAL OF IMMUNOLOGY 2001 166 1016-1027
2323,GRLTKHTKF,6.0,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q9Y3U8,TISSUE ANTIGENS 1996 48 509-518
2324,,,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q9Y3U8,TISSUE ANTIGENS 1996 48 509-518
2325,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q9Y3U8,TISSUE ANTIGENS 1996 48 509-518
2326,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q9Y3U8,ARTHRITIS & RHEUMATISM 1999 42 175-181
2327,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q9Y3U8,JOURNAL OF IMMUNOLOGY 2001 166 1016-1027
2328,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q9Y3U8,TISSUE ANTIGENS 1996 48 509-518
2329,GRRYGLIGL,2.0,B*2704,HLA-B27,CLASS-I,HUMAN,NEMATODE,Q9UG63,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 16744-16749
2330,,,B*2706,HLA-B27,CLASS-I,HUMAN,NEMATODE,Q9UG63,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 16744-16749
2331,GRVYGLIGL,2.0,B*2704,HLA-B27,CLASS-I,HUMAN,NEMATODE,Q9UG63,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 16744-16749
2332,,,B*2706,HLA-B27,CLASS-I,HUMAN,NEMATODE,Q9UG63,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 16744-16749
2333,GRYSGRKAV,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P08526,JOURNAL OF IMMUNOLOGY 2001 166 1016-1027
2334,GRYWAIRTR,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
2335,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
2336,GSENLKSLY,2.0,n/a,Mamu-A*02,CLASS-I,RHESUS,VIRAL,P05894,JOURNAL OF VIROLOGY 2002 76 11623-11636
2337,,,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05893,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
2338,GSHLEVQGYW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05902,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2339,GSPAIFQYT,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27973,JOURNAL OF VIROLOGY 2001 75 738-749
2340,GSPAIFQYTM,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27973,JOURNAL OF VIROLOGY 2001 75 738-749
2341,GSTAPPAHGV,5.0,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P15941,JOURNAL OF IMMUNOLOGY 1995 155 4766-4774
2342,,,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P15941,JOURNAL OF IMMUNOLOGY 1995 155 4766-4774
2343,,,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P15941,JOURNAL OF IMMUNOLOGY 1995 155 4766-4774
2344,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P15941,JOURNAL OF IMMUNOLOGY 1995 155 4766-4774
2345,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P15941,JOURNAL OF IMMUNOLOGY 1995 155 4766-4774
2346,GSTHVSWPK,6.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
2347,,,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 1996 45 79-93
2348,,,n/a,HLA-A31,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 1996 45 79-93
2349,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 1996 45 79-93
2350,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 1996 45 79-93
2351,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 1996 45 79-93
2352,GSVFLVSQLFTFSPR,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
2353,GSVVGNWQY,1.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43357,PROC.NATL.ACAD.SCI. USA 1994 91 2105-2109
2354,GTATLRLVK,3.0,n/a,HLA-A3,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
2355,,,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
2356,,,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
2357,GTATYLPPY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,not applicable,IMMUNOGENETICS 1997 45 249-258
2358,GTDEIRNIY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
2359,GTDEIRNLY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
2360,GTDELRNIY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
2361,GTDELRNLY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
2362,GTDNSVVLSR,6.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2363,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2364,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
2365,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2366,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2367,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2368,GTDNSVVLSRK,5.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2369,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2370,,,*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2371,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2372,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2373,GTGSGVSSK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
2374,,,A*0301,HLA-A3,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
2375,,,A*3101,HLA-A31,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
2376,,,A*3301,HLA-A33,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
2377,,,A*6801,HLA-A68,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
2378,GTGSGVSSKK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
2379,,,A*0301,HLA-A3,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
2380,,,A*3101,HLA-A31,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
2381,,,A*3301,HLA-A33,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
2382,,,A*6801,HLA-A68,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
2383,GTKVVPRKG,1.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P15663,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
2384,GTLGIVCPI,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
2385,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1995 154 5934-5943
2386,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
2387,GTLVALGL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
2388,GTMTTSIYK,3.0,A*0301,HLA-A3,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
2389,,,A*1101,HLA-A11,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
2390,,,A*1101,HLA-A11,CLASS-I,HUMAN,n/a,not applicable,TISSUE ANTIGENS 2002 59 251-258
2391,GTMTTSLYK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
2392,,,A*0301,HLA-A3,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
2393,GTQCALTRR,1.0,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
2394,GTQLFEDNY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,CANCER,P04626,IMMUNOGENETICS 1997 45 249-258
2395,GTSRNKRGVP,1.0,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
2396,GTTLEQQYNK,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
2397,GTYDYWAGY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P09790,IMMUNOGENETICS 1997 45 249-258
2398,GTYHFTKL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z8N8,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
2399,GVAGALVAFK,18.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
2400,,,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
2401,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
2402,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
2403,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
2404,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
2405,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
2406,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
2407,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
2408,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
2409,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
2410,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
2411,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
2412,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
2413,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
2414,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
2415,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
2416,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
2417,GVENPGGYCL,3.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
2418,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1993 67 2903-2907
2419,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
2420,GVGSPQILV,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20869,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
2421,GVLMKGQHL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
2422,GVMPSHFSR,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,n/a,not applicable,TISSUE ANTIGENS 2002 59 251-258
2423,GVSENIFLK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
2424,,,A*0301,HLA-A3,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
2425,,,A*3101,HLA-A31,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
2426,,,A*3301,HLA-A33,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
2427,,,A*6801,HLA-A68,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
2428,GVTAACSHAGK,1.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03452,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
2429,GVTSAPDTR,2.0,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P15941,JOURNAL OF IMMUNOLOGY 1995 155 4766-4774
2430,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P15941,JOURNAL OF IMMUNOLOGY 1995 155 4766-4774
2431,GVYDGREHTV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43358,JOURNAL OF MOLECULAR BIOLOGY 2001 310 1167-1176
2432,GVYQFKSV,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
2433,GWKGSPAIFQ,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
2434,GWLLSPRGSRPSWG,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
2435,GYCLTKWMI,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
2436,GYCLTKWMIL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
2437,GYELHPDKW,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P04589,HUMAN IMMUNOLOGY 2003 64 245-255
2438,GYIEAEVI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
2439,GYKDGNEYI,3.0,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,P13128,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
2440,,,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,P13128,IMMUNOGENETICS 2003 54 830-841
2441,,,A*2402,HLA-A24,CLASS-I,HUMAN,BACTERIAL,P13128,IMMUNOGENETICS 2003 54 830-841
2442,GYNKAMGFL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,Q53586,JOURNAL OF IMMUNOLOGY 2001 167 655-666
2443,GYSAGERI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
2444,GYSAGERIVDI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
2445,GYSPLSFQTRL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
2446,GYYDAQKLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,Q04609,CLINICAL CANCER RESEARCH 2002 8 3885-3892
2447,HAGPIAPGQMR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
2448,HAIHGLLV,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,SYNTHETIC,not applicable,TISSUE ANTIGENS 2001 57 405-414
2449,HANIEEVAL,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
2450,HDAEFCDM,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
2451,HDAEFCDML,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
2452,HDQLFSLL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,O86164,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
2453,HESTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
2454,HETTFNSI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,SELF PEPTIDE,P02571,JOURNAL OF IMMUNOLOGY 1994 153 3079-3092
2455,HFKVGWAWW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05902,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2456,HGDTPTLHEY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
2457,HIAKNCRAPR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
2458,HIPDVITY,2.0,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P37268,JOURNAL OF IMMUNOLOGY 2000 164 4130-4134
2459,,,B*3501,HLA-B35,CLASS-I,HUMAN,n/a,not applicable,JOURNAL OF IMMUNOLOGY 2000 164 4130-4134
2460,,,B*3503,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P37268,JOURNAL OF IMMUNOLOGY 2000 164 4130-4134
2461,,,B*3503,HLA-B35,CLASS-I,HUMAN,n/a,not applicable,JOURNAL OF IMMUNOLOGY 2000 164 4130-4134
2462,HIVWASRELER,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
2463,HLAVIGALL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
2464,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802
2465,HLDKKKQRFH,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03126,HUMAN IMMUNOLOGY 1995 44 189-198
2466,HLDKKQRFH,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
2467,HLDMLRHLY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,CANCER,P04626,IMMUNOGENETICS 1997 45 249-258
2468,HLEGKVILV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03368,CELL 1993 74 929-937
2469,HLESLFTAV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
2470,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
2471,HLETFKAVL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
2472,HLEVQGYW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05902,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2473,HLFGYSWYK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P06731,CANCER RESEARCH 1999 59 431-435
2474,HLFIAAFV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
2475,HLHAPTGSGK,1.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
2476,HLHLETFKA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
2477,HLHLETFKAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
2478,HLIFCHSKK,1.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
2479,HLIFCHSKKK,1.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
2480,HLIGLSNLT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
2481,HLLVGSSGL,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
2482,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
2483,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
2484,HLNEKRRFH,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
2485,HLPRELIFQV,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27976,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
2486,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27976,JOURNAL OF VIROLOGY 2001 75 738-749
2487,HLPRELIFQVW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05916,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2488,HLSLRGLPV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20977,CELL 1993 74 929-937
2489,HLSTAFARV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16790,CANCER RESEARCH 1999 59 5554-5559
2490,HLVDSGADV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
2491,HLYPVARQR,5.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 1996 45 79-93
2492,,,n/a,HLA-A31,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 1996 45 79-93
2493,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 1996 45 79-93
2494,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 1996 45 79-93
2495,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 1996 45 79-93
2496,HLYQGCQVV,8.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,INTERNATIONAL JOURNAL OF CANCER 1998 78 202-208
2497,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,CELL 1993 74 929-937
2498,,,*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2499,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
2500,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2501,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2502,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2503,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2504,HLYSHPIIL,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P17394,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
2505,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P17394,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
2506,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03159,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 1047-1058
2507,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05486,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
2508,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
2509,HMWNFISGI,6.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
2510,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
2511,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
2512,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
2513,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
2514,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
2515,HPAAMPHLL,11.0,B*1301,HLA-B13,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
2516,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P12933,IMMUNOGENETICS 2003 54 830-841
2517,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2518,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2519,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2520,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2521,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
2522,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 2003 64 211-223
2523,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P12933,IMMUNOGENETICS 2003 54 830-841
2524,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
2525,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2526,HPAAMPHLLV,5.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2527,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2528,,,*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2529,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2530,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2531,HPEATYTKCGSGPWL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
2532,HPEDTGQVF,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P07288,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2533,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P07288,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2534,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P07288,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2535,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P07288,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2536,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P07288,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2537,HPNIEEIAL,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
2538,HPNIEEIGL,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
2539,HPNIEEVAL,3.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 1998 47 256-263
2540,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
2541,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663http://www.expasy.ch/cgi-bin/get-sprot-entry,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
2542,HPQKVTKFM,5.0,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P07288,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2543,,,B*5101,HLA-B51,CLASS-I,HUMAN,CANCER,P07288,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2544,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P07288,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2545,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P07288,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2546,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P07288,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2547,HPSDGKCNL,5.0,n/a,HLA-B7,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
2548,,,B*3501,HLA-B35,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
2549,,,B*5101,HLA-B51,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
2550,,,B*5301,HLA-B53,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
2551,,,B*5401,HLA-B54,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
2552,HPTLFKVL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z6X9,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
2553,HPVHAGPIA,6.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
2554,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
2555,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
2556,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
2557,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P05889,HUMAN IMMUNOLOGY 2003 64 211-223
2558,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
2559,HPYLYRLL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z7Z1,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
2560,HRYPILAGH,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
2561,,,B*2705,HLA-B27,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
2562,HRYWAIRTR,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
2563,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
2564,HSAEALQKY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,Q59599,IMMUNOGENETICS 1997 45 249-258
2565,HSATGFKQSSK,2.0,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P11274,BLOOD 1995 85 2680-2684
2566,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P11274,BLOOD 1995 85 2680-2684
2567,HSAYGEPRK,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
2568,HSNIEEVAL,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
2569,HSPYFPCF,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
2570,HSTYFPCF,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
2571,HTEFEGQVY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P31501,IMMUNOGENETICS 1997 45 249-258
2572,HTLWKAGILY,6.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2573,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2574,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P12933,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
2575,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2576,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2577,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2578,HTLWKAGILYK,7.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2579,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2580,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P12933,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
2581,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P12933,JOURNAL OF IMMUNOLOGY 1999 162 3915-3925
2582,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2583,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2584,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2585,HTMEVTVYHR,1.0,n/a,HLA-A3,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
2586,HTMLCMCCK,2.0,A*1102,HLA-A11,CLASS-I,HUMAN,VIRAL,P06788,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
2587,,,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P06788,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
2588,HTPGCVPCVREGNSS,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
2589,HVDIRTLED,3.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
2590,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1995 154 5934-5943
2591,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2592,HVLSHNSTEK,3.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03445,IMMUNITY 1997 7 97-112
2593,,,A*0301,HLA-A3,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
2594,,,A*6801,HLA-A68,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
2595,HVLSHNSYEK,2.0,A*3101,HLA-A31,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
2596,,,A*3301,HLA-A33,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
2597,HVMNPLETL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
2598,HVSGHRMAWDMMMNW,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01404,JOURNAL OF HEPATOLOGY 2001 34 321-329
2599,HVTNDCSNSSIVYET,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26662,JOURNAL OF HEPATOLOGY 2001 34 321-329
2600,HWGVLAGLAYYSMVG,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
2601,HYCTPAGF,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
2602,HYCTPAGFAI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
2603,HYCTPAGFAIL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
2604,HYISMGTSGL,2.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
2605,,,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,P09991,IMMUNOGENETICS 2003 54 830-841
2606,HYNIVTFC,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03129,IMMUNOLOGY LETTERS 1995 47 1-8
2607,IAARTVEI,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,HUMAN IMMUNOLOGY 1999 60 177-186
2608,IAATYNFAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
2609,IADMGHLKY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,CANCER,P17918,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
2610,IAFPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2611,IAGGVMAVV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,not applicable,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
2612,IAGNSAYEY,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P13201,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
2613,IAKNCRAPR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
2614,IALNFPGSQK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
2615,,,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
2616,,,A*3101,HLA-A31,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
2617,,,A*3301,HLA-A33,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
2618,,,A*6801,HLA-A68,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
2619,IAPGQMREPR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
2620,IATVDSYVI,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P24821,JOURNAL OF IMMUNOLOGY 2003 171 22-26
2621,IDFPKTFGW,2.0,n/a,Gogo-B*0101,CLASS-I,GORILLA,VIRAL,P31818,JOURNAL OF IMMUNOLOGY 2001 166 3334-3344
2622,,,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2623,IDTLTCGFADLMGY,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27954,JOURNAL OF HEPATOLOGY 2001 34 321-329
2624,IEELRQHLLR,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
2625,IEFPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2626,IEGGWTGMI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03452,JOURNAL OF IMMUNOLOGY 1994 153 3079-3092
2627,IEITCVYCK,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
2628,IENLEYM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
2629,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
2630,IESTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
2631,IFALISFLL,3.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
2632,,,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,P09991,IMMUNOGENETICS 2003 54 830-841
2633,,,A*2402,HLA-A24,CLASS-I,HUMAN,BACTERIAL,P09991,IMMUNOGENETICS 2003 54 830-841
2634,IFATCLGLSY,1.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43357,PROC.NATL.ACAD.SCI. USA 1994 91 2105-2109
2635,IFEANGNLI,2.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P28730,IMMUNOGENETICS 2003 54 830-841
2636,,,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P28730,IMMUNOGENETICS 2003 54 830-841
2637,IFFKTSSFL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,O25915,JOURNAL OF IMMUNOLOGY 2001 167 655-666
2638,IFFPKTFGW,2.0,n/a,Gogo-B*0101,CLASS-I,GORILLA,VIRAL,P31818,JOURNAL OF IMMUNOLOGY 2001 166 3334-3344
2639,,,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2640,IFIAGNSAY,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P13201,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
2641,IFQPQNGQFI,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
2642,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
2643,IFSKASEYL,1.0,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P43356,CLINICAL CANCER RESEARCH 1999 5 2236-2241
2644,IFSKASSSL,2.0,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P43357,CANCER RESEARCH 1997 57 4465-4468
2645,,,A*2402,HLA-A24,CLASS-I,HUMAN,CANCER,P43357,INTERNATIONAL JOURNAL OF CANCER 1999 81 387-394
2646,IGFPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2647,IGRFYIQM,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,Q07546,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
2648,IHFPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2649,IHSAFSSL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P12388,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
2650,IIATDIQTK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03383,TISSUE ANTIGENS 2000 55 296-302
2651,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03383,TISSUE ANTIGENS 2000 55 296-302
2652,IIDQVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
2653,IIEDQYNRY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,Q60393,IMMUNOGENETICS 1997 45 249-258
2654,IIFLFILL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
2655,IIFPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2656,IILECVYCK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
2657,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
2658,IIRDYGKQM,3.0,A*2601,HLA-A26,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 1999 54 325-332
2659,,,A*2602,HLA-A26,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 1999 54 325-332
2660,,,A*2603,HLA-A26,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 1999 54 325-332
2661,IIRLHSDASK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
2662,,,A*0301,HLA-A3,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
2663,,,*3101,HLA-A31,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
2664,,,A*3301,HLA-A33,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
2665,,,A*6801,HLA-A68,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
2666,IISALVGIL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 21443-21449
2667,IISALVGIV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 21443-21449
2668,IISAVVGIL,2.0,n/a,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427
2669,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 21443-21449
2670,IISAVVGILL,3.0,n/a,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427
2671,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,INTERNATIONAL JOURNAL OF CANCER 1998 78 202-208
2672,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
2673,IISAVVGIV,2.0,n/a,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427
2674,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 21443-21449
2675,IISCTCPTV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03113,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2676,,,*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03113,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2677,IISFFSPL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
2678,IISHNFCNL,3.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
2679,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
2680,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
2681,IISLWDQSL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P12490,AIDS RESEARCH HUMAN RETROVIRUSES 1998 14 1669-1678
2682,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03377,JOURNAL OF IMMUNOLOGY 1995 155 2232-2239
2683,IKAVYNFATC,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
2684,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
2685,IKFPKTFGW,2.0,n/a,Gogo-B*0101,CLASS-I,GORILLA,VIRAL,P31818,JOURNAL OF IMMUNOLOGY 2001 166 3334-3344
2686,,,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2687,IKKEKVYLAW,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
2688,IKPSNSEDL,3.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
2689,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
2690,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
2691,ILAGYGAGV,8.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
2692,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
2693,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF VIROLOGY 1995 69 2462-2470
2694,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
2695,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
2696,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
2697,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
2698,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
2699,ILALVFGLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16790,CANCER RESEARCH 1999 59 5554-5559
2700,ILAQVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
2701,ILARNLVMV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P18139,IMMUNOGENETICS 1998 48 98-107
2702,ILARNLVPMV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
2703,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
2704,ILCWGELMTL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2705,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2706,ILDEAYVMA,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,INTERNATIONAL JOURNAL OF CANCER 1998 78 202-208
2707,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
2708,ILDKKVEKV,1.0,n/a,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P08238,JOURNAL OF IMMUNOLOGY 1992 149 1896-1904
2709,ILDQVPFSV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,CANCER IMMUNOLOGY IMMUNOTHERAPY 2003 52 199-206
2710,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
2711,ILEQLIKKEK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
2712,ILFPKTFGW,2.0,n/a,Gogo-B*0101,CLASS-I,GORILLA,VIRAL,P31818,JOURNAL OF IMMUNOLOGY 2001 166 3334-3344
2713,,,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2714,ILFQVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
2715,ILFTFLHLA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P30234,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
2716,ILGGWVAAQL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
2717,,,*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
2718,ILGVLLLI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
2719,ILHEPVHGV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P12499,JOURNAL OF EXPERIMENTAL MEDICINE 2001 194 833-846
2720,ILHNGAYSL,7.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,INTERNATIONAL JOURNAL OF CANCER 1998 78 202-208
2721,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2722,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
2723,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2724,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2725,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2726,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2727,ILIKRRQQK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P04626,CANCER RESEARCH 1999 59 431-435
2728,ILKANSFVI,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,not applicable,MOLECULAR IMMUNOLOGY 1996 33 1323-1333
2729,ILKEPVHG,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P12499,JOURNAL OF IMMUNOLOGY 1995 154 567-576
2730,ILKEPVHGV,32.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P20892,MOLECULAR IMMUNOLOGY 1994 31 813-822
2731,,,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1995 154 685-693
2732,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P12499,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427
2733,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P12499,JOURNAL OF IMMUNOLOGY 1995 154 567-576
2734,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,MOLECULAR IMMUNOLOGY 1994 31 813-822
2735,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,HUMAN IMMUNOLOGY 1995 44 189-198
2736,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,HUMAN IMMUNOLOGY 1995 44 189-198
2737,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
2738,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
2739,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
2740,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
2741,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
2742,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P12499,IMMUNOGENETICS 2000 51 99-107
2743,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P12499,JOURNAL OF MOLECULAR BIOLOGY 2001 310 1167-1176
2744,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P12499,JOURNAL OF EXPERIMENTAL MEDICINE 2001 194 833-846
2745,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03368,CELL 1993 74 929-937
2746,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1995 154 685-693
2747,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1999 162 3915-3925
2748,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
2749,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
2750,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1995 154 685-693
2751,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
2752,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
2753,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
2754,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P20892,MOLECULAR IMMUNOLOGY 1994 31 813-822
2755,,,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20875,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
2756,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
2757,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
2758,,,A*2401,HLA-A24,CLASS-I,HUMAN,VIRAL,P20892,MOLECULAR IMMUNOLOGY 1994 31 813-822
2759,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,MOLECULAR IMMUNOLOGY 1994 31 813-822
2760,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
2761,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
2762,ILKEPVHGVY,2.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P12499,JOURNAL OF IMMUNOLOGY 1995 154 567-576
2763,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
2764,ILKMVQLDSI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
2765,ILKQKIADL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P26892,JOURNAL OF IMMUNOLOGY 1994 152 163-175
2766,ILLEDSSGNLV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2767,,,A*0202,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2768,,,A*0203,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2769,,,A*0206,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2770,,,A*6802,HLA-A68,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2771,ILLEPVHGV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P12499,JOURNAL OF EXPERIMENTAL MEDICINE 2001 194 833-846
2772,ILLGIFFLC,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
2773,ILLLCLIFL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2774,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2775,ILLLCLIFLL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P30019,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2776,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2777,ILLLEAGAL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
2778,ILLSIARVV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,O86345,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
2779,ILMQVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
2780,ILRGSVAHK,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P15663,JOURNAL OF IMMUNOLOGY 1994 152 163-175
2781,ILRGTSFVYV,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03159,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 1047-1058
2782,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2783,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2784,ILRNQDDREL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
2785,ILSALVGIL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 21443-21449
2786,ILSALVGIV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 21443-21449
2787,ILSAVVGIL,2.0,n/a,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427
2788,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 21443-21449
2789,ILSAVVGIV,2.0,n/a,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427
2790,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 21443-21449
2791,ILSPFLPL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
2792,ILSPFMPLL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P17398,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2793,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2794,ILSQVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
2795,ILSSLGLPV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P36919,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
2796,ILSTLPETTV,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2797,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
2798,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P12901,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
2799,ILSVSSFLFV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,P05691,IMMUNITY 1997 7 97-112
2800,,,A*0202,HLA-A2,CLASS-I,HUMAN,PARASITE,P05691,IMMUNITY 1997 7 97-112
2801,,,A*0203,HLA-A2,CLASS-I,HUMAN,PARASITE,P05691,IMMUNITY 1997 7 97-112
2802,,,A*0206,HLA-A2,CLASS-I,HUMAN,PARASITE,P05691,IMMUNITY 1997 7 97-112
2803,,,*6802,HLA-A68,CLASS-I,HUMAN,PARASITE,P05691,IMMUNITY 1997 7 97-112
2804,ILTVILGV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
2805,ILTVILGVL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
2806,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1995 154 2257-2265
2807,ILTVILGVLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
2808,ILTVILGVLLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
2809,ILVESPAVL,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20869,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
2810,ILWKDIFHK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P04626,CANCER RESEARCH 1999 59 431-435
2811,ILWQVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
2812,ILYQVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
2813,IMDKNIIL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03496,INTERNATIONAL IMMUNOLOGY 1995 7 597-605
2814,IMDKNIILKA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03496,INTERNATIONAL IMMUNOLOGY 1995 7 597-605
2815,IMDQVPFSV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,CANCER IMMUNOLOGY IMMUNOTHERAPY 2003 52 199-206
2816,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
2817,IMIGHLVGV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF EXPERIMENTAL MEDICINE 2001 194 833-846
2818,IMIGVLVGV,6.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2819,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF EXPERIMENTAL MEDICINE 2001 194 833-846
2820,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2821,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2822,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2823,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2824,IMIVGGLVGL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P19550,AIDS RESEARCH HUMAN RETROVIRUSES 1998 14 1669-1678
2825,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03377,JOURNAL OF IMMUNOLOGY 1995 155 2232-2239
2826,IMMGVLVGV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF EXPERIMENTAL MEDICINE 2001 194 833-846
2827,IMMPARFYPK,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P24024,TISSUE ANTIGENS 2002 59 251-258
2828,IMPARFYPK,7.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P12933,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
2829,,,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P24024,HUMAN IMMUNOLOGY 1996 45 79-93
2830,,,n/a,HLA-A31,CLASS-I,HUMAN,VIRAL,P24024,HUMAN IMMUNOLOGY 1996 45 79-93
2831,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P24024,HUMAN IMMUNOLOGY 1996 45 79-93
2832,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P24024,TISSUE ANTIGENS 2002 59 251-258
2833,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P24024,HUMAN IMMUNOLOGY 1996 45 79-93
2834,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P24024,HUMAN IMMUNOLOGY 1996 45 79-93
2835,IMPGQEAGL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
2836,IMPKAGLLI,1.0,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P43357,CANCER RESEARCH 1997 57 4465-4468
2837,IMPKAGLLIIV,6.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2838,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
2839,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2840,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2841,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2842,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
2843,IMPKTGFLHII,1.0,A*2401,HLA-A24,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
2844,IMPKTGFLI,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
2845,,,A*2401,HLA-A24,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
2846,IMPKTGFLII,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
2847,INFPKTFGW,2.0,n/a,Gogo-B*0101,CLASS-I,GORILLA,VIRAL,P31818,JOURNAL OF IMMUNOLOGY 2001 166 3334-3344
2848,,,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2849,INKEEALQR,1.0,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P00519,BLOOD 1995 85 2680-2684
2850,INTDFAFSL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P29621,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
2851,IPAASQLDL,2.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 1998 47 256-263
2852,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
2853,IPAEFLENF,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,BACTERIAL,P12942,JOURNAL OF INFECTIOUS DISEASES 2001 183 928-934
2854,IPAKFLEGL,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,BACTERIAL,P31953,JOURNAL OF INFECTIOUS DISEASES 2001 183 928-934
2855,IPCLLISFL,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P32297,JOURNAL OF IMMUNOLOGY 2003 171 22-26
2856,IPEPEGPDA,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2857,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2858,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2859,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2860,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2861,IPFLTKFKL,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P03113,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2862,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03113,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2863,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03113,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2864,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03113,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2865,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03113,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2866,IPFPIVRYL,3.0,Cw*0401,HLA-Cw4,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
2867,,,Cw*0602,HLA-Cw6,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
2868,,,Cw*0702,HLA-Cw7,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
2869,IPFPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2870,IPFYGKAI,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2003 64 211-223
2871,IPIGTYGQM,1.0,n/a,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
2872,IPIHYCAPA,6.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
2873,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
2874,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
2875,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
2876,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P12490,HUMAN IMMUNOLOGY 2003 64 211-223
2877,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
2878,IPIKSQWTI,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03363,IMMUNOGENETICS 1998 47 256-263
2879,IPIPSSWA,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P31873,IMMUNOGENETICS 2003 54 830-841
2880,IPIPSSWAF,16.0,B*1301,HLA-B13,CLASS-I,HUMAN,VIRAL,P31868,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
2881,,,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P31868,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2882,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P31873,IMMUNOGENETICS 2003 54 830-841
2883,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P31868,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2884,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P31868,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2885,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P31868,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2886,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P31868,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2887,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P31868,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2888,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P31868,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2889,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P31868,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2890,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P31873,HUMAN IMMUNOLOGY 2003 64 211-223
2891,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P31873,IMMUNOGENETICS 2003 54 830-841
2892,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P31868,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
2893,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P31868,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
2894,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P31868,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2895,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P31868,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
2896,IPIPSSWAFA,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P31873,IMMUNOGENETICS 2003 54 830-841
2897,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P31873,IMMUNOGENETICS 2003 54 830-841
2898,IPIPSSWAI,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2899,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2900,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2901,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2902,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2903,IPLGDAKLV,3.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P35964,IMMUNOGENETICS 1996 43 268-276
2904,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P35964,IMMUNOGENETICS 1996 43 268-276
2905,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P35964,IMMUNOGENETICS 1996 43 268-276
2906,IPLTEEAEL,2.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1998 47 256-263
2907,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1999 49 819-822
2908,IPLYRNGDF,5.0,n/a,HLA-B51,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2909,,,B*5301,HLA-B53,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2910,,,B*5301,HLA-B53,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2911,,,B*5401,HLA-B54,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2912,,,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2913,IPPGNSGEETI,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27976,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
2914,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27976,JOURNAL OF VIROLOGY 2001 75 738-749
2915,IPPSFLQAM,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2916,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2917,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2918,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2919,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2920,IPPSRSML,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
2921,IPQSLDSWWTSL,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
2922,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
2923,IPSINNETPG,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
2924,IPSYKKLIM,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2925,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2926,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2927,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2928,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
2929,IPTSGDVVI,5.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P26664,IMMUNOGENETICS 1996 43 268-276
2930,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P26664,IMMUNOGENETICS 1996 43 268-276
2931,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26664,IMMUNOGENETICS 1998 47 256-263
2932,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,Q00269http://us.expasy.org/cgi-bin/get-sprot-entry,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
2933,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P26664,IMMUNOGENETICS 1996 43 268-276
2934,IPVEICGHKAI,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03369,HUMAN IMMUNOLOGY 1999 60 177-186
2935,IPVEVLVDLF,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P78395,HUMAN IMMUNOLOGY 2003 64 245-255
2936,IPYNPQSQGVV,5.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
2937,,,*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
2938,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
2939,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
2940,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
2941,IQESCDKHYW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2942,IQFPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2943,IRAPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2944,IRDMTEKQY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,Q06379,IMMUNOGENETICS 1997 45 249-258
2945,IRFAKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2946,IRFFKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2947,IRFKKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2948,IRFLKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2949,IRFNKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2950,IRFPDTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2951,IRFPFTFGW,1.0,/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2952,IRFPKFFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2953,IRFPKKFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2954,IRFPKLFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2955,IRFPKNFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2956,IRFPKSFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2957,IRFPKTAGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2958,IRFPKTFAW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2959,IRFPKTFFA,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2960,IRFPKTFFC,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2961,IRFPKTFFD,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2962,IRFPKTFFE,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2963,IRFPKTFFF,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2964,IRFPKTFFG,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2965,IRFPKTFFH,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2966,IRFPKTFFK,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2967,IRFPKTFFL,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2968,IRFPKTFFN,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2969,IRFPKTFFP,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2970,IRFPKTFFQ,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2971,IRFPKTFFS,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2972,IRFPKTFFT,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2973,IRFPKTFFW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2974,IRFPKTFGW,4.0,n/a,Mamu-B*17,CLASS-I,RHESUS,VIRAL,P11262,JOURNAL OF IMMUNOLOGY 2000 164 283-291
2975,,,n/a,Gogo-B*0101,CLASS-I,GORILLA,VIRAL,P31818,JOURNAL OF IMMUNOLOGY 2001 166 3334-3344
2976,,,n/a,Gogo-B*0101,CLASS-I,GORILLA,VIRAL,P31818,JOURNAL OF IMMUNOLOGY 2001 166 3334-3344
2977,,,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2978,IRFPKTFGWL,1.0,n/a,Mamu-B*17,CLASS-I,RHESUS,VIRAL,P11262,JOURNAL OF IMMUNOLOGY 2000 164 283-291
2979,IRFPKTFGWLW,1.0,n/a,Mamu-B*17,CLASS-I,RHESUS,VIRAL,P11262,JOURNAL OF IMMUNOLOGY 2000 164 283-291
2980,IRFPKTFGWLWK,1.0,n/a,Mamu-B*17,CLASS-I,RHESUS,VIRAL,P11262,JOURNAL OF IMMUNOLOGY 2000 164 283-291
2981,IRFPKTFKW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2982,IRFPKTFLW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2983,IRFPKTFNW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2984,IRFPKTKGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2985,IRFPKTLGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2986,IRFPKTNGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2987,IRFPKTYGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2988,IRFPLTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2989,IRFPNTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2990,IRFPRTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2991,IRFRYCAPPGY,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2992,IRIQRGPGRAFVTIGK,2.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P04582,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
2993,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P04582,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
2994,IRKPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2995,IRLPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2996,IRNPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2997,IRYPKTFGW,3.0,n/a,Gogo-B*0101,CLASS-I,GORILLA,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2001 166 3334-3344
2998,,,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
2999,,,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
3000,IRYPKTFGWLW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
3001,ISANNDSEI,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SYNTHETIC,P31681,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
3002,ISDESYRVY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,Q60393,IMMUNOGENETICS 1997 45 249-258
3003,ISEYRHYCY,2.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
3004,,,*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
3005,ISFAFCQL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9RB65,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
3006,ISFPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
3007,ISHNFCNL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
3008,ISNGNSDCL,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z7Z1,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
3009,ISPIETVPVK,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
3010,ISPSRSML,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
3011,ISQAVHAAHAEINE,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,MISCELLANEOUS,P01012,VACCINE 1999 17 675-685
3012,ISQAVHAAHAEINETYQRTRALV,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,VACCINE 1999 17 675-685
3013,ISVSNPGDL,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SYNTHETIC,P23700,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
3014,ISYPPLHER,5.0,n/a,HLA-A3,CLASS-I,HUMAN,CANCER,P43356,HUMAN IMMUNOLOGY 1996 45 79-93
3015,,,n/a,HLA-A31,CLASS-I,HUMAN,CANCER,P43356,HUMAN IMMUNOLOGY 1996 45 79-93
3016,,,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43356,HUMAN IMMUNOLOGY 1996 45 79-93
3017,,,A*3301,HLA-A33,CLASS-I,HUMAN,CANCER,P43356,HUMAN IMMUNOLOGY 1996 45 79-93
3018,,,A*6801,HLA-A68,CLASS-I,HUMAN,CANCER,P43356,HUMAN IMMUNOLOGY 1996 45 79-93
3019,ITAQVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
3020,ITDDQLLAL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
3021,ITDDQLLALL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
3022,ITDQVPFSV,9.0,n/a,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,CANCER RESEARCH 1999 59 6230-6238
3023,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,CELLULAR IMMUNOLOGY 2000 204 29-37
3024,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,IMMUNOLOGICAL REVIEWS 2002 188 136-146
3025,,,A*0201,HLA-A2,CLASS-I,HUMAN,MOUSE,Q60696,IMMUNOLOGICAL REVIEWS 2002 188 136-146
3026,,,A*0201,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,CANCER IMMUNOLOGY IMMUNOTHERAPY 2003 52 199-206
3027,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1995 154 3961-3968
3028,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802
3029,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 2000 164 2354-2361
3030,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
3031,ITEDMGHLKY,1.0,n/a,HLA-A3,CLASS-I,HUMAN,CANCER,P12004,JOURNAL OF IMMUNOLOGY 1994 152 620-631
3032,ITFPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
3033,ITFQVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
3034,ITLEDSSGNLL,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3035,,,A*0202,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3036,,,A*0203,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3037,,,A*0206,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3038,,,A*6802,HLA-A68,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3039,ITLWQRPLV,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20875,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
3040,ITMQVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
3041,ITPIGLAPT,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05885,JOURNAL OF VIROLOGY 2001 75 738-749
3042,ITSQVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
3043,ITTQHWLGL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
3044,ITWQVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
3045,ITWVRQVPGK,3.0,n/a,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
3046,,,n/a,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
3047,,,n/a,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
3048,ITWYSKNFW,1.0,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
3049,ITYFKKIYY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,not applicable,IMMUNOGENETICS 1997 45 249-258
3050,ITYKNSTWV,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P03471,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
3051,ITYQVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
3052,IVCPICSQK,3.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
3053,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03129,HUMAN IMMUNOLOGY 1995 44 189-198
3054,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
3055,IVFPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
3056,IVGAETFYV,3.0,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1995 154 685-693
3057,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1995 154 685-693
3058,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1995 154 685-693
3059,IVIWGKIPK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03383,TISSUE ANTIGENS 2000 55 296-302
3060,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03383,TISSUE ANTIGENS 2000 55 296-302
3061,IVIWGKTPK,6.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03383,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
3062,,,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P12499,HUMAN IMMUNOLOGY 1996 45 79-93
3063,,,n/a,HLA-A31,CLASS-I,HUMAN,VIRAL,P12499,HUMAN IMMUNOLOGY 1996 45 79-93
3064,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P12499,HUMAN IMMUNOLOGY 1996 45 79-93
3065,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P12499,HUMAN IMMUNOLOGY 1996 45 79-93
3066,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P12499,HUMAN IMMUNOLOGY 1996 45 79-93
3067,IVIWGKTPKF,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
3068,IVMGNGTLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,P18269,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
3069,IVQNLQGQM,3.0,A*2601,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
3070,,,A*2602,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
3071,,,A*2603,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
3072,IVTDFSVIK,7.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03203,MOLECULAR IMMUNOLOGY 1994 31 813-822
3073,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03211,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
3074,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03203,MOLECULAR IMMUNOLOGY 1994 31 813-822
3075,,,A*1101,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,TISSUE ANTIGENS 2002 59 251-258
3076,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03203,MOLECULAR IMMUNOLOGY 1994 31 813-822
3077,,,A*2401,HLA-A24,CLASS-I,HUMAN,VIRAL,P03203,MOLECULAR IMMUNOLOGY 1994 31 813-822
3078,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03203,MOLECULAR IMMUNOLOGY 1994 31 813-822
3079,IVTMFEAL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
3080,IVWASRELER,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
3081,IVYETADMIMHTPGC,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26662,JOURNAL OF HEPATOLOGY 2001 34 321-329
3082,IVYRDGNPY,4.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
3083,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03126,HUMAN IMMUNOLOGY 1995 44 189-198
3084,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03126,HUMAN IMMUNOLOGY 1995 44 189-198
3085,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
3086,IWGCSGKLI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P35961,IMMUNOGENETICS 2003 54 830-841
3087,IYAGIKVKQL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
3088,IYATVAGSL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P03451,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
3089,IYETYGDTW,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P05926,IMMUNOGENETICS 2003 54 830-841
3090,IYHTQGYF,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03405,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
3091,IYIGPGRAF,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
3092,IYKRWIIL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
3093,IYKRWIILGL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
3094,IYNRNVNRL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,PARASITE,P13814,INFECTION AND IMMUNITY 2000 68 3403-3411
3095,IYPGIKTKHL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27973,JOURNAL OF VIROLOGY 2001 75 738-749
3096,IYPNASLLI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,CANCER,P06731,INTERNATIONAL JOURNAL OF CANCER 1999 80 92-97
3097,IYQEPFKNL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
3098,IYQKANTFL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,P39682,JOURNAL OF IMMUNOLOGY 2001 167 655-666
3099,IYQYMDDL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
3100,IYTQNRRAL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
3101,IYVKTSSFL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,O35660,JOURNAL OF IMMUNOLOGY 2001 167 655-666
3102,KAACWWAGI,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
3103,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
3104,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
3105,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
3106,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
3107,KAAYNFATCGI,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 2001 75 5099-5107
3108,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 2001 75 5099-5107
3109,KAAYNFATM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 2001 75 5099-5107
3110,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 2001 75 5099-5107
3111,KAEVHTFYY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P09790,IMMUNOGENETICS 1997 45 249-258
3112,KAGGPIYKA,1.0,n/a,HLA-A68,CLASS-I,HUMAN,VIRAL,P21433,JOURNAL OF IMMUNOLOGY 1999 162 331-337
3113,KAGGPIYKK,1.0,n/a,HLA-A68,CLASS-I,HUMAN,VIRAL,P21433,JOURNAL OF IMMUNOLOGY 1999 162 331-337
3114,KAGGPIYKR,1.0,n/a,HLA-A68,CLASS-I,HUMAN,VIRAL,P21433,JOURNAL OF IMMUNOLOGY 1999 162 331-337
3115,KAGYVTNRGR,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
3116,KALGFPESL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P54726,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
3117,KALQRPVSDF,1.0,n/a,HLA-A24,CLASS-I,HUMAN,VIRAL,P09991,BLOOD 1995 85 2680-2684
3118,KALYNFATM,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF MOLECULAR BIOLOGY 2000 302 873-885
3119,KAMVQAWPFT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
3120,KAREFSSEQTR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
3121,KASEYLQLV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3122,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3123,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3124,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3125,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3126,KAVANFATM,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF MOLECULAR BIOLOGY 2000 302 873-885
3127,KAVFNFATM,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF MOLECULAR BIOLOGY 2000 302 873-885
3128,KAVSNFATM,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF MOLECULAR BIOLOGY 2000 302 873-885
3129,KAVYNFAT,4.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
3130,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1997 234 62-73
3131,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
3132,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1997 234 62-73
3133,KAVYNFATC,10.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
3134,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
3135,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1997 234 62-73
3136,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
3137,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1998 161 5087-5096
3138,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1999 256 246-257
3139,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 2001 75 5099-5107
3140,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 2002 168 283-289
3141,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1998 161 5087-5096
3142,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1997 234 62-73
3143,KAVYNFATCG,4.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
3144,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1997 234 62-73
3145,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
3146,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1997 234 62-73
3147,KAVYNFATCGI,11.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
3148,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
3149,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
3150,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1997 234 62-73
3151,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
3152,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
3153,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
3154,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
3155,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 2001 75 5099-5107
3156,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 2001 75 5099-5107
3157,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1997 234 62-73
3158,KAVYNFATCGIF,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
3159,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
3160,KAVYNFATM,5.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 2001 75 5099-5107
3161,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF MOLECULAR BIOLOGY 2000 302 873-885
3162,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 2001 75 5099-5107
3163,,,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P09991,EURO.JOURNAL OF IMMUNOLOGY 2001 31 2986-2996
3164,,,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P09991,EURO.JOURNAL OF IMMUNOLOGY 2001 31 2986-2996
3165,KAVYNYATM,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF MOLECULAR BIOLOGY 2000 302 873-885
3166,KAWGQYWQV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1997 70 302-309
3167,KCIDFYSRI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
3168,KDATNLLNGL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
3169,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
3170,KECVLHDDL,2.0,B*4001,HLA-B40,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,HUMAN IMMUNOLOGY 2003 64 245-255
3171,,,n/a,HLA-B60,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 169 3131-3136
3172,KECVLHDDLL,2.0,B*4001,HLA-B40,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,HUMAN IMMUNOLOGY 2003 64 245-255
3173,,,n/a,HLA-B60,CLASS-I,HUMAN,SYNTHETIC,P03206,JOURNAL OF IMMUNOLOGY 2002 169 3131-3136
3174,KECVLRDDL,2.0,B*4001,HLA-B40,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,HUMAN IMMUNOLOGY 2003 64 245-255
3175,,,n/a,HLA-B60,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 169 3131-3136
3176,KECVLRDDLL,2.0,B*4001,HLA-B40,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,HUMAN IMMUNOLOGY 2003 64 245-255
3177,,,n/a,HLA-B60,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 169 3131-3136
3178,KEGPFGTL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P39876,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
3179,KEMKAKVI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,SELF PEPTIDE,P36402,JOURNAL OF IMMUNOLOGY 1994 153 3079-3092
3180,KESTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
3181,KESTLHLVL,2.0,n/a,Mamu-A*11,CLASS-I,RHESUS,MISCELLANEOUS,P49634,JOURNAL OF IMMUNOLOGY 2000 164 283-291
3182,,,n/a,HLA-B60,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 169 3131-3136
3183,KEVYNFATCGI,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
3184,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
3185,KFEAWGYT,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
3186,KFIKSLFHI,2.0,H-2Kd,H-2d,CLASS-I,MOUSE,n/a,not applicable,IMMUNOGENETICS 2003 54 830-841
3187,,,A*2402,HLA-A24,CLASS-I,HUMAN,n/a,not applicable,IMMUNOGENETICS 2003 54 830-841
3188,KFYSKISEY,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
3189,KGILGFVFTLTV,5.0,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P21429,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3190,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P21429,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3191,,,n/a,HLA-B27,CLASS-I,HUMAN,VIRAL,P21429,JOURNAL OF IMMUNOLOGY 1992 149 1896-1904
3192,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3193,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3194,KGYAPQGL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,P24028,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
3195,KGYAWQYT,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
3196,KGYVYQGL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
3197,KICQNFILL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z7Z1,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
3198,,,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z7Z1,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
3199,KIEELRQHLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
3200,KIFAMPMQDI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
3201,KIFGSLAFL,9.0,n/a,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427
3202,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3203,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,INTERNATIONAL JOURNAL OF CANCER 1998 78 202-208
3204,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
3205,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04626,CANCER IMMUNOLOGY IMMUNOTHER 2004 53 307-314
3206,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3207,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3208,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3209,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3210,KIFIAGNSA,2.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P13201,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
3211,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P13201,JOURNAL OF IMMUNOLOGY 1994 152 163-175
3212,KIFMLVTAVV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P19996,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
3213,KIFSEVTLK,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,TISSUE ANTIGENS 2002 59 251-258
3214,KIGPENPYNT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
3215,KIKALVEICT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
3216,KIKPPLPSV,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20877,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
3217,KILSVFFLA,10.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
3218,,,A*0202,HLA-A2,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
3219,,,A*0203,HLA-A2,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
3220,,,A*1101,HLA-A11,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
3221,,,A*0206,HLA-A2,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
3222,,,A*0301,HLA-A3,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
3223,,,A*3101,HLA-A31,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
3224,,,A*3301,HLA-A33,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
3225,,,A*6801,HLA-A68,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
3226,,,A*6802,HLA-A68,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
3227,KIMKWNYER,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,n/a,not applicable,TISSUE ANTIGENS 2002 59 251-258
3228,KIQNFRVYY,4.0,A*2601,HLA-A26,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 1999 54 325-332
3229,,,A*2602,HLA-A26,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 1999 54 325-332
3230,,,A*2603,HLA-A26,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 1999 54 325-332
3231,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P04589,HUMAN IMMUNOLOGY 2003 64 245-255
3232,KIQNFRVYYR,6.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
3233,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
3234,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
3235,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
3236,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
3237,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
3238,KIRKYTMRR,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P04626,CANCER RESEARCH 1999 59 431-435
3239,KISKIGPENP,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
3240,KIWEELSVL,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3241,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3242,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3243,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3244,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3245,KIWGQYWQV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1997 70 302-309
3246,KIYYAESVK,1.0,n/a,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
3247,KKKEYNETW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2002 168 210-219
3248,KKKKRRYPNAVYL,2.0,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P26032,VACCINE 2002 20 249-261
3249,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P26032,VACCINE 2002 20 249-261
3250,KKRRYPNAVYL,2.0,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P26032,VACCINE 2002 20 249-261
3251,,,*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P26032http://ca.expasy.org/cgi-bin/get-sprot-entry,VACCINE 2002 20 249-261
3252,KKTGMLEMW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05897,JOURNAL OF IMMUNOLOGY 2002 168 210-219
3253,KLAFHHMAR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20867,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
3254,KLAGGVAVI,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P06806,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
3255,,,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P06806,EURO.JOURNAL OF IMMUNOLOGY 2001 31 3602-3611
3256,KLAGGVAVL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P06806,EURO.JOURNAL OF IMMUNOLOGY 2001 31 3602-3611
3257,KLBPVQLWV,5.0,,,,,,,
3258,,,,,,,,,
3259,,,,,,,,,
3260,,,,,,,,,
3261,,,,,,,,,
3262,KLCPVQLWV,7.0,n/a,HLA-A,CLASS-I,HUMAN,SELF PEPTIDE,P04637,SCAND.JOURNAL OF IMMUNOLOGY 2001 53 357-364
3263,,,n/a,HLA-A,CLASS-I,HUMAN,SELF PEPTIDE,P04637,SCAND.JOURNAL OF IMMUNOLOGY 2001 53 357-364
3264,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3265,,,A*0202,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3266,,,A*0203,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3267,,,A*0206,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3268,,,A*6802,HLA-A68,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3269,KLFCQLAKV,4.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3270,,,A*0202,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3271,,,A*0203,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3272,,,A*6802,HLA-A68,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3273,KLFGSLAFV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3274,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3275,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3276,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3277,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3278,KLFNIMVTY,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,HUMAN IMMUNOLOGY 1995 44 189-198
3279,KLFPEVIDL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,P18269,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
3280,KLGEFYNQMM,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P13885,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
3281,KLGKAGYVT,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20875,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
3282,KLHKQRAKS,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,HUMAN IMMUNOLOGY 1995 44 189-198
3283,KLHLYSHPI,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03159,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 1047-1058
3284,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
3285,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
3286,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3287,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3288,KLKPGMDGPK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
3289,KLLRGTKALT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
3290,KLNSWDVFGNW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2002 168 210-219
3291,KLNWASQIYP,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
3292,KLPDLCTEL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
3293,KLPQLCTEL,7.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,HUMAN IMMUNOLOGY 1995 44 189-198
3294,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,HUMAN IMMUNOLOGY 1995 44 189-198
3295,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
3296,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
3297,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
3298,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
3299,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
3300,KLPSDYFPSV,8.0,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
3301,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
3302,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
3303,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
3304,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
3305,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
3306,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,HUMAN IMMUNOLOGY 1997 58 12-20
3307,,,A*0207,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,HUMAN IMMUNOLOGY 2001 62 1200-1216
3308,KLQERLAKL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P06806,EURO.JOURNAL OF IMMUNOLOGY 2001 31 3602-3611
3309,KLRHLNEKR,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
3310,KLRKPKHKK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,PARASITE,P05691,IMMUNITY 1997 7 97-112
3311,,,A*0301,HLA-A3,CLASS-I,HUMAN,PARASITE,P05691,IMMUNITY 1997 7 97-112
3312,,,A*3101,HLA-A31,CLASS-I,HUMAN,PARASITE,P05691,IMMUNITY 1997 7 97-112
3313,,,A*3101,HLA-A31,CLASS-I,HUMAN,PARASITE,P05691,IMMUNITY 1997 7 97-112
3314,,,A*6801,HLA-A68,CLASS-I,HUMAN,PARASITE,P05691,IMMUNITY 1997 7 97-112
3315,KLSDGVAVL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P10809,EURO.JOURNAL OF IMMUNOLOGY 2001 31 3602-3611
3316,KLTADGVLTA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q02251,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
3317,KLTPCVTL,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20871,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
3318,KLTPLCVTL,13.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P35961,AIDS RESEARCH HUMAN RETROVIRUSES 1998 14 1669-1678
3319,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P12489,JOURNAL OF VIROLOGY 2001 75 1301-1311
3320,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P12489,JOURNAL OF IMMUNOLOGY 1995 155 2232-2239
3321,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
3322,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P12489,JOURNAL OF IMMUNOLOGY 1999 162 3915-3925
3323,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
3324,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P12489,JOURNAL OF VIROLOGY 2001 75 1301-1311
3325,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P12489,JOURNAL OF VIROLOGY 2001 75 1301-1311
3326,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
3327,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
3328,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P12489,JOURNAL OF VIROLOGY 2001 75 1301-1311
3329,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P12489,JOURNAL OF VIROLOGY 2001 75 1301-1311
3330,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
3331,KLVALGINAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
3332,KLVANNTRL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P31952,JOURNAL OF IMMUNOLOGY 2000 165 6463-6471
3333,KLVANNTRLWV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P31952,JOURNAL OF IMMUNOLOGY 2000 165 6463-6471
3334,KLVAYQATV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
3335,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
3336,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
3337,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
3338,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
3339,KLVDFRELNK,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
3340,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
3341,KLVGKLNWA,10.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
3342,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
3343,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
3344,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
3345,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
3346,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
3347,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
3348,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
3349,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
3350,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
3351,KLWGQYWQV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1997 70 302-309
3352,KLWVTVYYGV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P19550,AIDS RESEARCH HUMAN RETROVIRUSES 1998 14 1669-1678
3353,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03377,JOURNAL OF IMMUNOLOGY 1995 155 2232-2239
3354,KLYEKVYTY,1.0,n/a,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 163-175
3355,KMFBQLAKV,5.0,,,,,,,
3356,,,,,,,,,
3357,,,,,,,,,
3358,,,,,,,,,
3359,,,,,,,,,
3360,KMFCQLAKT,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3361,,,A*0202,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3362,,,A*0203,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3363,,,A*0206,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3364,,,A*6802,HLA-A68,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3365,KMIGGIGGFI,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
3366,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
3367,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
3368,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
3369,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
3370,KMILKMVQL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
3371,KMVELVHFLL,1.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43356,PROC.NATL.ACAD.SCI. USA 1994 91 2105-2109
3372,KMVELVHFLV,1.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43356,PROC.NATL.ACAD.SCI. USA 1994 91 2105-2109
3373,KMWGQYWQV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1997 70 302-309
3374,KPFKYAAAF,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 168 210-219
3375,KPGMDGPKV,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P20892,HUMAN IMMUNOLOGY 1999 60 177-186
3376,KPIVQYDNF,11.0,A*0101,HLA-A1,CLASS-I,HUMAN,PARASITE,not applicable,MOLECULAR IMMUNOLOGY 1994 31 813-822
3377,,,B*3502,HLA-B35,CLASS-I,HUMAN,PARASITE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3378,,,n/a,HLA-B7,CLASS-I,HUMAN,PARASITE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3379,,,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,not applicable,MOLECULAR IMMUNOLOGY 1994 31 813-822
3380,,,A*1101,HLA-A11,CLASS-I,HUMAN,PARASITE,not applicable,MOLECULAR IMMUNOLOGY 1994 31 813-822
3381,,,A*2401,HLA-A24,CLASS-I,HUMAN,PARASITE,not applicable,MOLECULAR IMMUNOLOGY 1994 31 813-822
3382,,,A*0301,HLA-A3,CLASS-I,HUMAN,PARASITE,not applicable,MOLECULAR IMMUNOLOGY 1994 31 813-822
3383,,,B*3501,HLA-B35,CLASS-I,HUMAN,PARASITE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3384,,,B*3503,HLA-B35,CLASS-I,HUMAN,PARASITE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3385,,,B*5301,HLA-B53,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNOGENETICS 1999 49 819-822
3386,,,B*5401,HLA-B54,CLASS-I,HUMAN,PARASITE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3387,KPPTKGANF,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
3388,KPQRKTKRNTNRRP,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
3389,KQSSKALQR,3.0,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P11274,BLOOD 1995 85 2680-2684
3390,,,n/a,HLA-A3,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 169 3131-3136
3391,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P11274,BLOOD 1995 85 2680-2684
3392,KRFEGLTQR,3.0,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,TISSUE ANTIGENS 1996 48 509-518
3393,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,TISSUE ANTIGENS 1996 48 509-518
3394,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,TISSUE ANTIGENS 1996 48 509-518
3395,KRFPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
3396,KRGILTLKY,7.0,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P02570,TISSUE ANTIGENS 1996 48 509-518
3397,,,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P02570,TISSUE ANTIGENS 1996 48 509-518
3398,,,n/a,Mamu-B*03,CLASS-I,RHESUS,SELF PEPTIDE,P02571,JOURNAL OF IMMUNOLOGY 2000 164 283-291
3399,,,n/a,Gogo-B*0101,CLASS-I,GORILLA,SELF PEPTIDE,P02571,JOURNAL OF IMMUNOLOGY 2001 166 3334-3344
3400,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P02570,TISSUE ANTIGENS 1996 48 509-518
3401,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P02571,ARTHRITIS & RHEUMATISM 1999 42 175-181
3402,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P02570,TISSUE ANTIGENS 1996 48 509-518
3403,KRKKAYADF,5.0,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P09669,TISSUE ANTIGENS 1996 48 509-518
3404,,,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P09669,TISSUE ANTIGENS 1996 48 509-518
3405,,,n/a,Gogo-B*0101,CLASS-I,GORILLA,BOVINE,P04038,JOURNAL OF IMMUNOLOGY 2001 166 3334-3344
3406,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P09669,TISSUE ANTIGENS 1996 48 509-518
3407,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P09669,TISSUE ANTIGENS 1996 48 509-518
3408,KRWIAVPTW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05902,JOURNAL OF IMMUNOLOGY 2002 168 210-219
3409,KRWIILGLNK,9.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3410,,,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
3411,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1992 149 1896-1904
3412,,,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3413,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3414,,,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3415,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
3416,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3417,,,B*0801,HLA-B8,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3418,KRWIILGLNKIVRMY,10.0,n/a,HLA-DR7,CLASS-2,HUMAN,VIRAL,P05889,JOURNAL OF VIROLOGY 2001 75 4195-4207
3419,,,n/a,HLA-B27,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3420,,,n/a,HLA-B27,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3421,,,n/a,HLA-B27,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3422,,,n/a,HLA-B27,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3423,,,n/a,HLA-B27,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3424,,,n/a,HLA-B27,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3425,,,n/a,HLA-B27,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3426,,,n/a,HLA-B27,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3427,,,n/a,HLA-B27,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3428,KRYEGLTQR,11.0,B*0801,HLA-B8,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3429,,,A*0101,HLA-A1,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3430,,,A*0101,HLA-A1,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1994 31 813-822
3431,,,n/a,HLA-B7,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3432,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1994 31 813-822
3433,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3434,,,A*0302,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3435,,,A*1101,HLA-A11,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1994 31 813-822
3436,,,A*2401,HLA-A24,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1994 31 813-822
3437,,,A*0301,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1994 31 813-822
3438,,,B*2705,HLA-B27,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3439,KRYKSIVKY,8.0,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P14324,TISSUE ANTIGENS 1996 48 509-518
3440,,,B*2703,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P14324,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
3441,,,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P14324,TISSUE ANTIGENS 1996 48 509-518
3442,,,n/a,Gogo-B*0101,CLASS-I,GORILLA,SELF PEPTIDE,P14324,JOURNAL OF IMMUNOLOGY 2001 166 3334-3344
3443,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P14324,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
3444,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P14324,TISSUE ANTIGENS 1996 48 509-518
3445,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P05369,ARTHRITIS & RHEUMATISM 1999 42 175-181
3446,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P14324,TISSUE ANTIGENS 1996 48 509-518
3447,KRYWAIRTR,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
3448,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
3449,KSKSIFFEY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,Q60393,IMMUNOGENETICS 1997 45 249-258
3450,KSLYDEHIK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
3451,,,A*0301,HLA-A3,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
3452,,,A*3101,HLA-A31,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
3453,,,A*3301,HLA-A33,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
3454,,,A*6801,HLA-A68,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
3455,KSLYDEHIKK,3.0,A*1101,HLA-A11,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
3456,,,A*0301,HLA-A3,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
3457,,,A*3101,HLA-A31,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
3458,KSPTKGANF,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
3459,KSSFYRNL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P03452,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
3460,KSWQEWNIY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P09790,IMMUNOGENETICS 1997 45 249-258
3461,KTAGQYWQV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1997 70 302-309
3462,KTAVVPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
3463,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
3464,KTCPVQLWV,7.0,n/a,HLA-A,CLASS-I,HUMAN,SELF PEPTIDE,P04637,SCAND.JOURNAL OF IMMUNOLOGY 2001 53 357-364
3465,,,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,SCAND.JOURNAL OF IMMUNOLOGY 2001 53 357-364
3466,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3467,,,A*0202,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3468,,,A*0203,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3469,,,A*0206,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3470,,,A*6802,HLA-A68,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3471,KTFGPIYKR,1.0,n/a,HLA-A68,CLASS-I,HUMAN,VIRAL,P21433,JOURNAL OF IMMUNOLOGY 1999 162 331-337
3472,KTFGWLWKL,1.0,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
3473,KTFGWLWKLV,1.0,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
3474,KTGFLIIVLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
3475,KTGGAIYKR,1.0,n/a,HLA-A68,CLASS-I,HUMAN,VIRAL,P21433,JOURNAL OF IMMUNOLOGY 1999 162 331-337
3476,KTGGPAAAAAAAIYKR,1.0,n/a,HLA-A68,CLASS-I,HUMAN,VIRAL,P21433,JOURNAL OF IMMUNOLOGY 1999 162 331-337
3477,KTGGPAAAAAIYKR,1.0,n/a,HLA-A68,CLASS-I,HUMAN,VIRAL,P21433,JOURNAL OF IMMUNOLOGY 1999 162 331-337
3478,KTGGPAAAIYKR,1.0,n/a,HLA-A68,CLASS-I,HUMAN,VIRAL,P21433,JOURNAL OF IMMUNOLOGY 1999 162 331-337
3479,KTGGPAIYKR,1.0,n/a,HLA-A68,CLASS-I,HUMAN,VIRAL,P21433,JOURNAL OF IMMUNOLOGY 1999 162 331-337
3480,KTGGPIYKA,1.0,n/a,HLA-A68,CLASS-I,HUMAN,VIRAL,P21433,JOURNAL OF IMMUNOLOGY 1999 162 331-337
3481,KTGGPIYKK,1.0,n/a,HLA-A68,CLASS-I,HUMAN,VIRAL,P21433,JOURNAL OF IMMUNOLOGY 1999 162 331-337
3482,KTGGPIYKR,1.0,n/a,HLA-A68,CLASS-I,HUMAN,VIRAL,P21433,JOURNAL OF IMMUNOLOGY 1999 162 331-337
3483,KTKFFTRRL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
3484,KTKPPLPSV,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20877,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
3485,KTPYDINQML,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
3486,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
3487,KTQNGKKQY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,not applicable,IMMUNOGENETICS 1997 45 249-258
3488,KTRPILSPLTK,1.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P21429,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
3489,KTSERSQPR,15.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P27959,HUMAN IMMUNOLOGY 1996 45 79-93
3490,,,n/a,HLA-A31,CLASS-I,HUMAN,VIRAL,P27959,HUMAN IMMUNOLOGY 1996 45 79-93
3491,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3492,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
3493,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P27959,HUMAN IMMUNOLOGY 1996 45 79-93
3494,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
3495,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3496,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3497,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
3498,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
3499,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3500,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P27959,HUMAN IMMUNOLOGY 1996 45 79-93
3501,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
3502,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P27959,HUMAN IMMUNOLOGY 1996 45 79-93
3503,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3504,KTVHNILPHDL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
3505,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
3506,KTVLELTEV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
3507,KTVLPVTIM,1.0,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
3508,KTWAQYWQV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1997 70 302-309
3509,KTWGAYWQV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1997 70 302-309
3510,KTWGKYWQV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,MOUSE,Q60696,IMMUNOLOGICAL REVIEWS 2002 188 136-146
3511,KTWGQAWQV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1997 70 302-309
3512,KTWGQYAQV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1997 70 302-309
3513,KTWGQYWAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1997 70 302-309
3514,KTWGQYWQA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1997 70 302-309
3515,KTWGQYWQV,6.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1997 70 302-309
3516,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,CELLULAR IMMUNOLOGY 2000 204 29-37
3517,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,IMMUNOLOGICAL REVIEWS 2002 188 136-146
3518,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802
3519,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1995 154 3961-3968
3520,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 2000 164 2354-2361
3521,KTWGQYWQVL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1995 154 3961-3968
3522,KVADLVGFL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
3523,KVADLVGFLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
3524,KVAEIVHFL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF EXPERIMENTAL MEDICINE 2001 194 833-846
3525,KVAELVHFL,7.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43357,PROC.NATL.ACAD.SCI. USA 1994 91 2105-2109
3526,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF EXPERIMENTAL MEDICINE 2001 194 833-846
3527,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3528,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3529,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3530,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3531,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3532,KVAELVWFL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF EXPERIMENTAL MEDICINE 2001 194 833-846
3533,KVCGSNLLSI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
3534,KVDGLSTEA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
3535,KVFGSLAFV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3536,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3537,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3538,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3539,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3540,KVFPCALINK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,HUMAN IMMUNOLOGY 1995 44 189-198
3541,KVFPYALINK,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
3542,,,A*0301,HLA-A3,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGICAL METHODS 1997 200 89-97
3543,,,B*0702,HLA-B7,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
3544,KVFVLGGCR,6.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P20975,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
3545,,,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P03166,HUMAN IMMUNOLOGY 1996 45 79-93
3546,,,n/a,HLA-A31,CLASS-I,HUMAN,VIRAL,P03166,HUMAN IMMUNOLOGY 1996 45 79-93
3547,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03166,HUMAN IMMUNOLOGY 1996 45 79-93
3548,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03166,HUMAN IMMUNOLOGY 1996 45 79-93
3549,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03166,HUMAN IMMUNOLOGY 1996 45 79-93
3550,KVGKFYEL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P54276,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
3551,KVGNFTGLY,5.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
3552,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
3553,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
3554,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
3555,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
3556,KVKRKKNVL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
3557,KVLEYVIKV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
3558,KVLFLDGIDK,1.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
3559,KVLFLNGIDK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03383,TISSUE ANTIGENS 2000 55 296-302
3560,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 2000 55 296-302
3561,KVLRENTSPK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P04626,CANCER RESEARCH 1999 59 431-435
3562,KVRMYVGGV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27961,JOURNAL OF HEPATOLOGY 2001 34 321-329
3563,KVRQLCKLLR,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
3564,KVRRPEGRTWAQPG,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
3565,KVVNPLFEK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,P11518,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
3566,,,A*0301,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P11518,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
3567,KVVRFDKL,2.0,H-2Kb,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,P01012,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
3568,,,H-2Kb,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,P01012,NATURE IMMUNOLOGY 2000 1 145-150
3569,KVWGQYWQV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1997 70 302-309
3570,KVYLAWVPAHK,6.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
3571,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
3572,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
3573,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
3574,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
3575,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
3576,KYADKIYSI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,Q04609,CLINICAL CANCER RESEARCH 2002 8 3885-3892
3577,KYAGESFPGI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,Q04609,CLINICAL CANCER RESEARCH 2002 8 3885-3892
3578,KYFDEHYEY,2.0,Cw*0401,HLA-Cw4,CLASS-I,HUMAN,SELF PEPTIDE,P33552,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3579,,,Cw*0702,HLA-Cw7,CLASS-I,HUMAN,SELF PEPTIDE,P33552,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3580,KYKVIKIEPL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
3581,KYNKANWFL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2001 167 655-666
3582,KYNPMKTHI,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
3583,KYPDFVDAL,2.0,Cw*0401,HLA-Cw4,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3584,,,Cw*0702,HLA-Cw7,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3585,KYPENFFLL,1.0,A*2401,HLA-A24,CLASS-I,HUMAN,SELF PEPTIDE,P30154,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
3586,KYQAVTTTL,2.0,H-2Kd,H-2d,CLASS-I,MOUSE,n/a,not applicable,IMMUNOGENETICS 2003 54 830-841
3587,,,A*2402,HLA-A24,CLASS-I,HUMAN,n/a,not applicable,IMMUNOGENETICS 2003 54 830-841
3588,KYTAFTIPSI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
3589,KYWWSLLQYWI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
3590,KYYKNSQFL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,P44601,JOURNAL OF IMMUNOLOGY 2001 167 655-666
3591,KYYKTSNFL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,Q03780,JOURNAL OF IMMUNOLOGY 2001 167 655-666
3592,LAAVVGLSAGEQEY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SYNTHETIC,P07029,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
3593,LAAVVGLSPGEQEY,1.0,B*3503,HLA-B35,CLASS-I,HUMAN,n/a,not applicable,J.EXP.MED 2001 193 1189-1198
3594,LACAGLAYK,11.0,n/a,HLA-A11,CLASS-I,HUMAN,BACTERIAL,P16893,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
3595,,,n/a,HLA-A3,CLASS-I,HUMAN,BACTERIAL,P16893,HUMAN IMMUNOLOGY 1996 45 79-93
3596,,,n/a,HLA-A31,CLASS-I,HUMAN,BACTERIAL,P16893,HUMAN IMMUNOLOGY 1996 45 79-93
3597,,,A*1101,HLA-A11,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
3598,,,A*1101,HLA-A11,CLASS-I,HUMAN,BACTERIAL,P16893,HUMAN IMMUNOLOGY 1996 45 79-93
3599,,,A*0301,HLA-A3,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
3600,,,A*3101,HLA-A31,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
3601,,,A*3301,HLA-A33,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
3602,,,A*3301,HLA-A33,CLASS-I,HUMAN,BACTERIAL,P16893,HUMAN IMMUNOLOGY 1996 45 79-93
3603,,,A*6801,HLA-A68,CLASS-I,HUMAN,BACTERIAL,P16893,HUMAN IMMUNOLOGY 1996 45 79-93
3604,,,A*6801,HLA-A68,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
3605,LAEAMSQV,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P05889http://us.expasy.org/cgi-bin/get-sprot-entry,HUMAN IMMUNOLOGY 1999 60 177-186
3606,LAFHHMAR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20867,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
3607,LAFLQYRRL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
3608,LAFQGKAR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
3609,LAGAWGDLW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2002 168 210-219
3610,LAGTFTWTL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
3611,LAHGVRVLEDGVNY,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
3612,LALVLLMLPV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q50097,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
3613,LAMPFATPM,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P78358,JOURNAL OF IMMUNOLOGY 2003 171 6283-6289
3614,LAMPFATPMEAEL,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P78358,JOURNAL OF IMMUNOLOGY 2003 171 6283-6289
3615,LAPFPFDL,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 2001 167 4207-4214
3616,LAPPQHLIRV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3617,,,A*0202,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3618,,,A*0203,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3619,,,A*0206,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3620,,,A*6802,HLA-A68,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3621,LAPVPIPF,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF VIROLOGY 2001 75 738-749
3622,LAPVPIPFA,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF VIROLOGY 2001 75 738-749
3623,LARAYDTEV,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1997 46 245-248
3624,LASTNAGSI,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,Q66282,MOLECULAR IMMUNOLOGY 1996 33 1323-1333
3625,LAWVPAHKGI,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P20892,HUMAN IMMUNOLOGY 1999 60 177-186
3626,LAYLGWLVF,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P19473,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
3627,,,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P19473,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
3628,LCLIFLLV,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P17397,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
3629,LDGGNMLESI,3.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
3630,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
3631,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
3632,LDSQNRKDI,4.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
3633,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
3634,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
3635,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
3636,LDVGSDLEI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 44 233-241
3637,LEILNGEI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,SELF PEPTIDE,P06909,TISSUE ANTIGENS 2001 57 405-414
3638,LESTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
3639,LFIHFRIGCRHSR,7.0,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P05928,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3640,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P05928,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3641,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P05928,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3642,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P05928,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3643,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P05928,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3644,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P05928,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3645,,,n/a,HLA-DR13,CLASS-I,HUMAN,VIRAL,P05928,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3646,LFILLLCL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P17397,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
3647,LFKTTVNSL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
3648,LFLNTLSFV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06788,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
3649,LFLPSDFFPSV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P17391,JOURNAL OF IMMUNOLOGY 2003 170 2977-2984
3650,LFRAVITKK,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
3651,LFVGSDLEI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 44 233-241
3652,LFVVYRDSI,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
3653,LGAVVGASPGEQEY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SYNTHETIC,P07029,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
3654,LGAVVGLSAGEQEY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
3655,LGAVVGLSPGEQEY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
3656,LGDGVKDHY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P01558,IMMUNOGENETICS 1997 45 249-258
3657,LGDYKLVEI,1.0,n/a,Mamu-A*11,CLASS-I,RHESUS,VIRAL,P05885,JOURNAL OF IMMUNOLOGY 2000 164 283-291
3658,LGEGHGAGGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05916,JOURNAL OF IMMUNOLOGY 2002 168 210-219
3659,LGFGAYMSK,10.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
3660,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3661,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
3662,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3663,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3664,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
3665,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3666,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
3667,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
3668,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3669,LGFVFTLTV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P03487,JOURNAL OF IMMUNOLOGY 1994 152 163-175
3670,LGPHYTPKIV,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27973,JOURNAL OF VIROLOGY 2001 75 738-749
3671,LGQFNLGFI,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P54279,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
3672,LGSVVGNWQY,1.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43357,PROC.NATL.ACAD.SCI. USA 1994 91 2105-2109
3673,LGVGSDLEI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 44 233-241
3674,LHEYKQGDY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,not applicable,IMMUNOGENETICS 1997 45 249-258
3675,LHVGSDLEI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 44 233-241
3676,LICPTDCFRKHPEAT,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
3677,LIDYNKAAL,4.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
3678,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
3679,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
3680,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1999 256 246-257
3681,LIFCHSKKK,10.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
3682,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3683,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
3684,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3685,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3686,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
3687,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3688,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
3689,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
3690,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3691,LIFNYPGV,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z7Z1,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
3692,LIGCWYCRRR,1.0,n/a,HLA-A3,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
3693,LIGLSNLTHV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
3694,LIGNESFAL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
3695,LIIVLVMIA,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
3696,LIKFLYQSNPPPN,7.0,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P04616,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3697,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P04616,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3698,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P04616,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3699,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P04616,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3700,,,n/a,HLA-DR13,CLASS-I,HUMAN,VIRAL,P04616,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3701,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P04616,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3702,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P04616,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
3703,LIRCLRCQK,2.0,A*1102,HLA-A11,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
3704,,,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
3705,LIYNYPGV,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z6X8,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
3706,LIYRRRLMK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
3707,LKEPVHGV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P12499,JOURNAL OF IMMUNOLOGY 1995 154 567-576
3708,LKIFIAGNS,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P13201,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
3709,LLAAGVADPV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P06806,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
3710,LLACAGLAY,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
3711,,,A*0301,HLA-A3,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
3712,,,A*3101,HLA-A31,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
3713,,,A*3301,HLA-A33,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
3714,,,A*6801,HLA-A68,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
3715,LLACAGLAYK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
3716,,,A*0301,HLA-A3,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
3717,,,A*3101,HLA-A31,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
3718,,,A*3301,HLA-A33,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
3719,,,A*6801,HLA-A68,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
3720,LLACAVIHA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,not applicable,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
3721,LLAFLQYRRL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
3722,LLAGLVSLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
3723,LLALLSCLTI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
3724,LLALLSCLTV,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P29846,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
3725,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF VIROLOGY 1995 69 2462-2470
3726,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
3727,LLAQFTSAI,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03159,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 1047-1058
3728,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3729,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
3730,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
3731,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3732,LLATVFKLTA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q02251,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
3733,LLAVGATKV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802
3734,LLAVLYCLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
3735,LLCCSGVATA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P19996,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
3736,LLCELGRPSM,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
3737,LLCLIFLLV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3738,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3739,LLCLVVFFL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
3740,LLDDEAGPL,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P17394,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
3741,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P17394,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
3742,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P17394,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3743,LLDDTATLRL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802
3744,LLDDTDTIML,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,MOUSE,Q60696,IMMUNOLOGICAL REVIEWS 2002 188 136-146
3745,LLDGTATLRL,6.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
3746,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,CELLULAR IMMUNOLOGY 2000 204 29-37
3747,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,IMMUNOLOGICAL REVIEWS 2002 188 136-146
3748,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
3749,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1995 154 3961-3968
3750,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 2000 164 2354-2361
3751,LLDTASALY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03146,IMMUNOGENETICS 1997 45 249-258
3752,LLDVPTAAV,2.0,n/a,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P13284,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
3753,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P13284,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
3754,LLDYQGMLPV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3755,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P17399,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3756,LLERASATL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
3757,LLETSEGCR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
3758,LLFGAPVYV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03409,PROC.NATL.ACAD.SCI. USA 1995 92 4036-4040
3759,LLFGYAVYV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03409,PROC.NATL.ACAD.SCI. USA 1995 92 4036-4040
3760,LLFGYPVAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03409,PROC.NATL.ACAD.SCI. USA 1995 92 4036-4040
3761,LLFGYPVYV,7.0,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1995 154 685-693
3762,,,n/a,HLA-B27,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1992 149 1896-1904
3763,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03409,PROC.NATL.ACAD.SCI. USA 1995 92 4036-4040
3764,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
3765,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF MOLECULAR BIOLOGY 2001 310 1167-1176
3766,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1995 154 685-693
3767,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1995 154 685-693
3768,LLFLGVVFL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03409,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
3769,LLFLLLADA,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3770,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3771,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3772,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3773,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3774,LLFNILGGWV,8.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
3775,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3776,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF VIROLOGY 1995 69 2462-2470
3777,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
3778,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3779,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3780,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3781,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
3782,LLFRFMRPL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P41514,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
3783,LLFRFMRPLI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P41514,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
3784,LLGCAANWI,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
3785,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P12900,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
3786,LLGCAANWIL,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03159,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 1047-1058
3787,,,*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3788,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3789,LLGDNQIMP,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
3790,LLGDNQIMPK,4.0,n/a,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
3791,,,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
3792,,,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43357,PROC.NATL.ACAD.SCI. USA 1994 91 2105-2109
3793,,,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
3794,LLGFQLPPL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16790,CANCER RESEARCH 1999 59 5554-5559
3795,LLGICLTSTV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,INTERNATIONAL JOURNAL OF CANCER 1998 78 202-208
3796,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
3797,LLGLWGLTGL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,not applicable,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
3798,LLGPGRPYK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P40126,JOURNAL OF IMMUNOLOGY 1998 160 890-897
3799,,,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P40126,JOURNAL OF IMMUNOLOGY 1998 160 890-897
3800,,,A*3101,HLA-A31,CLASS-I,HUMAN,CANCER,P40126,JOURNAL OF IMMUNOLOGY 1998 160 890-897
3801,,,A*3301,HLA-A33,CLASS-I,HUMAN,CANCER,P40126,JOURNAL OF IMMUNOLOGY 1998 160 890-897
3802,,,A*6801,HLA-A68,CLASS-I,HUMAN,CANCER,P40126,JOURNAL OF IMMUNOLOGY 1998 160 890-897
3803,LLGPGRPYR,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,P40126,JOURNAL OF IMMUNOLOGY 1998 160 890-897
3804,,,A*0301,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P40126,JOURNAL OF IMMUNOLOGY 1998 160 890-897
3805,,,A*3101,HLA-A31,CLASS-I,HUMAN,SELF PEPTIDE,P40126,JOURNAL OF IMMUNOLOGY 1998 160 890-897
3806,,,A*3301,HLA-A33,CLASS-I,HUMAN,SELF PEPTIDE,P40126,JOURNAL OF IMMUNOLOGY 1998 160 890-897
3807,,,A*6801,HLA-A68,CLASS-I,HUMAN,SELF PEPTIDE,P40126,JOURNAL OF IMMUNOLOGY 1998 160 890-897
3808,LLGRNSFEV,9.0,A*0101,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P04637,MOLECULAR IMMUNOLOGY 1994 31 813-822
3809,,,A*0205,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 1995 154 685-693
3810,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,MOLECULAR IMMUNOLOGY 1994 31 813-822
3811,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,CELL 1993 74 929-937
3812,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 1995 154 685-693
3813,,,A*0202,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 1995 154 685-693
3814,,,A*1101,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,P04637,MOLECULAR IMMUNOLOGY 1994 31 813-822
3815,,,A*2401,HLA-A24,CLASS-I,HUMAN,SELF PEPTIDE,P04637,MOLECULAR IMMUNOLOGY 1994 31 813-822
3816,,,A*0301,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P04637,MOLECULAR IMMUNOLOGY 1994 31 813-822
3817,LLGSFELTGI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P19993,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
3818,LLIFHINGK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
3819,,,A*0301,HLA-A3,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
3820,,,A*3101,HLA-A31,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
3821,,,A*3301,HLA-A33,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
3822,,,A*6801,HLA-A68,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
3823,LLIPAPAPGL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16790,CANCER RESEARCH 1999 59 5554-5559
3824,LLIRCINCQK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
3825,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
3826,LLIRCLRCQ,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
3827,LLKDEALAI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
3828,LLLCLIFLL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P30019,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3829,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3830,LLLCLIFLLV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3831,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03139,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3832,LLLDVTPLSL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P19993,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
3833,LLLEAGALV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
3834,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
3835,LLLEAVPAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,not applicable,CANCER RESEARCH 2000 60 6448-6456
3836,LLLETSWEAI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q02251,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
3837,LLLFLLLAD,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
3838,LLLGLWGFAA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,P18269,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
3839,LLLLGLWGL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,not applicable,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
3840,LLLLTVLTV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P15941,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
3841,LLLTVLTVV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P15941,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
3842,LLMGTLGIV,7.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,HUMAN IMMUNOLOGY 1995 44 189-198
3843,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,HUMAN IMMUNOLOGY 1995 44 189-198
3844,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
3845,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
3846,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
3847,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1995 154 5934-5943
3848,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
3849,LLMPVHPQRL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16790,CANCER RESEARCH 1999 59 5554-5559
3850,LLMRNHLRDLM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
3851,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
3852,LLMWITQCFL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P78358,CANCER RESEARCH 2002 62 3630-3635
3853,LLNATDIAV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P35961,AIDS RESEARCH HUMAN RETROVIRUSES 1998 14 1669-1678
3854,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03377,JOURNAL OF IMMUNOLOGY 1995 155 2232-2239
3855,LLNATDIAVA,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P35961,AIDS RESEARCH HUMAN RETROVIRUSES 1998 14 1669-1678
3856,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03377,JOURNAL OF IMMUNOLOGY 1995 155 2232-2239
3857,LLPENNVLSPL,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3858,,,A*0202,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3859,,,A*0203,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3860,,,A*0206,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3861,,,A*6802,HLA-A68,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3862,LLPENNVLSPV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3863,,,A*0202,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3864,,,A*0203,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3865,,,A*0206,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3866,,,A*6802,HLA-A68,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3867,LLPIFFCL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P17397,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
3868,LLPIFFCLWV,6.0,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1995 154 685-693
3869,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P17397,JOURNAL OF IMMUNOLOGY 1995 154 685-693
3870,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P17397,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3871,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
3872,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3873,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1995 154 685-693
3874,LLPLGYPFV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P47769,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
3875,LLPPQHLIRV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3876,,,A*0202,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3877,,,A*0203,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3878,,,A*0206,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3879,,,A*6802,HLA-A68,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
3880,LLPRELFPPL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
3881,LLPRRGPRL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
3882,LLPSLFLLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,P18269,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
3883,LLQLTVWGI,6.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
3884,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
3885,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
3886,,,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20871,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
3887,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
3888,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
3889,LLQTGIHVRV,3.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P18139,IMMUNOGENETICS 1998 48 98-107
3890,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
3891,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
3892,LLQYWSQEL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P35961,AIDS RESEARCH HUMAN RETROVIRUSES 1998 14 1669-1678
3893,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03377,JOURNAL OF IMMUNOLOGY 1995 155 2232-2239
3894,LLRARGETY,1.0,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
3895,LLRHVMNPL,1.0,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
3896,LLRIPQAVV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01403,JOURNAL OF HEPATOLOGY 2001 34 321-329
3897,LLRIPQAVVDMVAGA,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01403,JOURNAL OF HEPATOLOGY 2001 34 321-329
3898,LLRREVYDF,1.0,A*2401,HLA-A24,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
3899,LLSCLGCKI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
3900,LLSCLGCKIL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
3901,LLSFLPSDF,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF IMMUNOLOGY 1994 152 163-175
3902,LLSLLLLMPV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16790,CANCER RESEARCH 1999 59 5554-5559
3903,LLSPRGSRP,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
3904,LLSSNLSWL,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
3905,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
3906,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
3907,LLTQDLVQEK,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
3908,LLVFACSAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
3909,LLVFACSAVPV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
3910,LLVFNYPGI,2.0,H-2Db,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z6X9,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
3911,,,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z6X9,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
3912,LLVGAAAFC,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
3913,LLVGSDLEI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 44 233-241
3914,LLVLQAGFFL,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03140,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
3915,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03138,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3916,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3917,LLVPFVQWFV,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3918,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
3919,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q02317,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3920,LLVSGSNVL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
3921,LLVVMFTLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
3922,LLWFHISCL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3923,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P12901,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
3924,LLWKGEGAV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
3925,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03368,CELL 1993 74 929-937
3926,LLWQDPVPA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q08129,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
3927,LLWSFQTSA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
3928,LLYSDDALHL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,P18269,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
3929,LMAVVGLSPGEQEY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
3930,LMAVVLASL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
3931,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802
3932,LMDKSLHV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
3933,LMHPAQTSQW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
3934,LMIGTAAAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P17944,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
3935,LMIGTAAAVV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P17944,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
3936,LMKGQHLHL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
3937,LMLPGMNGI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q9CCJ2,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
3938,LMQGSTLPR,5.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P18277,HUMAN IMMUNOLOGY 1996 45 79-93
3939,,,n/a,HLA-A31,CLASS-I,HUMAN,VIRAL,P18277,HUMAN IMMUNOLOGY 1996 45 79-93
3940,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P18277,HUMAN IMMUNOLOGY 1996 45 79-93
3941,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P18277,HUMAN IMMUNOLOGY 1996 45 79-93
3942,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P18277,HUMAN IMMUNOLOGY 1996 45 79-93
3943,LMSGFRQM,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z7H7,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
3944,LMVGSDLEI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 44 233-241
3945,LMWITQCFL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P78358,CANCER RESEARCH 2002 62 3630-3635
3946,LNEDLRSWTAADTAA,1.0,DQA1*0103/DQB1*0603,HLA-DQ6,CLASS-2,HUMAN,SELF PEPTIDE,P01889,CLINICAL EXPERIMENTAL IMMUNOLOGY 2002 129 429-437
3947,LNFPISPI,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20875,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
3948,LNNQFGTM,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
3949,LNNTRPPRGNWFGCT,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27960,JOURNAL OF HEPATOLOGY 2001 34 321-329
3950,LPAKFLEGF,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,BACTERIAL,P17944,JOURNAL OF INFECTIOUS DISEASES 2001 183 928-934
3951,LPALGWLVF,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P19473,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
3952,,,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P19473,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
3953,LPALSTGLI,5.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P26664,IMMUNOGENETICS 1996 43 268-276
3954,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P26664,IMMUNOGENETICS 1996 43 268-276
3955,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26664,IMMUNOGENETICS 1998 47 256-263
3956,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663http://us.expasy.org/cgi-bin/get-sprot-entry,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
3957,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P26664,IMMUNOGENETICS 1996 43 268-276
3958,LPAVVGLSPGEQEY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
3959,LPCRIKQII,9.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1996 43 268-276
3960,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1996 43 268-276
3961,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1998 47 256-263
3962,,,*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1999 49 819-822
3963,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1997 46 245-248
3964,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,HUMAN IMMUNOLOGY 1999 60 177-186
3965,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1996 43 268-276
3966,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1999 49 819-822
3967,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1999 49 819-822
3968,LPDGQVIWV,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
3969,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
3970,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
3971,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
3972,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
3973,LPEKDSWTV,4.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 43 268-276
3974,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 43 268-276
3975,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 43 268-276
3976,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P20892,HUMAN IMMUNOLOGY 1999 60 177-186
3977,LPENNVLSPL,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P04637,HUMAN IMMUNOLOGY 2003 64 245-255
3978,LPFDFTPGY,5.0,B*3502,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3979,,,n/a,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3980,,,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3981,,,B*3503,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3982,,,B*5401,HLA-B54,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
3983,LPFRNCPRF,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
3984,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
3985,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
3986,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
3987,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
3988,LPGCSFSIF,14.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
3989,,,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,Q01403,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
3990,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P27958,IMMUNOGENETICS 1998 47 256-263
3991,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,Q01403,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
3992,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
3993,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
3994,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,Q01403,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
3995,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
3996,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
3997,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,Q01403,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
3998,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P27954,HUMAN IMMUNOLOGY 2003 64 211-223
3999,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P27954,HUMAN IMMUNOLOGY 2003 64 211-223
4000,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
4001,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,Q01403,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4002,LPGCSFSIFLLALL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27954,JOURNAL OF HEPATOLOGY 2001 34 321-329
4003,LPGPKFLQY,5.0,B*3502,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4004,,,n/a,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4005,,,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4006,,,B*3503,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4007,,,B*5401,HLA-B54,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4008,LPHSSSHWL,1.0,n/a,HLA-B7,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
4009,LPIVGAETY,2.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03369,IMMUNOGENETICS 1999 49 819-822
4010,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03369,IMMUNOGENETICS 1999 49 819-822
4011,LPIWARPDY,2.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 1998 47 256-263
4012,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
4013,LPKEACMEI,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4014,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4015,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4016,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4017,,,*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4018,LPKLPGVPF,4.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 1998 47 256-263
4019,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 1999 49 819-822
4020,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
4021,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 1999 49 819-822
4022,LPPGSTKRAL,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P04637,HUMAN IMMUNOLOGY 2003 64 245-255
4023,LPPIPVGEI,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1997 46 245-248
4024,LPPLERLTL,4.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P04622,IMMUNOGENETICS 1996 43 268-276
4025,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P04622,IMMUNOGENETICS 1996 43 268-276
4026,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P04622,AIDS 1996 10 1075-1083
4027,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P04622,IMMUNOGENETICS 1996 43 268-276
4028,LPPTTGPPI,6.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,Q00269,IMMUNOGENETICS 1996 43 268-276
4029,,,B*5103,HLA-B51,CLASS-I,HUMAN,MISCELLANEOUS,P41237,IMMUNOGENETICS 1996 43 268-276
4030,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,Q00269,IMMUNOGENETICS 1999 49 819-822
4031,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,Q00269,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
4032,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,Q00269,IMMUNOGENETICS 1999 49 819-822
4033,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,Q00269,IMMUNOGENETICS 1996 43 268-276
4034,LPPVVAKEI,5.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 43 268-276
4035,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 43 268-276
4036,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 43 268-276
4037,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,HUMAN IMMUNOLOGY 1999 60 177-186
4038,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1999 49 819-822
4039,LPQANRDTL,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,n/a,not applicable,JOURNAL OF IMMUNOLOGY 2003 171 22-26
4040,LPQAVMGSSY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
4041,LPQGWKGSPAI,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P20892,HUMAN IMMUNOLOGY 1999 60 177-186
4042,LPQPPICTI,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P00533,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4043,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P00533,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4044,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P00533,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4045,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P00533,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4046,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P00533,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4047,LPRAWLQRL,1.0,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,not applicable,JOURNAL OF MEDICAL VIROLOGY 2004 72 635-645
4048,LPRDTGPEL,1.0,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P03233,JOURNAL OF MEDICAL VIROLOGY 2004 72 635-645
4049,LPRELFPPL,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P78395,HUMAN IMMUNOLOGY 2003 64 245-255
4050,LPRRLFPPLF,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P78395,HUMAN IMMUNOLOGY 2003 64 245-255
4051,LPSDFFPSV,18.0,B*1301,HLA-B13,CLASS-I,HUMAN,VIRAL,P03146,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
4052,,,B*3502,HLA-B35,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4053,,,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P03146,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4054,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P17391,IMMUNOGENETICS 2003 54 830-841
4055,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P17391,HUMAN IMMUNOLOGY 2003 64 211-223
4056,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24023,MOLECULAR IMMUNOLOGY 1994 31 813-822
4057,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
4058,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4059,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03146,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4060,,,B*3503,HLA-B35,CLASS-I,HUMAN,VIRAL,P03146,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4061,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4062,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4063,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4064,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03146,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4065,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P17391,IMMUNOGENETICS 2003 54 830-841
4066,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
4067,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4068,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
4069,LPSIPVHPI,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,Q04609,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4070,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,Q04609,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4071,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,Q04609,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4072,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,Q04609,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4073,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,Q04609,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4074,LPSPACQLV,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4075,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4076,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4077,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4078,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4079,LPSSADVEF,2.0,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 2000 164 4130-4134
4080,,,B*3503,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 2000 164 4130-4134
4081,LPTLAKFSPY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P78395,HUMAN IMMUNOLOGY 2003 64 245-255
4082,LPTNASLSF,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4083,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4084,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4085,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4086,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4087,LPTSHPKIV,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,O75398,JOURNAL OF IMMUNOLOGY 2003 171 22-26
4088,LPTTLFQPV,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4089,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4090,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4091,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4092,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4093,LPVCAFSSA,3.0,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P03166,IMMUNOGENETICS 2003 54 830-841
4094,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03166,HUMAN IMMUNOLOGY 2003 64 211-223
4095,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03166,IMMUNOGENETICS 2003 54 830-841
4096,LPVCAPSSA,2.0,B*1301,HLA-B13,CLASS-I,HUMAN,VIRAL,O43504,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
4097,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,O43504,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
4098,LPVFTWLAL,5.0,n/a,HLA-B51,CLASS-I,HUMAN,PARASITE,O13332,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4099,,,B*3501,HLA-B35,CLASS-I,HUMAN,PARASITE,O13332,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4100,,,B*5301,HLA-B53,CLASS-I,HUMAN,PARASITE,O13332,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4101,,,B*5401,HLA-B54,CLASS-I,HUMAN,PARASITE,O13332,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4102,,,B*0702,HLA-B7,CLASS-I,HUMAN,PARASITE,O13332,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4103,LPVGSDLEI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 44 233-241
4104,LPWHRLFLL,6.0,n/a,HLA-B51,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4105,,,n/a,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
4106,,,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4107,,,B*5301,HLA-B53,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4108,,,B*5401,HLA-B54,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4109,,,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4110,LPYAGWLVF,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P19473,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
4111,,,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P19473,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
4112,LPYGRTNL,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,BACTERIAL,P16893,HUMAN IMMUNOLOGY 2003 64 211-223
4113,LPYLAWLVF,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P19473,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
4114,,,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P19473,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
4115,LPYLGALVF,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P19473,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
4116,,,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P19473,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
4117,LPYLGWAVF,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P19473,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
4118,,,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P19473,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
4119,LPYLGWLAF,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P19473,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
4120,,,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P19473,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
4121,LPYLGWLVA,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P19473,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
4122,,,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P19473,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
4123,LPYLGWLVF,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P19473,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
4124,,,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P19473,EURO.JOURNAL OF IMMUNOLOGY 1994 24 2740-2745
4125,LQAGFFLL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
4126,LQDIEITCV,3.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
4127,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
4128,,,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
4129,LQIGNIISI,1.0,H-2Dd,H-2d,CLASS-I,MOUSE,VIRAL,P03471,JOURNAL OF IMMUNOLOGICAL METHODS 1994 177 261-268
4130,LQLPPIERL,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20869,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
4131,LQQRYSRL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z7W9,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
4132,LQTTIHDII,15.0,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
4133,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,HUMAN IMMUNOLOGY 1995 44 189-198
4134,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,HUMAN IMMUNOLOGY 1995 44 189-198
4135,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
4136,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
4137,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
4138,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
4139,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
4140,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
4141,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1995 154 5934-5943
4142,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
4143,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
4144,,,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
4145,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
4146,,,A*2401,HLA-A24,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
4147,LQVGSDLEI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 44 233-241
4148,LRCNDTNYSGF,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2002 168 210-219
4149,LRFPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
4150,LRRYLENGK,4.0,B*2703,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P30467,TISSUE ANTIGENS 1997 49 23-28
4151,,,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P30467,TISSUE ANTIGENS 1997 49 23-28
4152,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P30467,TISSUE ANTIGENS 1997 49 23-28
4153,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P30467,TISSUE ANTIGENS 1997 49 23-28
4154,LRSLNQTVHSL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
4155,LRTELTYLQY,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
4156,LRVGSDLEI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 44 233-241
4157,LRYWAIRTR,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
4158,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
4159,LSAFPFDL,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 1998 160 77-86
4160,,,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 2001 167 4207-4214
4161,LSAFSLHSY,1.0,n/a,HLA-A1,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
4162,LSAIPPSRSM,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4163,LSAIPPSRSML,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4164,LSGNGHFHY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P09790,IMMUNOGENETICS 1997 45 249-258
4165,LSKVAPVIKARMMEYG,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q05329,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4166,LSLDVSAAFY,1.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
4167,LSPAPFDL,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 2001 167 4207-4214
4168,LSPFAFDL,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 2001 167 4207-4214
4169,LSPFPADL,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 2001 167 4207-4214
4170,LSPFPFAL,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 2001 167 4207-4214
4171,LSPFPFDA,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 2001 167 4207-4214
4172,LSPFPFDL,7.0,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 1998 160 77-86
4173,,,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 1995 154 567-576
4174,,,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 1998 160 77-86
4175,,,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,MOLECULAR IMMUNOLOGY 1997 34 273-281
4176,,,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
4177,,,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 2001 167 4207-4214
4178,,,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 1995 154 567-576
4179,LSPIPPSRSM,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4180,LSPIPPSRSML,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4181,LSPRTLNAW,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF VIROLOGY 2001 75 738-749
4182,LSPYAVRI,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4183,LSPYPFDL,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 1995 154 567-576
4184,LSQDALTNY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P09790,IMMUNOGENETICS 1997 45 249-258
4185,LSQEQEGCY,1.0,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05897,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
4186,LSSIFSRI,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
4187,LSTNLPYGK,2.0,n/a,HLA-A11,CLASS-I,HUMAN,BACTERIAL,P16893,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
4188,,,n/a,HLA-A11,CLASS-I,HUMAN,BACTERIAL,P16893,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
4189,LSTYAVRI,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4190,LSVGSDLEI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 44 233-241
4191,LSVMEVYDGR,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
4192,LSYSAGAL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P21429,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
4193,LTAGLDFAY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P09790,IMMUNOGENETICS 1997 45 249-258
4194,LTALGNHI,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4195,LTARGLLNM,1.0,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
4196,LTCSPQPEY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,CANCER,P04626,IMMUNOGENETICS 1997 45 249-258
4197,LTDVSPEPL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4198,LTEAVQKITT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4199,LTEEKIKALV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4200,LTEKEGSYPK,1.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03452,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
4201,LTEVFEFAF,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
4202,LTFGWCFKL,11.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
4203,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
4204,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
4205,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
4206,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
4207,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
4208,,,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20867,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
4209,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
4210,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
4211,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
4212,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
4213,LTFGWCFKLV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
4214,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
4215,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
4216,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
4217,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
4218,LTFGWCYKL,6.0,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P05855,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
4219,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P05855,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
4220,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P05855,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
4221,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P05855,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
4222,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P05855,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
4223,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P05855,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
4224,LTFTNDSII,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
4225,LTFTNDSSI,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
4226,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
4227,LTHVLYPVPL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4228,LTINKEEAL,2.0,n/a,HLA-B8,CLASS-I,HUMAN,CANCER,P00519,BLOOD 1995 85 2680-2684
4229,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P00519,BLOOD 1995 85 2680-2684
4230,LTINKEEALQR,2.0,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P00519,BLOOD 1995 85 2680-2684
4231,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P00519,BLOOD 1995 85 2680-2684
4232,LTKQYLNLY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P17395,IMMUNOGENETICS 1997 45 249-258
4233,LTPEKGWL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4234,LTPEKGWLSL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4235,LTPEKGWLST,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4236,LTPEKGWLSTL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4237,LTPEKGWLSTY,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4238,LTPERGWL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27974,JOURNAL OF VIROLOGY 2001 75 738-749
4239,LTPKWNNETW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2002 168 210-219
4240,LTPLGNHI,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4241,LTPRCMVDY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P29846,IMMUNOGENETICS 1997 45 249-258
4242,LTPTLAAKDASIPTA,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01404,JOURNAL OF HEPATOLOGY 2001 34 321-329
4243,LTQDLVQEK,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
4244,LTQDLVQEKY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
4245,LTSELPQWL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P31952,JOURNAL OF IMMUNOLOGY 2000 165 6463-6471
4246,LTSLFTPGPAQKIQL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01404,JOURNAL OF HEPATOLOGY 2001 34 321-329
4247,LTVILGVLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1995 154 2257-2265
4248,LTYKYNQFY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P46081,IMMUNOGENETICS 1997 45 249-258
4249,LURCNCQK,1.0,,,,,,,
4250,LVALVGLFV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
4251,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,INTERNATIONAL JOURNAL OF CANCER 2000 87 241-246
4252,LVDFRELNK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 2000 55 296-302
4253,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 2000 55 296-302
4254,LVDRFELNKR,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4255,LVEICTEMEK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4256,LVELAGQSL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4257,LVFACSAVPV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
4258,LVFDECGIT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4259,LVFGIELMEV,6.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43357,PROC.NATL.ACAD.SCI. USA 1994 91 2105-2109
4260,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
4261,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
4262,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
4263,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
4264,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 2001 167 787-796
4265,LVFGIEVVEV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 2001 167 787-796
4266,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 2001 167 787-796
4267,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 2001 167 787-796
4268,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 2001 167 787-796
4269,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 2001 167 787-796
4270,LVGFLLLKY,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
4271,LVGFLLLKYR,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
4272,LVGPTPVNI,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
4273,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
4274,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
4275,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
4276,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
4277,LVHFLLLKY,2.0,n/a,HLA-A3,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
4278,,,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
4279,LVKLWYQLEK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4280,LVKSPNHVK,6.0,n/a,HLA-A3,CLASS-I,HUMAN,HUMAN,P04626,HUMAN IMMUNOLOGY 1996 45 79-93
4281,,,n/a,HLA-A31,CLASS-I,HUMAN,HUMAN,P04626,HUMAN IMMUNOLOGY 1996 45 79-93
4282,,,A*1101,HLA-A11,CLASS-I,HUMAN,HUMAN,P04626,HUMAN IMMUNOLOGY 1996 45 79-93
4283,,,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P04626,CANCER RESEARCH 1999 59 431-435
4284,,,A*3301,HLA-A33,CLASS-I,HUMAN,HUMAN,P04626,HUMAN IMMUNOLOGY 1996 45 79-93
4285,,,A*6801,HLA-A68,CLASS-I,HUMAN,HUMAN,P04626,HUMAN IMMUNOLOGY 1996 45 79-93
4286,LVLGTLEEV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
4287,LVLMAVLYV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
4288,LVMAPRTVL,6.0,A*0101,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P30463,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4289,,,n/a,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P30463,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4290,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P30463,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4291,,,A*0302,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P30463,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4292,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P30463,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4293,,,B*0801,HLA-B8,CLASS-I,HUMAN,SELF PEPTIDE,P30463,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4294,LVQEKYLEY,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
4295,LVQNANPDCK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03383,TISSUE ANTIGENS 2000 55 296-302
4296,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03383,TISSUE ANTIGENS 2000 55 296-302
4297,LVSIFLHL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
4298,LVSLLTFMI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
4299,LVTCLGLSY,1.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43356,PROC.NATL.ACAD.SCI. USA 1994 91 2105-2109
4300,LVVDFSQFSR,7.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4301,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4302,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
4303,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
4304,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4305,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4306,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4307,LVVSQLLRIPQAVVD,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01403,JOURNAL OF HEPATOLOGY 2001 34 321-329
4308,LVYNYPGV,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z6X7,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
4309,LWAVVGLSPGEQEY,2.0,B*3501,HLA-B35,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 1189-1198
4310,,,*3503,HLA-B35,CLASS-I,HUMAN,n/a,not applicable,J.EXP.MED 2001 193 1189-1198
4311,LWKGEGAVVI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P04589,HUMAN IMMUNOLOGY 2003 64 245-255
4312,LWVGSDLEI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 44 233-241
4313,LWYQLEKEPI,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4314,LYCVHQRI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
4315,LYGNEGCGWAGWLL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27961,JOURNAL OF HEPATOLOGY 2001 34 321-329
4316,LYGPDAPTI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,CANCER,P06731,INTERNATIONAL JOURNAL OF CANCER 1999 80 92-97
4317,LYGPDTPII,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,CANCER,P06731,INTERNATIONAL JOURNAL OF CANCER 1999 80 92-97
4318,LYIFATCLGL,1.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43357,PROC.NATL.ACAD.SCI. USA 1994 91 2105-2109
4319,LYILVTCLGL,1.0,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P43356,CLINICAL CANCER RESEARCH 1999 5 2236-2241
4320,LYKYKVIKI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
4321,LYLLMDCSGSI,2.0,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,P16893http://us.expasy.org/cgi-bin/get-sprot-entry,IMMUNOGENETICS 2003 54 830-841
4322,,,A*2402,HLA-A24,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNOGENETICS 2003 54 830-841
4323,LYNFTQIPHL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,Q04609,CLINICAL CANCER RESEARCH 2002 8 3885-3892
4324,LYNLLIRCL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
4325,,,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
4326,LYNTVATL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
4327,LYPLTSLR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
4328,LYPLTSLRSL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
4329,LYPLTSLRSLF,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
4330,LYQNVGTYV,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P03451,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
4331,LYSDPADYF,1.0,A*0201,HLA-A24,CLASS-I,HUMAN,SELF PEPTIDE,Q04609,CLINICAL CANCER RESEARCH 2002 8 3885-3892
4332,LYSILSPFL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
4333,LYTVKYPNL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
4334,LYVGSDLED,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 44 233-241
4335,LYVGSDLEF,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 44 233-241
4336,LYVGSDLEG,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 44 233-241
4337,LYVGSDLEI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
4338,LYVGSDLEL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 44 233-241
4339,LYVGSDLEP,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 44 233-241
4340,LYVGSDLEQ,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 44 233-241
4341,LYVGSDLER,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 44 233-241
4342,LYVGSDLES,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 44 233-241
4343,LYVGSDLEW,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 44 233-241
4344,MAGDDCVASR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
4345,MALLRLPLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,O07214,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
4346,MASDFNLPPV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
4347,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
4348,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
4349,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
4350,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
4351,MASDFNLPPVV,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P20892,HUMAN IMMUNOLOGY 1999 60 177-186
4352,MAVFIHNFKR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
4353,MAYPFQLGL,1.0,n/a,H-2M3,CLASS-IB,MOUSE,SELF PEPTIDE,P50672,JOURNAL OF IMMUNOLOGY 1998 161 5171-5178
4354,MEKEGKISKI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4355,MENRWQVMIVWQVDR,7.0,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,Q70623,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
4356,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,Q70623,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
4357,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,Q70623,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
4358,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q70623,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
4359,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q70623,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
4360,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q70623,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
4361,,,n/a,HLA-DR13,CLASS-2,HUMAN,VIRAL,Q70623,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
4362,MESTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
4363,MFEALPHII,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
4364,MFFINILTL,1.0,n/a,H-2M3,CLASS-IB,MOUSE,SELF PEPTIDE,P03889,JOURNAL OF IMMUNOLOGY 1998 161 5171-5178
4365,MFINRWLFS,1.0,n/a,H-2M3,CLASS-IB,MOUSE,VIRAL,Q36347,JOURNAL OF IMMUNOLOGY 1998 161 5171-5178
4366,MFPDLESEF,1.0,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P43356,CLINICAL CANCER RESEARCH 1999 5 2236-2241
4367,MGLIYNRM,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P21429,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
4368,MHLPLWGRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4369,MHLPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4370,MHLPLWVRMG,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4371,MHPAQTSQW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
4372,MHQKRTAMF,1.0,A*2401,HLA-A24,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
4373,MHRPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4374,MIDGIGRFY,1.0,n/a,HLA-A1,CLASS-I,HUMAN,VIRAL,P06826,JOURNAL OF IMMUNOLOGY 1993 151 5930-5935
4375,MIENLEYM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
4376,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
4377,MINLRRLLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4378,MITQFESL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P08273,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
4379,MLARACQHA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
4380,MLASTLTDA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q02251,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
4381,MLATDLSLRV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q08129,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
4382,MLDLQPETT,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
4383,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1995 154 5934-5943
4384,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
4385,MLESVIKNY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
4386,MLESVIKNYK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
4387,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
4388,MLGNAPSVV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,not applicable,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
4389,MLGTHTMEV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
4390,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802
4391,MLKIILPSL,1.0,n/a,H-2M3,CLASS-IB,MOUSE,SELF PEPTIDE,P03911,JOURNAL OF IMMUNOLOGY 1998 161 5171-5178
4392,MLLAVLYCL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1995 154 3961-3968
4393,MLLSVPLLL,3.0,/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04626,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427
4394,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14211,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 21443-21449
4395,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P27797,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 47320-47328
4396,MLNIPSINV,3.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P18139,IMMUNOGENETICS 1998 48 98-107
4397,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
4398,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
4399,MLQDGNKGSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,not applicable,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
4400,MLQDMAILT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P06806,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
4401,MLSAKQLHTL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16790,CANCER RESEARCH 1999 59 5554-5559
4402,MLTDVSPEPL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4403,MMETQTSTW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2002 168 210-219
4404,MMIWHSNL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,Q07546,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
4405,MMWYWGPSL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P17398,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
4406,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
4407,MMWYWGPSLY,5.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4408,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4409,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4410,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4411,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4412,MNENLFASF,1.0,n/a,H-2M3,CLASS-IB,MOUSE,SELF PEPTIDE,P00848,JOURNAL OF IMMUNOLOGY 1998 161 5171-5178
4413,MNIFTTSIL,1.0,n/a,H-2M3,CLASS-IB,MOUSE,SELF PEPTIDE,P03921,JOURNAL OF IMMUNOLOGY 1998 161 5171-5178
4414,MNIQFTAV,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P03452,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
4415,MNLYTVIFI,1.0,n/a,H-2M3,CLASS-IB,MOUSE,SELF PEPTIDE,P03899,JOURNAL OF IMMUNOLOGY 1998 161 5171-5178
4416,MNNYIFVLS,1.0,n/a,H-2M3,CLASS-IB,MOUSE,SELF PEPTIDE,P03925,JOURNAL OF IMMUNOLOGY 1998 161 5171-5178
4417,MNPITLAIL,1.0,n/a,H-2M3,CLASS-IB,MOUSE,SELF PEPTIDE,P03893,JOURNAL OF IMMUNOLOGY 1998 161 5171-5178
4418,MNYYWTLL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P03452,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
4419,MPFAGLLII,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4420,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4421,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4422,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4423,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4424,MPFATPMEAEL,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P78358,JOURNAL OF IMMUNOLOGY 2003 171 6283-6289
4425,MPKAGLLII,6.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4426,,,n/a,HLA-B7,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
4427,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4428,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4429,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4430,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P43357,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4431,MPLANNSEY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,MISCELLANEOUS,Q03364,IMMUNOGENETICS 1998 47 256-263
4432,MPLETQLAI,12.0,B*3502,HLA-B35,CLASS-I,HUMAN,BACTERIAL,P17503,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4433,,,n/a,HLA-B7,CLASS-I,HUMAN,BACTERIAL,P17503,IMMUNITY 1997 7 97-112
4434,,,n/a,HLA-B7,CLASS-I,HUMAN,BACTERIAL,P17503,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4435,,,B*3501,HLA-B35,CLASS-I,HUMAN,BACTERIAL,P17503,IMMUNITY 1997 7 97-112
4436,,,B*3501,HLA-B35,CLASS-I,HUMAN,BACTERIAL,P17503,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4437,,,B*3503,HLA-B35,CLASS-I,HUMAN,BACTERIAL,P17503,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4438,,,B*5101,HLA-B51,CLASS-I,HUMAN,BACTERIAL,P17503,IMMUNITY 1997 7 97-112
4439,,,B*5301,HLA-B53,CLASS-I,HUMAN,BACTERIAL,P17503,IMMUNITY 1997 7 97-112
4440,,,B*5401,HLA-B54,CLASS-I,HUMAN,BACTERIAL,P17503,IMMUNITY 1997 7 97-112
4441,,,B*5401,HLA-B54,CLASS-I,HUMAN,BACTERIAL,P17503,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4442,,,B*0702,HLA-B7,CLASS-I,HUMAN,BACTERIAL,P17503,HUMAN IMMUNOLOGY 2003 64 211-223
4443,,,B*0702,HLA-B7,CLASS-I,HUMAN,BACTERIAL,P17503,HUMAN IMMUNOLOGY 2003 64 211-223
4444,MPNDPNRNV,5.0,B*3502,HLA-B35,CLASS-I,HUMAN,PARASITE,P05691,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4445,,,n/a,HLA-B7,CLASS-I,HUMAN,PARASITE,P05691,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4446,,,B*3501,HLA-B35,CLASS-I,HUMAN,PARASITE,P05691,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4447,,,B*3503,HLA-B35,CLASS-I,HUMAN,PARASITE,P05691,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4448,,,B*5401,HLA-B54,CLASS-I,HUMAN,PARASITE,P05691,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4449,MPNQAQMRI,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4450,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4451,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4452,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4453,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4454,MPQLDTSTW,1.0,n/a,H-2M3,CLASS-IB,MOUSE,SELF PEPTIDE,P03930,JOURNAL OF IMMUNOLOGY 1998 161 5171-5178
4455,MPREDAHFI,6.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4456,,,n/a,HLA-B7,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
4457,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4458,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4459,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4460,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4461,MPREDAHFIY,1.0,n/a,HLA-B7,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
4462,MPSTFFNLT,1.0,n/a,H-2M3,CLASS-IB,MOUSE,SELF PEPTIDE,P03903,JOURNAL OF IMMUNOLOGY 1998 161 5171-5178
4463,MPVGGQSSF,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,BACTERIAL,P12942,JOURNAL OF INFECTIOUS DISEASES 2001 183 928-934
4464,MPVGGQSSFY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,BACTERIAL,P12942,JOURNAL OF INFECTIOUS DISEASES 2001 183 928-934
4465,MRCNKSETDRW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2002 168 210-219
4466,MRHVLEPF,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05897,JOURNAL OF IMMUNOLOGY 2002 168 210-219
4467,MRVTAPRTL,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P30477,JOURNAL OF IMMUNOLOGY 2001 166 1016-1027
4468,MRYWAIRTR,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
4469,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
4470,MSLEQRSLH,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
4471,MSLQRQFLR,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,not applicable,JOURNAL OF IMMUNOLOGY 1998 160 890-897
4472,,,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,not applicable,JOURNAL OF IMMUNOLOGY 1998 160 890-897
4473,,,A*3101,HLA-A31,CLASS-I,HUMAN,CANCER,not applicable,JOURNAL OF IMMUNOLOGY 1998 160 890-897
4474,,,A*3301,HLA-A33,CLASS-I,HUMAN,CANCER,not applicable,JOURNAL OF IMMUNOLOGY 1998 160 890-897
4475,,,A*6801,HLA-A68,CLASS-I,HUMAN,CANCER,not applicable,JOURNAL OF IMMUNOLOGY 1998 160 890-897
4476,MSPSYVKL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27976,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4477,MSPSYVKY,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27976,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4478,MSPSYVKYRL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27976,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4479,MSPSYVKYRY,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27976,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4480,MSPSYVKYRYL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27976,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4481,MSTIPKPQRKTKRN,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
4482,MTKILEPFR,6.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
4483,,,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P12499,HUMAN IMMUNOLOGY 1996 45 79-93
4484,,,n/a,HLA-A31,CLASS-I,HUMAN,VIRAL,P12499,HUMAN IMMUNOLOGY 1996 45 79-93
4485,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P12499,HUMAN IMMUNOLOGY 1996 45 79-93
4486,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P12499,HUMAN IMMUNOLOGY 1996 45 79-93
4487,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P12499,HUMAN IMMUNOLOGY 1996 45 79-93
4488,MTKKRKVDGL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4489,MTLPLWGRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4490,MTLPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4491,MTNNPPIPV,10.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF VIROLOGY 2001 75 1301-1311
4492,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
4493,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
4494,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF VIROLOGY 2001 75 1301-1311
4495,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF VIROLOGY 2001 75 1301-1311
4496,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
4497,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
4498,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF VIROLOGY 2001 75 1301-1311
4499,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF VIROLOGY 2001 75 1301-1311
4500,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
4501,MTPAERLI,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27973,JOURNAL OF VIROLOGY 2001 75 738-749
4502,MTRPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4503,MTYAAPLFV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P47766,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
4504,MVAGAHWGVLAGLAY,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01403,JOURNAL OF HEPATOLOGY 2001 34 321-329
4505,MVHQAISPR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
4506,MVLASTTAK,1.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P21429,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
4507,MVLPLWGRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4508,MVLPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4509,MVLPLWVRMG,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4510,MVMELVRMIK,1.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P15663,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
4511,MVQAWPFTC,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4512,MVRPLWGRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4513,MVRPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4514,MVRPLWVRMG,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4515,MVWLSANPC,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4516,MWYWGPSL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
4517,MYAPPIGGQI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
4518,MYELQKLNSW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2002 168 210-219
4519,MYGLKGPDI,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
4520,MYPHFMPTNL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P11210,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
4521,MYSPTSIL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
4522,MYSPTSILDI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
4523,MYSPTSILDIR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
4524,MYVGGVEHRL,1.0,n/a,HLA-A24,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
4525,NADPTGHSY,1.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 10227-10234
4526,NALFRNLDV,4.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P03383,IMMUNOGENETICS 1996 43 268-276
4527,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P03383,IMMUNOGENETICS 1996 43 268-276
4528,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03383,HUMAN IMMUNOLOGY 1999 60 177-186
4529,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03383,IMMUNOGENETICS 1996 43 268-276
4530,NANPDCKTI,5.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1996 43 268-276
4531,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1996 43 268-276
4532,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,HUMAN IMMUNOLOGY 1999 60 177-186
4533,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1999 49 819-822
4534,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1996 43 268-276
4535,NAPPAYEKL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1995 154 2257-2265
4536,NAPPIGGQI,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1997 46 245-248
4537,NCERKKPPV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
4538,NCSVYDFFV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
4539,NDDSYIPSAEKI,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,PARASITE,P06915,EURO.JOURNAL OF IMMUNOLOGY 1993 23 1118-1124
4540,NEKSFKDI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,PARASITE,P13664,INFECTION AND IMMUNITY 1999 67 6358-6363
4541,NESTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
4542,NFLPSDFFPSV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P17391,JOURNAL OF IMMUNOLOGY 2003 170 2977-2984
4543,NFMKTAGFI,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,O26954,JOURNAL OF IMMUNOLOGY 2001 167 655-666
4544,NFPQITILWQR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
4545,NGLDFSEV,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
4546,NGLWNLDVI,2.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
4547,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
4548,NGMLIMCNA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01718,CANCER RESEARCH 1997 57 4348-4355
4549,NHPVFSPL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z7W9,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
4550,NIMMQRGNF,3.0,A*2601,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
4551,,,A*2602,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
4552,,,A*2603,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
4553,NIMMQRGNFR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
4554,NISGYNFSL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
4555,NIVTDSQYAL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4556,NIWATHACV,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20871,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
4557,NKADVILKY,1.0,Cw*0401,HLA-Cw4,CLASS-I,HUMAN,SELF PEPTIDE,O14602,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4558,NKEEALQR,1.0,n/a,HLA-B27,CLASS-I,HUMAN,CANCER,P00519,BLOOD 1995 85 2680-2684
4559,NKKTFDHTL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
4560,NLGATLKGV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P19544,IMMUNOGENETICS 2000 51 99-107
4561,NLGKVIDTLTCGFA,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27954,JOURNAL OF HEPATOLOGY 2001 34 321-329
4562,NLGNLNVSI,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03155,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
4563,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
4564,NLIYYADSV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
4565,NLKTGKYAR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
4566,NLKTGKYARMR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
4567,NLKTGKYART,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4568,NLLMNGQQI,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
4569,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
4570,NLQSLTNLL,4.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
4571,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
4572,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
4573,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P17394,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
4574,NLRRLLLSHI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4575,NLSWLSLDV,7.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
4576,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03159,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 1047-1058
4577,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
4578,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P12933,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
4579,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
4580,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
4581,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P12933,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
4582,NLTHVLYPV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4583,NLTISDVSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P15941,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
4584,NLVPMVATV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
4585,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
4586,NLYVSLLLL,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03155,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
4587,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03155,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
4588,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
4589,NMVPFFPPV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
4590,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
4591,NNIYNATFL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P15116,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
4592,,,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P15116,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
4593,NPAQEDDQY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26664,IMMUNOGENETICS 1998 47 256-263
4594,NPDIVIYQY,2.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1998 47 256-263
4595,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1999 49 819-822
4596,NPEIVIYQY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1998 47 256-263
4597,NPNQNKNVAL,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,Q15717,JOURNAL OF IMMUNOLOGY 2003 171 22-26
4598,NPPIPVGEI,5.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1996 43 268-276
4599,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1996 43 268-276
4600,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1996 43 268-276
4601,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1997 46 245-248
4602,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,HUMAN IMMUNOLOGY 1999 60 177-186
4603,NPRLPVCNL,1.0,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P03193,JOURNAL OF MEDICAL VIROLOGY 2004 72 635-645
4604,NRFPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2002 168 210-219
4605,NRYWAIRTR,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
4606,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
4607,NSHHYISM,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
4608,NSMINNIII,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,Q66282,MOLECULAR IMMUNOLOGY 1996 33 1323-1333
4609,NTFVQANLY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P09790,IMMUNOGENETICS 1997 45 249-258
4610,NTGLYNLLI,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
4611,NTVATLYCV,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20873,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
4612,NTVVFDAL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,P23700,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
4613,NVKNLYEKVK,1.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03452,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
4614,NVSIPWTHK,11.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4615,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4616,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
4617,,,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 1996 45 79-93
4618,,,n/a,HLA-A31,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 1996 45 79-93
4619,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
4620,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 1996 45 79-93
4621,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4622,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 1996 45 79-93
4623,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 1996 45 79-93
4624,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4625,NVWATHACV,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20871,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
4626,NWAKVLVVMLLFAGV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
4627,NWASQIYPGI,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4628,NWQYFFPVI,2.0,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P43357,CANCER RESEARCH 1997 57 4465-4468
4629,,,A*2402,HLA-A24,CLASS-I,HUMAN,CANCER,P43357,INTERNATIONAL JOURNAL OF CANCER 1999 81 387-394
4630,NYARTEDFF,1.0,A*0201,HLA-A24,CLASS-I,HUMAN,SELF PEPTIDE,Q04609,CLINICAL CANCER RESEARCH 2002 8 3885-3892
4631,NYDPEGNEI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,BACTERIAL,P13128,IMMUNOGENETICS 2003 54 830-841
4632,NYKHCFPEI,1.0,A*2401,HLA-A24,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
4633,NYKHCFPEIF,1.0,A*2401,HLA-A24,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
4634,NYPIVQNL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
4635,NYPLWSQSY,2.0,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P43357,CANCER RESEARCH 1997 57 4465-4468
4636,,,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43357,PROC.NATL.ACAD.SCI. USA 1994 91 2105-2109
4637,NYQHLWRWGTL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
4638,NYSKFWYL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
4639,NYTNTIYTL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
4640,NYTNTIYTLL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
4641,NYTNYRLI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
4642,NYTPGPGI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03405,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
4643,OPLVGAPLGGAARA,1.0,,,,,,,
4644,PEDNEPSGY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P16504,IMMUNOGENETICS 1997 45 249-258
4645,PEGRTWAQPGYPWP,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
4646,PESTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
4647,PFGMSRILL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
4648,PFLPSDFFPSV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P17391,JOURNAL OF IMMUNOLOGY 2003 170 2977-2984
4649,PFLWMGYEL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P04589,HUMAN IMMUNOLOGY 2003 64 245-255
4650,PFQWMGYELW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05897,JOURNAL OF IMMUNOLOGY 2002 168 210-219
4651,PGDPPQPEY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P26664,IMMUNOGENETICS 1997 45 249-258
4652,PGGGQIVGGVYLLP,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
4653,PGYRWMCL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P17397,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
4654,PHFKVGWAW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05902,JOURNAL OF IMMUNOLOGY 2002 168 210-219
4655,PIAPGQMREPR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
4656,PIETVPVKLK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4657,PISPIETVPV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4658,PIVGAETFYV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4659,PLDEDFRKYT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4660,PLDKGIKPY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03158,IMMUNOGENETICS 1997 45 249-258
4661,PLEEELPRL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
4662,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
4663,PLGGAARAL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27954,JOURNAL OF HEPATOLOGY 2001 34 321-329
4664,PLLLLGLWGL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,not applicable,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
4665,PLLPIFFCL,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
4666,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
4667,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
4668,PLNPFVSHK,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P16507,JOURNAL OF IMMUNOLOGY 1994 152 163-175
4669,PLPIHTAEL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
4670,PLQALLERA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4671,PLTEEAELEL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4672,PLTEEKIKAL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4673,PLTFGWCYKL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P03405,JOURNAL OF EXPERIMENTAL MEDICINE 2000 191 239-252
4674,PLTFGWCYKLV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P03405,JOURNAL OF EXPERIMENTAL MEDICINE 2000 191 239-252
4675,PLTINKEEA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P00519,BLOOD 1995 85 2680-2684
4676,PLTINKEEAL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P00519,BLOOD 1995 85 2680-2684
4677,PLTSIISAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,CELL 1993 74 929-937
4678,PLTSLRSLF,3.0,A*2601,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
4679,,,A*2602,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
4680,,,A*2603,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
4681,PLVGAPLGG,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27954,JOURNAL OF HEPATOLOGY 2001 34 321-329
4682,PMQDIKMIL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4683,PPAVHGCPL,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,n/a,not applicable,IMMUNOGENETICS 1999 49 819-822
4684,PPRGNWFGCTWMNST,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27960,JOURNAL OF HEPATOLOGY 2001 34 321-329
4685,PRRGPRLGV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
4686,PRYWAIRTR,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
4687,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
4688,PSDFFPSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24023,MOLECULAR IMMUNOLOGY 1994 31 813-822
4689,PSDGNCTCI,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P17397,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
4690,PSLKIFIAG,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P13201,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
4691,PSLKIFIAGNS,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P13201,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
4692,PSLKIFIAGNSAYE,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P13201,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
4693,PTAPPEESF,3.0,A*2601,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
4694,,,A*2603,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
4695,,,A*2602,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
4696,PTDPRRRSRNLGKV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27954,JOURNAL OF HEPATOLOGY 2001 34 321-329
4697,PTLAKFSPYL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4698,PTTGRTSLY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03156,IMMUNOGENETICS 1997 45 249-258
4699,PVNIIGRNL,3.0,A*2601,HLA-A26,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 1999 54 325-332
4700,,,A*2602,HLA-A26,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 1999 54 325-332
4701,,,A*2603,HLA-A26,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 1999 54 325-332
4702,PVNRPIDWK,5.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4703,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4704,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4705,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4706,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4707,PVRPQVPLR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20867,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
4708,PVTIGECPK,1.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03452,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
4709,PVVPNAPPA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1995 154 2257-2265
4710,PYCWHYAPQPCGIVP,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
4711,PYDINQML,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
4712,PYEILYKV,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
4713,PYIACRTSI,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
4714,PYNTPMFAI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
4715,PYVSRLLGI,1.0,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P04626,BRITISH JOURNAL OF CANCER 2001 84 94-99
4716,QACPKVSFEPI,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,HUMAN IMMUNOLOGY 1999 60 177-186
4717,QADPTGDSY,2.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 10227-10234
4718,,,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 10227-10234
4719,QADPTGHDY,1.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 10227-10234
4720,QADPTGHNY,2.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 10227-10234
4721,,,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 10227-10234
4722,QADPTGHSY,2.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 10227-10234
4723,,,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 10227-10234
4724,QAEPDRAHY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
4725,QAFIFRAA,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9KPN9,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
4726,QAFIYRAL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
4727,QAFTFSPTYK,2.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
4728,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
4729,QAFTSPTYK,5.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4730,,,n/a,HLA-A24,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4731,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4732,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4733,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
4734,QAPTNRWML,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z6X7,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
4735,QASPFPFDL,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
4736,,,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 2001 167 4207-4214
4737,QAVVDMVAGAHWGVL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01403,JOURNAL OF HEPATOLOGY 2001 34 321-329
4738,QAWCWFGGKW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2002 168 210-219
4739,QDCNCSIYPGHVSGH,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01403,JOURNAL OF HEPATOLOGY 2001 34 321-329
4740,QDDPTGHDY,1.0,n/a,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P43355,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 10227-10234
4741,QDDPTGHSY,1.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 10227-10234
4742,QDSKYSHGM,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
4743,QDVKFPGGGQIVGG,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
4744,QEADNMITEM,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
4745,QEADNMITEML,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
4746,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
4747,QESCYGRL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,P23700,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
4748,QESTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
4749,QFADVIVLF,4.0,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,Q9UJ83,JOURNAL OF IMMUNOLOGY 2000 164 4130-4134
4750,,,B*3501,HLA-B35,CLASS-I,HUMAN,n/a,not applicable,JOURNAL OF IMMUNOLOGY 2000 164 4130-4134
4751,,,B*3503,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,Q9UJ83,JOURNAL OF IMMUNOLOGY 2000 164 4130-4134
4752,,,B*3503,HLA-B35,CLASS-I,HUMAN,n/a,not applicable,JOURNAL OF IMMUNOLOGY 2000 164 4130-4134
4753,QFDQGWGPITYNESH,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
4754,QGINNLDNL,3.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P03070,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
4755,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P03070,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
4756,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P03070,VIROLOGY 1999 256 246-257
4757,QGQYMNTP,1.0,n/a,Mamu-B*04,CLASS-I,RHESUS,VIRAL,P11262,JOURNAL OF IMMUNOLOGY 2000 164 283-291
4758,QGQYMNTPW,1.0,n/a,Mamu-B*04,CLASS-I,RHESUS,VIRAL,P11262,JOURNAL OF IMMUNOLOGY 2000 164 283-291
4759,QGRGQCTEV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
4760,QGWKGSPAI,5.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 43 268-276
4761,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 43 268-276
4762,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26664,IMMUNOGENETICS 1999 49 819-822
4763,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P20892,HUMAN IMMUNOLOGY 1999 60 177-186
4764,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 43 268-276
4765,QGYVYQGL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
4766,QHLPLWGRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4767,QHLPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4768,QHLPLWVRMG,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4769,QHRPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4770,QIIEQLIKKE,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4771,QIIGYVIGT,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
4772,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
4773,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
4774,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
4775,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
4776,QIISFFSPL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
4777,QIKNFHEL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
4778,QITKIQNFR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
4779,QIVGGVYLL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
4780,QIVGGVYLLPRRGP,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
4781,QIYQEPFKNL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4782,QIYQEPFKNLK,1.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
4783,QKEPPFLWMG,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4784,QKIQLVNTNGSQHIN,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
4785,QKITTESIVI,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4786,QKLVGKLNWA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4787,QLAAFCPAL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16790,CANCER RESEARCH 1999 59 5554-5559
4788,QLAPFPFDL,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
4789,,,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 2001 167 4207-4214
4790,QLCKLLRGTK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4791,QLDCTHLEGK,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P04589,HUMAN IMMUNOLOGY 2003 64 245-255
4792,QLDSIEDLEV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4793,QLFEDNYAL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,INTERNATIONAL JOURNAL OF CANCER 1998 78 202-208
4794,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
4795,QLFEDNYALA,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,INTERNATIONAL JOURNAL OF CANCER 1998 78 202-208
4796,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
4797,QLFHLCLII,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03113 ,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
4798,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03113 ,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
4799,QLFTFSPRR,15.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P27954 ,HUMAN IMMUNOLOGY 1996 45 79-93
4800,,,n/a,HLA-A31,CLASS-I,HUMAN,VIRAL,P27954 ,HUMAN IMMUNOLOGY 1996 45 79-93
4801,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P27954 ,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
4802,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958 ,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
4803,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P27954 ,HUMAN IMMUNOLOGY 1996 45 79-93
4804,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958 ,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
4805,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P27954 ,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
4806,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P27954 ,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
4807,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P27958 ,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
4808,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P27958 ,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
4809,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P27954 ,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
4810,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P27954 ,HUMAN IMMUNOLOGY 1996 45 79-93
4811,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P27954 ,HUMAN IMMUNOLOGY 1996 45 79-93
4812,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958 ,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
4813,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P27954 ,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
4814,QLGIPHPAGL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4815,QLGLAANQT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726 ,CANCER RESEARCH 1997 57 4348-4355
4816,QLGYSYAIDL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126 ,CANCER RESEARCH 1998 58 4895-4901
4817,QLIKKEKVYL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4818,QLIPCMDVV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,ALLERGEN,P04721 ,JOURNAL OF IMMUNOLOGY 2003 170 2719-2726
4819,QLIPCMDVVL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,ALLERGEN,P04721 ,JOURNAL OF IMMUNOLOGY 2003 170 2719-2726
4820,QLLALLPSL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395 ,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4821,QLLRHVMNPL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395 ,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4822,QLLRIPQAV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01403 ,JOURNAL OF HEPATOLOGY 2001 34 321-329
4823,QLLSRLEEI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16790 ,CANCER RESEARCH 1999 59 5554-5559
4824,QLLWFHISCL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146 ,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
4825,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P12901 ,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
4826,QLMPYGCLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626 ,INTERNATIONAL JOURNAL OF CANCER 1998 78 202-208
4827,QLNFRATQPL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16790 ,CANCER RESEARCH 1999 59 5554-5559
4828,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16790 ,CANCER RESEARCH 2000 60 6995-7001
4829,QLPPNSLLI,1.0,H-2Db,H-2b,CLASS-I,MOUSE,BACTERIAL,Q9Z7P3 ,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
4830,QLRSLTEILK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P04626 ,CANCER RESEARCH 1999 59 431-435
4831,QLSAFPFDL,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597 ,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
4832,,,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597 ,JOURNAL OF IMMUNOLOGY 2001 167 4207-4214
4833,QLSPAPFDL,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597 ,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
4834,,,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597 ,JOURNAL OF IMMUNOLOGY 2001 167 4207-4214
4835,QLSPFAFDL,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597 ,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
4836,,,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597 ,JOURNAL OF IMMUNOLOGY 2001 167 4207-4214
4837,QLSPFPADL,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597 ,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
4838,,,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597 ,JOURNAL OF IMMUNOLOGY 2001 167 4207-4214
4839,QLSPFPFAL,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597 ,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
4840,,,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597 ,JOURNAL OF IMMUNOLOGY 2001 167 4207-4214
4841,QLSPFPFDA,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597 ,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
4842,,,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597 ,JOURNAL OF IMMUNOLOGY 2001 167 4207-4214
4843,QLSPFPFDL,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597 ,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
4844,,,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597 ,JOURNAL OF IMMUNOLOGY 2001 167 4207-4214
4845,QLSVLSLSGV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395 ,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4846,QLTEAVQKIT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4847,QLVFGIELMEV,6.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43357 ,JOURNAL OF IMMUNOLOGY 2001 167 787-796
4848,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43357 ,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
4849,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P43357 ,JOURNAL OF IMMUNOLOGY 2001 167 787-796
4850,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P43357 ,JOURNAL OF IMMUNOLOGY 2001 167 787-796
4851,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P43357 ,JOURNAL OF IMMUNOLOGY 2001 167 787-796
4852,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P43357 ,JOURNAL OF IMMUNOLOGY 2001 167 787-796
4853,QLVLHQILK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P40967 ,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
4854,QMAVFIHNFK,6.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03368 ,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
4855,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369 ,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
4856,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369 ,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
4857,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369 ,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
4858,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369 ,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
4859,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369 ,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
4860,QMGRNSMKL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126 ,CANCER RESEARCH 1998 58 4895-4901
4861,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126 ,INTERNATIONAL JOURNAL OF CANCER 2000 87 241-246
4862,QMINLRRLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395 ,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4863,QMINLRRLLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395 ,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4864,QMPRQTGGFF,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27973 ,JOURNAL OF VIROLOGY 2001 75 738-749
4865,QMTFHLFI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905 ,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
4866,QMTFHLFIA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905 ,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
4867,QNDPTGHNY,1.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43355 ,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 10227-10234
4868,QNDPTGHSY,1.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43355 ,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 10227-10234
4869,QNDYDEDDY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P09790 ,IMMUNOGENETICS 1997 45 249-258
4870,QNPIPVGNI,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634 ,JOURNAL OF VIROLOGY 2001 75 738-749
4871,QPFILYAHI,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P06789 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4872,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P06789 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4873,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P06789 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4874,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P06789 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4875,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P06789 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4876,QPGYPWPLY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26664 ,IMMUNOGENETICS 1998 47 256-263
4877,QPKKVKRRL,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P03113 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4878,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03113 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4879,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03113 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4880,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03113 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4881,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03113 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4882,QPLTDAKVA,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P04014 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4883,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P04014 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4884,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P04014 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4885,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P04014 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4886,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P04014 ,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
4887,QPPAPIRPIPT,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03204 ,HUMAN IMMUNOLOGY 2003 64 211-223
4888,QPQNGQFI,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991 ,JOURNAL OF VIROLOGY 1995 69 2297-2305
4889,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991 ,JOURNAL OF VIROLOGY 1995 69 2297-2305
4890,QPQNYLRL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,O86164 ,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
4891,QPQRGQENF,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P09992 ,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
4892,QPRAPIRPI,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03204 ,IMMUNOGENETICS 2003 54 830-841
4893,QPRAPIRPIPT,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03204 ,HUMAN IMMUNOLOGY 2003 64 211-223
4894,QPRGRRQPIPKVRR,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959 ,JOURNAL OF HEPATOLOGY 2001 34 321-329
4895,QPRPRDNF,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,BACTERIAL,P16893 ,HUMAN IMMUNOLOGY 2003 64 211-223
4896,QPRPRGDNF,5.0,n/a,HLA-B7,CLASS-I,HUMAN,BACTERIAL,P16893 ,IMMUNITY 1997 7 97-112
4897,,,B*3501,HLA-B35,CLASS-I,HUMAN,BACTERIAL,P16893 ,IMMUNITY 1997 7 97-112
4898,,,B*5101,HLA-B51,CLASS-I,HUMAN,BACTERIAL,P16893 ,IMMUNITY 1997 7 97-112
4899,,,B*5301,HLA-B53,CLASS-I,HUMAN,BACTERIAL,P16893 ,IMMUNITY 1997 7 97-112
4900,,,B*5401,HLA-B54,CLASS-I,HUMAN,BACTERIAL,P16893 ,IMMUNITY 1997 7 97-112
4901,QPRYPVNSV,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P17987 ,JOURNAL OF IMMUNOLOGY 2003 171 22-26
4902,QQLLRREVY,3.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03126 ,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
4903,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03126 ,HUMAN IMMUNOLOGY 1995 44 189-198
4904,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03126 ,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
4905,QREPWDEW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05957 ,JOURNAL OF IMMUNOLOGY 2002 168 210-219
4906,QRESTAMAY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,not applicable,IMMUNOGENETICS 1997 45 249-258
4907,QRYWAIRTR,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277 ,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
4908,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277 ,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
4909,QSPGGLDKGL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903 ,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4910,QSPSLQYL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903 ,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4911,QSPSLQYLAL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903 ,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4912,QSSKALQR,2.0,n/a,HLA-A11,CLASS-I,HUMAN,RAT,P05432 ,BLOOD 1995 85 2680-2684
4913,,,A*0302,HLA-A3,CLASS-I,HUMAN,RAT,P05432 ,BLOOD 1995 85 2680-2684
4914,QTFVVGCI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,PARASITE,P13664 ,INFECTION AND IMMUNITY 1999 67 6358-6363
4915,QTGFLAALFYTHREN,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663 ,JOURNAL OF HEPATOLOGY 2001 34 321-329
4916,QTIVKHPRY,1.0,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05884 ,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
4917,QTLKAMVQA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395 ,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
4918,QTLPLWGRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4919,QTLPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4920,QTNFKSLLR,10.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,Q9TW79 ,HUMAN IMMUNOLOGY 1996 45 79-93
4921,,,n/a,HLA-A31,CLASS-I,HUMAN,VIRAL,Q9TW79 ,HUMAN IMMUNOLOGY 1996 45 79-93
4922,,,A*1101,HLA-A11,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
4923,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,Q9TW79 ,HUMAN IMMUNOLOGY 1996 45 79-93
4924,,,A*0301,HLA-A3,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
4925,,,A*3101,HLA-A31,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
4926,,,A*3301,HLA-A33,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
4927,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,Q9TW79 ,HUMAN IMMUNOLOGY 1996 45 79-93
4928,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,Q9TW79 ,HUMAN IMMUNOLOGY 1996 45 79-93
4929,,,A*6801,HLA-A68,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
4930,QTPLNDVVQAL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991 ,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
4931,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991 ,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
4932,QTRPLWGRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4933,QTRPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4934,QTRPLWVRMG,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4935,QTSAGHFPR,1.0,n/a,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,P14679 ,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
4936,QTSQWDDPW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05861 ,JOURNAL OF IMMUNOLOGY 2002 168 210-219
4937,QTYKWETFL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P31952 ,JOURNAL OF IMMUNOLOGY 2000 165 6463-6471
4938,QTYKWETFLT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P31952 ,JOURNAL OF IMMUNOLOGY 2000 165 6463-6471
4939,QVEKALEEANSK,2.0,n/a,H-2d,CLASS-I,MOUSE,BACTERIAL,P02977 ,EURO.JOURNAL OF IMMUNOLOGY 1999 29 2414-2419
4940,,,n/a,H-2d,CLASS-I,MOUSE,BACTERIAL,P02977 ,EURO.JOURNAL OF IMMUNOLOGY 1999 29 2414-2419
4941,QVLPLWGRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4942,QVLPLWGRMG,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4943,QVLPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4944,QVLPLWVRMG,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4945,QVMSLHNLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126 ,CANCER RESEARCH 1998 58 4895-4901
4946,QVPKFHLPV,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27973 ,JOURNAL OF VIROLOGY 2001 75 738-749
4947,QVPLRPMTYK,10.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03405 ,MOLECULAR IMMUNOLOGY 1994 31 813-822
4948,,,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P03405 ,JOURNAL OF IMMUNOLOGY 1995 154 685-693
4949,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03405 ,MOLECULAR IMMUNOLOGY 1994 31 813-822
4950,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03405 ,JOURNAL OF IMMUNOLOGY 1995 154 685-693
4951,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03405 ,JOURNAL OF IMMUNOLOGY 1995 154 685-693
4952,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03405 ,MOLECULAR IMMUNOLOGY 1994 31 813-822
4953,,,A*2401,HLA-A24,CLASS-I,HUMAN,VIRAL,P03405 ,MOLECULAR IMMUNOLOGY 1994 31 813-822
4954,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03405 ,HUMAN IMMUNOLOGY 1995 44 189-198
4955,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03405 ,HUMAN IMMUNOLOGY 1995 44 189-198
4956,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03405 ,MOLECULAR IMMUNOLOGY 1994 31 813-822
4957,QVPSLQYL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903 ,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4958,QVPSLQYLA,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27974 ,JOURNAL OF VIROLOGY 2001 75 738-749
4959,QVPSLQYLAL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903 ,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
4960,QVRPLWGRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4961,QVRPLWGRMG,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4962,QVRPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4963,QVRPLWVRMG,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
4964,QWTYQIYQEP,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
4965,QYDDAVYKL,2.0,Cw*0401,HLA-Cw4,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4966,,,Cw*0702,HLA-Cw7,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
4967,QYDQIPVEI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368 ,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
4968,QYLAGLSTL,1.0,n/a,HLA-A24,CLASS-I,HUMAN,VIRAL,P27958 ,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
4969,QYNKTGYFI,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,Q9ZD54 ,JOURNAL OF IMMUNOLOGY 2001 167 655-666
4970,QYNVLPQGW,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P04589 ,HUMAN IMMUNOLOGY 2003 64 245-255
4971,QYNVLPQGWK,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03368 ,TISSUE ANTIGENS 2000 55 296-302
4972,QYSPGQRVEF,1.0,n/a,HLA-A24,CLASS-I,HUMAN,VIRAL,P27958 ,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
4973,QYSWFVNGTF,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,CANCER,P06731 ,INTERNATIONAL JOURNAL OF CANCER 1999 80 92-97
4974,RAAGLQDCT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663 ,JOURNAL OF VIROLOGY 1995 69 2462-2470
4975,RAAHGLTSLFTPFPA,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01404 ,JOURNAL OF HEPATOLOGY 2001 34 321-329
4976,RAHYNIVT,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03129 ,IMMUNOLOGY LETTERS 1995 47 1-8
4977,RAHYNIVTF,2.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03129 ,IMMUNOLOGY LETTERS 1995 47 1-8
4978,,,A*2401,HLA-A24,CLASS-I,HUMAN,VIRAL,P03129 ,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
4979,RAHYNIVTFC,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03129 ,IMMUNOLOGY LETTERS 1995 47 1-8
4980,RAKWNNTLK,6.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P19551 ,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
4981,,,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P05880 ,HUMAN IMMUNOLOGY 1996 45 79-93
4982,,,n/a,HLA-A31,CLASS-I,HUMAN,VIRAL,P05880 ,HUMAN IMMUNOLOGY 1996 45 79-93
4983,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P05880 ,HUMAN IMMUNOLOGY 1996 45 79-93
4984,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P05880 ,HUMAN IMMUNOLOGY 1996 45 79-93
4985,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P05880 ,HUMAN IMMUNOLOGY 1996 45 79-93
4986,RALAETSYV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355 ,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
4987,RALAETSYVK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355 ,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
4988,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355 ,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
4989,RALMDKSLHV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655 ,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
4990,RAMASDFNL,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF VIROLOGY 2001 75 1301-1311
4991,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF VIROLOGY 2001 75 1301-1311
4992,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF VIROLOGY 2001 75 1301-1311
4993,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF VIROLOGY 2001 75 1301-1311
4994,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF VIROLOGY 2001 75 1301-1311
4995,RAPRRQGCW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05893 ,JOURNAL OF IMMUNOLOGY 2002 168 210-219
4996,RARWRRLTV,5.0,B*2702,HLA-B27,CLASS-I,HUMAN,VIRAL,P13285 ,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
4997,,,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P13285 ,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
4998,,,B*2704,HLA-B27,CLASS-I,HUMAN,VIRAL,P13285 ,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
4999,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P13285 ,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5000,,,B*2706,HLA-B27,CLASS-I,HUMAN,VIRAL,P13285 ,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5001,RAWENTTIDL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991 ,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5002,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991 ,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5003,RAYRAILHI,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551 ,HUMAN IMMUNOLOGY 1999 60 177-186
5004,RAYVYQGL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
5005,RCQKPLNPA,1.0,A*1102,HLA-A11,CLASS-I,HUMAN,VIRAL,P06463 ,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
5006,RCWVALTPTLAAKDA,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01404 ,JOURNAL OF HEPATOLOGY 2001 34 321-329
5007,RESTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
5008,RETKLGKAGY,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
5009,REVINIVII,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991 ,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5010,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991 ,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5011,REVYDFAF,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03126 ,IMMUNOLOGY LETTERS 1995 47 1-8
5012,REVYDFAFR,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03126 ,IMMUNOLOGY LETTERS 1995 47 1-8
5013,REVYDFAFRD,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03126 ,IMMUNOLOGY LETTERS 1995 47 1-8
5014,REVYDFAFRDL,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03126 ,IMMUNOLOGY LETTERS 1995 47 1-8
5015,REVYDFAFRDLA,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03126 ,IMMUNOLOGY LETTERS 1995 47 1-8
5016,RFDSDADNPRFEPQAPWMEQE,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P01899 ,INTERNATIONAL IMMUNOLOGY 1999 11 1897-1905
5017,RFDSDADNPRFEPRAPWMEQE,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P01899 ,INTERNATIONAL IMMUNOLOGY 1999 11 1897-1905
5018,RFDSDAENPRYEPQAPWMEQE,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P01899 ,INTERNATIONAL IMMUNOLOGY 1999 11 1897-1905
5019,RFDSDAENPRYEPQARWMEQE,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P01899 ,INTERNATIONAL IMMUNOLOGY 1999 11 1897-1905
5020,RFDSDAENPRYEPRAPWMEQE,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P01899 ,INTERNATIONAL IMMUNOLOGY 1999 11 1897-1905
5021,RFDSDAENPRYEPRARWMEQE,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P01899 ,INTERNATIONAL IMMUNOLOGY 1999 11 1897-1905
5022,,,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P01901 ,INTERNATIONAL IMMUNOLOGY 1999 11 1897-1905
5023,RFHNIRGRW,1.0,A*2401,HLA-A24,CLASS-I,HUMAN,VIRAL,P03126 ,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
5024,RFIIFLFI,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P17397 ,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
5025,RFLPSDFFPSV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P17391 ,JOURNAL OF IMMUNOLOGY 2003 170 2977-2984
5026,RFPKTFGW,1.0,n/a,Mamu-B*17,CLASS-I,RHESUS,VIRAL,P11262 ,JOURNAL OF IMMUNOLOGY 2000 164 283-291
5027,RFPRAHKYQV,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903 ,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
5028,RFYRTCKL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P21426 ,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
5029,RFYVYQGL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
5030,RGDNFAVEK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,BACTERIAL,P16893 ,IMMUNITY 1997 7 97-112
5031,,,A*0301,HLA-A3,CLASS-I,HUMAN,BACTERIAL,P16893 ,IMMUNITY 1997 7 97-112
5032,,,A*3101,HLA-A31,CLASS-I,HUMAN,BACTERIAL,P16893 ,IMMUNITY 1997 7 97-112
5033,,,A*3301,HLA-A33,CLASS-I,HUMAN,BACTERIAL,P16893 ,IMMUNITY 1997 7 97-112
5034,,,A*6801,HLA-A68,CLASS-I,HUMAN,BACTERIAL,P16893 ,IMMUNITY 1997 7 97-112
5035,RGEVYQGL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
5036,RGFYVQGL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
5037,RGNSNYKAV,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991 ,VIROLOGY 1998 240 158-167
5038,RGPGRAFVTI,4.0,H-2Dd,H-2d,CLASS-I,MOUSE,VIRAL,P04578 ,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
5039,,,H-2Dd,H-2d,CLASS-I,MOUSE,VIRAL,Q9PXE1 ,MOLECULAR IMMUNOLOGY 1997 34 273-281
5040,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P04578 ,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
5041,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,Q9PXE1 ,MOLECULAR IMMUNOLOGY 1997 34 273-281
5042,RGPNVVTL,1.0,H-2Dd,H-2d,CLASS-I,MOUSE,VIRAL,P09991 ,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
5043,RGSGRAFVTIGK,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P19551 ,JOURNAL OF IMMUNOLOGY 1992 149 1896-1904
5044,RGVINIVII,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991 ,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5045,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991 ,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5046,RGYAYQGL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
5047,RGYKYQGL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11210 ,JOURNAL OF IMMUNOLOGY 1999 162 3388-3394
5048,RGYRYQGL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
5049,RGYVFQGL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11210 ,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
5050,RGYVPQGL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
5051,RGYVWQGL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
5052,RGYVYEGL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
5053,RGYVYGGL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
5054,RGYVYGHL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
5055,RGYVYNGL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
5056,RGYVYQEL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
5057,RGYVYQGF,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
5058,RGYVYQGL,11.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11210 ,NATURE IMMUNOLOGY 2000 1 145-150
5059,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,IMMUNITY 2001 14 231-242
5060,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,IMMUNITY 2001 14 231-242
5061,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-
5062,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
5063,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
5064,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
5065,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF IMMUNOLOGICAL METHODS 1994 177 261-268
5066,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,EURO.JOURNAL OF IMMUNOLOGY 2001 31 2986-2996
5067,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,EURO.JOURNAL OF IMMUNOLOGY 2001 31 2986-2996
5068,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,IMMUNITY 2001 14 231-242
5069,RGYVYQGT,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
5070,RGYVYQGY,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
5071,RGYVYQHL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
5072,RGYVYQYL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11212 ,JOURNAL OF IMMUNOLOGICAL METHODS 1996 192 149-155
5073,RHLPLWGRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
5074,RHLPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
5075,RHQTVQDCNCSIYPG,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959 ,JOURNAL OF HEPATOLOGY 2001 34 321-329
5076,RHRILDMYL,1.0,n/a,Mamu-B*03,CLASS-I,RHESUS,VIRAL,P11262 ,JOURNAL OF IMMUNOLOGY 2000 164 283-291
5077,RHRPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
5078,RHTMLCMCC,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P06788 ,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
5079,RIANGMGATV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P30234 ,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
5080,RIDSFFRL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P35689 ,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
5081,RILGAVAKV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P18206 ,JOURNAL OF EXPERIMENTAL MEDICINE 1996 183 2509-2516
5082,RILHNGAYSL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626 ,INTERNATIONAL JOURNAL OF CANCER 1998 78 202-208
5083,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626 ,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
5084,RILQQLLEI,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05952 ,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
5085,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P05952 ,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
5086,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P05952 ,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
5087,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P05952 ,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
5088,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P05952 ,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
5089,RILQQLLFI,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05954 ,JOURNAL OF VIROLOGY 2001 75 1301-1311
5090,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P05954 ,JOURNAL OF VIROLOGY 2001 75 1301-1311
5091,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P05954 ,JOURNAL OF VIROLOGY 2001 75 1301-1311
5092,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P05954 ,JOURNAL OF VIROLOGY 2001 75 1301-1311
5093,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P05954 ,JOURNAL OF VIROLOGY 2001 75 1301-1311
5094,RILQRALFM,1.0,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05957 ,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
5095,RINEEKHEK,5.0,A*3301,HLA-A33,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
5096,,,A*1101,HLA-A11,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
5097,,,A*0301,HLA-A3,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
5098,,,A*3101,HLA-A31,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
5099,,,A*6801,HLA-A68,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
5100,RINGIPQQH,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P06731 ,CANCER RESEARCH 1999 59 431-435
5101,RIPERLERW,2.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903 ,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
5102,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27974 ,JOURNAL OF VIROLOGY 2001 75 738-749
5103,RIQRGSGRAFVTIGK,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P19551 ,JOURNAL OF IMMUNOLOGY 1992 149 1896-1904
5104,RIWSWLLGA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679 ,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
5105,RKYTAFTIPS,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892 ,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
5106,RLADEGLNR,7.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P12933 ,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
5107,,,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P12933 ,HUMAN IMMUNOLOGY 1996 45 79-93
5108,,,n/a,HLA-A31,CLASS-I,HUMAN,VIRAL,P12933 ,HUMAN IMMUNOLOGY 1996 45 79-93
5109,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P12933 ,HUMAN IMMUNOLOGY 1996 45 79-93
5110,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P12933 ,TISSUE ANTIGENS 2002 59 251-258
5111,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P12933 ,HUMAN IMMUNOLOGY 1996 45 79-93
5112,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P12933 ,HUMAN IMMUNOLOGY 1996 45 79-93
5113,RLAFHHMAR,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20867,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
5114,RLAYLHARL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5115,RLCCKKLKI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5116,RLCVQSTHV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,CELL 1993 74 929-937
5117,RLDAFRQTY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,Q06379,IMMUNOGENETICS 1997 45 249-258
5118,RLDCWRGGQV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802
5119,RLDQLLRHV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5120,RLGPTLMCL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,not applicable,CANCER RESEARCH 2000 60 6448-6456
5121,RLGVRATRK,9.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
5122,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
5123,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
5124,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
5125,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
5126,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
5127,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
5128,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
5129,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
5130,RLGVRATRKTSERS,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
5131,RLHGLSAFSL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
5132,RLHKRQRPV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
5133,RLHSDASKNK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
5134,,,A*0301,HLA-A3,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
5135,,,A*3101,HLA-A31,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
5136,,,A*3301,HLA-A33,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
5137,,,A*6801,HLA-A68,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
5138,RLIQNSLTI,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,Q07546,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
5139,RLIVFPDLGV,7.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
5140,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
5141,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF VIROLOGY 1995 69 2462-2470
5142,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
5143,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
5144,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
5145,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
5146,RLLAPITAY,1.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
5147,RLLDDTPEV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P02944,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
5148,RLLGSLNST,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
5149,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
5150,RLLLSHIHA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5151,RLLQETELV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,INTERNATIONAL JOURNAL OF CANCER 1998 78 202-208
5152,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
5153,RLLQTGIHV,3.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P18139,IMMUNOGENETICS 1998 48 98-107
5154,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
5155,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
5156,RLMIGTAAA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P17944,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
5157,RLMKQDFSV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
5158,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802
5159,RLPLVLPAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,O07214,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
5160,RLQLSNGNR,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P06731,CANCER RESEARCH 1999 59 431-435
5161,RLQPQVGWEV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q08129,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
5162,RLRDLLLIVTR,7.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P04578,MOLECULAR IMMUNOLOGY 1994 31 813-822
5163,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P04578,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
5164,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P04578,MOLECULAR IMMUNOLOGY 1994 31 813-822
5165,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P04578,MOLECULAR IMMUNOLOGY 1994 31 813-822
5166,,,A*2401,HLA-A24,CLASS-I,HUMAN,VIRAL,P04578,MOLECULAR IMMUNOLOGY 1994 31 813-822
5167,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P04578,MOLECULAR IMMUNOLOGY 1994 31 813-822
5168,,,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P04578,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
5169,RLRELLCEL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5170,RLRKGYTPL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,INTERNATIONAL JOURNAL OF CANCER 2000 87 241-246
5171,RLSCVVSGL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
5172,RLSEGDVMHL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5173,RLTEELNTI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,P18269,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
5174,RLVELAGQSL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5175,RLVSGLVGA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P17944,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
5176,RLVTLKDIV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P04020,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
5177,RLWVYCGNGT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P31952,JOURNAL OF IMMUNOLOGY 2000 165 6463-6471
5178,RMFAANLGV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,O07214,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
5179,RMFPNAPYL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P19544,IMMUNOGENETICS 2000 51 99-107
5180,RMGVQMQRFK,1.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P21429,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
5181,RMILTHFF,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 2003 54 830-841
5182,RMMETQTSTW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2002 168 210-219
5183,RMPAVTDLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P19993,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
5184,RMSRVTTFTV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,O86345,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
5185,RMYGVLPWI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
5186,RMYVGGVEHIR,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
5187,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
5188,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
5189,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
5190,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
5191,RMYVGGVEHR,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
5192,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
5193,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
5194,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
5195,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
5196,RNEFSNVEY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,not applicable,IMMUNOGENETICS 1997 45 249-258
5197,RPDLSLRSY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,Q9JTK4,IMMUNOGENETICS 1997 45 249-258
5198,RPDYNPPLL,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26664,IMMUNOGENETICS 1998 47 256-263
5199,RPILTIITL,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P04637,HUMAN IMMUNOLOGY 2003 64 245-255
5200,RPIVSTQLL,3.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03383,IMMUNOGENETICS 1999 49 819-822
5201,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03378,IMMUNOGENETICS 1998 47 256-263
5202,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03383,AIDS 1996 10 1075-1083
5203,RPIVSTQLM,2.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03383,IMMUNOGENETICS 1999 49 819-822
5204,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03383,IMMUNOGENETICS 1999 49 819-822
5205,RPMTYKAALDI,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03383,HUMAN IMMUNOLOGY 1999 60 177-186
5206,RPPIFIRRL,3.0,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P12977,IMMUNOGENETICS 2003 54 830-841
5207,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P12977,HUMAN IMMUNOLOGY 2003 64 211-223
5208,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P12977,HUMAN IMMUNOLOGY 2003 64 211-223
5209,RPQASGVYM,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
5210,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P09992,MOLECULAR IMMUNOLOGY 1997 34 273-281
5211,RPQVPLRPM,2.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P12478,IMMUNOGENETICS 1998 47 256-263
5212,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P09992,AIDS 1996 10 1075-1083
5213,RPQVPLRPMTY,2.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03405,IMMUNOGENETICS 1999 49 819-822
5214,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03405,AIDS 1996 10 1075-1083
5215,RPRFEHPHL,1.0,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P13288,JOURNAL OF MEDICAL VIROLOGY 2004 72 635-645
5216,RPRGDNFAV,8.0,n/a,HLA-B7,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
5217,,,H-2Ld,H-2d,CLASS-I,MOUSE,n/a,not applicable,IMMUNOGENETICS 2003 54 830-841
5218,,,B*3501,HLA-B35,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
5219,,,B*5101,HLA-B51,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
5220,,,B*5301,HLA-B53,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
5221,,,B*5401,HLA-B54,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
5222,,,B*0702,HLA-B7,CLASS-I,HUMAN,BACTERIAL,P16893,HUMAN IMMUNOLOGY 2003 64 211-223
5223,,,B*0702,HLA-B7,CLASS-I,HUMAN,n/a,not applicable,IMMUNOGENETICS 2003 54 830-841
5224,RPRNRYSQL,1.0,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P03194,JOURNAL OF MEDICAL VIROLOGY 2004 72 635-645
5225,RPRPPARSL,1.0,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,not applicable,JOURNAL OF MEDICAL VIROLOGY 2004 72 635-645
5226,RPRRWKLQV,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P78395,HUMAN IMMUNOLOGY 2003 64 245-255
5227,RPSWGPTDPRRRSR,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27954,JOURNAL OF HEPATOLOGY 2001 34 321-329
5228,RPYSNVSNL,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,O95248,JOURNAL OF IMMUNOLOGY 2003 171 22-26
5229,RQERLQRRR,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
5230,RQIKNFHEL,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
5231,RQIYDLIEL,2.0,B*2702,HLA-B27,CLASS-I,HUMAN,VIRAL,P03204,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5232,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P03204,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5233,RQPIPKVRRPEGRT,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
5234,RQTGIVLNR,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,BACTERIAL,Q60301,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 48740-48747
5235,RQVIPIIGK,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q13435,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 48740-48747
5236,RRARSLSAERY,10.0,B*2701,HLA-B27,CLASS-I,HUMAN,VIRAL,P03203,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5237,,,B*2702,HLA-B27,CLASS-I,HUMAN,VIRAL,P03203,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5238,,,B*2702,HLA-B27,CLASS-I,HUMAN,VIRAL,P03203,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5239,,,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P03203,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5240,,,B*2704,HLA-B27,CLASS-I,HUMAN,VIRAL,P03203,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5241,,,B*2704,HLA-B27,CLASS-I,HUMAN,VIRAL,P03203,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5242,,,B*3909,HLA-B39,CLASS-I,HUMAN,VIRAL,P03203,TISSUE ANTIGENS 1999 53 227-236
5243,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P03203,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5244,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P03203,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5245,,,B*2706,HLA-B27,CLASS-I,HUMAN,VIRAL,P03203,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5246,RRFAPYYV,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
5247,RRFESEKSL,2.0,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P23588,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 16744-16749
5248,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P23588,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 16744-16749
5249,RRFFAYYV,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
5250,RRFFIYYV,1.0,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
5251,RRFFLYYV,1.0,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
5252,RRFFPYAV,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
5253,RRFFPYFV,1.0,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
5254,RRFFPYHV,1.0,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
5255,RRFFPYLV,1.0,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
5256,RRFFPYTV,1.0,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
5257,RRFFPYVV,1.0,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
5258,RRFFPYWV,1.0,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
5259,RRFFPYYV,4.0,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
5260,,,B*3909,HLA-B39,CLASS-I,HUMAN,SELF PEPTIDE,P20618,TISSUE ANTIGENS 1999 53 227-236
5261,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 164 329-337
5262,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGICAL METHODS 2001 255 57-66
5263,RRFFPYYVY,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 164 329-337
5264,RRFFPYYVYN,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 164 329-337
5265,RRFFPYYVYNI,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 164 329-337
5266,RRFFVYYV,1.0,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
5267,RRFGDKLNF,2.0,B*3901,HLA-B39,CLASS-I,HUMAN,SELF PEPTIDE,Q13794,ARTHRITIS & RHEUMATISM 1999 42 175-181
5268,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q13794,ARTHRITIS & RHEUMATISM 1999 42 175-181
5269,RRFIPYYV,1.0,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
5270,RRFKEGGRGGKY,4.0,B*2702,HLA-B27,CLASS-I,HUMAN,BACTERIAL,O84799,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 37573-37581
5271,,,B*2704,HLA-B27,CLASS-I,HUMAN,BACTERIAL,O84799,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 37573-37581
5272,,,B*2705,HLA-B27,CLASS-I,HUMAN,BACTERIAL,O84799,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 37573-37581
5273,,,B*2706,HLA-B27,CLASS-I,HUMAN,BACTERIAL,O84799,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 37573-37581
5274,RRFLPYYV,1.0,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
5275,RRFTRPEH,3.0,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q9UPT9,TISSUE ANTIGENS 1996 48 509-518
5276,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q9UPT9,TISSUE ANTIGENS 1996 48 509-518
5277,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q9UPT9,TISSUE ANTIGENS 1996 48 509-518
5278,RRFVNVVPTF,9.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q05472,TISSUE ANTIGENS 1996 48 509-518
5279,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q05472,TISSUE ANTIGENS 1996 48 509-518
5280,,,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q05472,TISSUE ANTIGENS 1996 48 509-518
5281,,,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q05472,TISSUE ANTIGENS 1996 48 509-518
5282,,,B*3901,HLA-B39,CLASS-I,HUMAN,SELF PEPTIDE,Q05472,ARTHRITIS & RHEUMATISM 1999 42 175-181
5283,,,B*3909,HLA-B39,CLASS-I,HUMAN,SELF PEPTIDE,Q05472,TISSUE ANTIGENS 1999 53 227-236
5284,,,n/a,Mamu-B*03,CLASS-I,RHESUS,SELF PEPTIDE,Q05472,JOURNAL OF IMMUNOLOGY 2000 164 283-291
5285,,,n/a,Gogo-B*0101,CLASS-I,GORILLA,SELF PEPTIDE,Q05472,JOURNAL OF IMMUNOLOGY 2001 166 3334-3344
5286,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q05472,ARTHRITIS & RHEUMATISM 1999 42 175-181
5287,RRFVPYYV,1.0,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
5288,RRFWPYYV,1.0,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
5289,RRFYPYYV,1.0,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 165 5680-5685
5290,RRGPRLGVRATRKT,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
5291,RRHRILDMYL,1.0,n/a,Mamu-B*03,CLASS-I,RHESUS,VIRAL,P11262,JOURNAL OF IMMUNOLOGY 2000 164 283-291
5292,RRIKEIVKK,4.0,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P07900,TISSUE ANTIGENS 1996 48 509-518
5293,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P07900,TISSUE ANTIGENS 1996 48 509-518
5294,,,B*2705,HLA-B27,CLASS-I,HUMAN,MISCELLANEOUS,P11501,JOURNAL OF IMMUNOLOGY 2001 166 1016-1027
5295,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P07900,TISSUE ANTIGENS 1996 48 509-518
5296,RRISGVDRY,4.0,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,O15239,TISSUE ANTIGENS 1996 48 509-518
5297,,,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,O15239,JOURNAL OF IMMUNOLOGY 1992 149 1896-1904
5298,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,O15239,TISSUE ANTIGENS 1996 48 509-518
5299,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,O15239,TISSUE ANTIGENS 1996 48 509-518
5300,RRIYDLIEL,11.0,B*2701,HLA-B27,CLASS-I,HUMAN,VIRAL,P03204,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5301,,,B*2702,HLA-B27,CLASS-I,HUMAN,VIRAL,P03204,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5302,,,B*2702,HLA-B27,CLASS-I,HUMAN,VIRAL,P03204,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5303,,,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P03204,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5304,,,B*2704,HLA-B27,CLASS-I,HUMAN,VIRAL,P03204,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5305,,,B*2704,HLA-B27,CLASS-I,HUMAN,VIRAL,P03204,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5306,,,B*3909,HLA-B39,CLASS-I,HUMAN,VIRAL,P03204,TISSUE ANTIGENS 1999 53 227-236
5307,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P03204,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5308,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P03204,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5309,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P03204,JOURNAL OF IMMUNOLOGY 2001 166 1016-1027
5310,,,B*2706,HLA-B27,CLASS-I,HUMAN,VIRAL,P03204,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5311,RRKSSGGKGGSY,4.0,B*2702,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P30467,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 37573-37581
5312,,,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P30467,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 37573-37581
5313,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P30467,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 37573-37581
5314,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P30467,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 37573-37581
5315,RRLTNHTKF,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q9Y3U8,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
5316,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q9Y3U8,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
5317,RRRESEKSL,2.0,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P23588,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 16744-16749
5318,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P23588,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 16744-16749
5319,RRRSRNLGKVIDTL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
5320,RRRWRRLTV,13.0,B*2701,HLA-B27,CLASS-I,HUMAN,VIRAL,P13285,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5321,,,B*2702,HLA-B27,CLASS-I,HUMAN,VIRAL,P13285,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5322,,,B*2702,HLA-B27,CLASS-I,HUMAN,VIRAL,P13285,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5323,,,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P13285,TISSUE ANTIGENS 1997 49 23-28
5324,,,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P13285,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5325,,,B*2704,HLA-B27,CLASS-I,HUMAN,VIRAL,P13285,TISSUE ANTIGENS 1997 49 23-28
5326,,,B*2704,HLA-B27,CLASS-I,HUMAN,VIRAL,P13285,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5327,,,B*2704,HLA-B27,CLASS-I,HUMAN,VIRAL,P13285,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5328,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P13285,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5329,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P13285,TISSUE ANTIGENS 1997 49 23-28
5330,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P13285,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5331,,,B*2706,HLA-B27,CLASS-I,HUMAN,VIRAL,P13285,TISSUE ANTIGENS 1997 49 23-28
5332,,,B*2706,HLA-B27,CLASS-I,HUMAN,VIRAL,P13285,INTERNATIONAL IMMUNOLOGY 1998 10 259-266
5333,RRSKEITVR,4.0,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P17844,TISSUE ANTIGENS 1996 48 509-518
5334,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P17844,TISSUE ANTIGENS 1996 48 509-518
5335,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P17844,ARTHRITIS & RHEUMATISM 1999 42 175-181
5336,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P17844,TISSUE ANTIGENS 1996 48 509-518
5337,RRVESEKSL,2.0,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P23588,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 16744-16749
5338,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P23588,JOURNAL OF BIOLOGICAL CHEMISTRY 2002 277 16744-16749
5339,RRVKEVVKK,5.0,B*2703,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P08238,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
5340,,,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P08238,TISSUE ANTIGENS 1996 48 509-518
5341,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P08238,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
5342,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P08238,TISSUE ANTIGENS 1996 48 509-518
5343,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P08238,TISSUE ANTIGENS 1996 48 509-518
5344,RRWLPAGDA,4.0,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P13639,TISSUE ANTIGENS 1996 48 509-518
5345,,,B*3909,HLA-B39,CLASS-I,HUMAN,SELF PEPTIDE,P13639,TISSUE ANTIGENS 1999 53 227-236
5346,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P13639,TISSUE ANTIGENS 1996 48 509-518
5347,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P13639,TISSUE ANTIGENS 1996 48 509-518
5348,RRYDRKQSGY,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P09896,JOURNAL OF IMMUNOLOGY 2001 166 1016-1027
5349,RRYLENGKETL,5.0,B*2703,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P30467,TISSUE ANTIGENS 1997 49 23-28
5350,,,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P30467,TISSUE ANTIGENS 1997 49 23-28
5351,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P30467,TISSUE ANTIGENS 1997 49 23-28
5352,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P10316,JOURNAL OF IMMUNOLOGY 2001 166 1016-1027
5353,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P30467,TISSUE ANTIGENS 1997 49 23-28
5354,RRYPNAVYL,4.0,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P26032,VACCINE 2002 20 249-261
5355,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P26032,VACCINE 2002 20 249-261
5356,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P26032,VACCINE 2002 20 249-261
5357,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P26032,VACCINE 2002 20 249-261
5358,RRYQKSTEL,22.0,A*0101,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P06351,JOURNAL OF IMMUNOLOGY 1995 154 247-259
5359,,,A*0101,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P06351,MOLECULAR IMMUNOLOGY 1994 31 813-822
5360,,,B*2704,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P16106,TISSUE ANTIGENS 1996 48 509-518
5361,,,B*2703,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P16106,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
5362,,,B*3901,HLA-B39,CLASS-I,HUMAN,SELF PEPTIDE,P06351,ARTHRITIS & RHEUMATISM 1999 42 175-181
5363,,,B*3909,HLA-B39,CLASS-I,HUMAN,SELF PEPTIDE,P06351,TISSUE ANTIGENS 1999 53 227-236
5364,,,n/a,Mamu-B*03,CLASS-I,RHESUS,SELF PEPTIDE,P06351,JOURNAL OF IMMUNOLOGY 2000 164 283-291
5365,,,n/a,Gogo-B*0101,CLASS-I,GORILLA,SELF PEPTIDE,P06351,JOURNAL OF IMMUNOLOGY 2001 166 3334-3344
5366,,,n/a,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P06351,JOURNAL OF IMMUNOLOGY 1995 154 247-259
5367,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06351,MOLECULAR IMMUNOLOGY 1994 31 813-822
5368,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06351,JOURNAL OF IMMUNOLOGY 1995 154 247-259
5369,,,A*1101,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,P06351,MOLECULAR IMMUNOLOGY 1994 31 813-822
5370,,,A*2401,HLA-A24,CLASS-I,HUMAN,SELF PEPTIDE,P06351,MOLECULAR IMMUNOLOGY 1994 31 813-822
5371,,,A*0301,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P06351,MOLECULAR IMMUNOLOGY 1994 31 813-822
5372,,,A*0302,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P06351,JOURNAL OF IMMUNOLOGY 1995 154 247-259
5373,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P16106,TISSUE ANTIGENS 1996 48 509-518
5374,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P16106,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
5375,,,B*2705,HLA-B27,CLASS-I,HUMAN,BOVINE,P16105,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 48740-48747
5376,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P06351,JOURNAL OF IMMUNOLOGY 1995 154 247-259
5377,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P06351,ARTHRITIS & RHEUMATISM 1999 42 175-181
5378,,,B*2706,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P16106,TISSUE ANTIGENS 1996 48 509-518
5379,,,B*0801,HLA-B8,CLASS-I,HUMAN,SELF PEPTIDE,P06351,JOURNAL OF IMMUNOLOGY 1995 154 247-259
5380,RRYWAIRTR,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
5381,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
5382,RSAEPVPL,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20869,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
5383,RSARASSRY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,Q02251,IMMUNOGENETICS 1997 45 249-258
5384,RSEDTAVYY,2.0,n/a,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
5385,,,n/a,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
5386,RSIQNAQFL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P24638,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
5387,,,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P24638,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
5388,RSPRAHKYQV,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
5389,RSQGENPTW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05902,JOURNAL OF IMMUNOLOGY 2002 168 210-219
5390,RSVINIVII,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5391,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5392,RSYLIRAL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P21426,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
5393,RSYNLKLSY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,not applicable,IMMUNOGENETICS 1997 45 249-258
5394,RTFSFQNI,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P08273,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
5395,RTFYDPEPI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5396,RTFYDPEPIL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5397,RTGLYGAQY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P31848,IMMUNOGENETICS 1997 45 249-258
5398,RTIISLNKY,1.0,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
5399,RTLLSRVY,1.0,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
5400,RTLNAWVKV,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20873,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
5401,RTLPLWGRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
5402,RTLPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
5403,RTLPLWVRMG,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
5404,RTLTLFNVTR,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P06731,CANCER RESEARCH 1999 59 431-435
5405,RTQDFWEVQL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
5406,RTQNVLGEK,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,P23396,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
5407,RTRGAHTNDV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
5408,RTRPLWGRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
5409,RTRPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
5410,RTRPLWVRMG,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
5411,RVCEKMALY,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
5412,RVEQAVESMVK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
5413,,,A*0301,HLA-A3,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
5414,RVIEASFPA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16790,CANCER RESEARCH 1999 59 5554-5559
5415,RVIEVLQRA,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P35961,AIDS RESEARCH HUMAN RETROVIRUSES 1998 14 1669-1678
5416,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03377,JOURNAL OF IMMUNOLOGY 1995 155 2232-2239
5417,RVLPLWGRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
5418,RVLPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
5419,RVLPLWVRMG,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
5420,RVMAPRALL,8.0,A*0101,HLA-A1,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 1995 154 247-259
5421,,,n/a,HLA-B7,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
5422,,,n/a,HLA-B7,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 1995 154 247-259
5423,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 1995 154 247-259
5424,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 1995 154 247-259
5425,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
5426,,,B*2705,HLA-B27,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 1995 154 247-259
5427,,,B*0801,HLA-B8,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 1995 154 247-259
5428,RVRFFFPSLR,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
5429,RVRPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
5430,RVTGGVFLVDK,2.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
5431,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
5432,RVTGGVVFLVDK,3.0,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
5433,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
5434,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
5435,RWGLLLALL,1.0,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P04626,BRITISH JOURNAL OF CANCER 2001 84 94-99
5436,RYLENGKETL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,HUMAN,P30501,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
5437,RYLKDQQLL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P04578,IMMUNOGENETICS 1996 44 233-241
5438,RYLKNGKETL,3.0,H-2Kd,H-2d,CLASS-I,MOUSE,HUMAN,P30503,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
5439,,,H-2Kd,H-2d,CLASS-I,MOUSE,HUMAN,P04222,EURO.JOURNAL OF IMMUNOLOGY 1993 23 1118-1124
5440,,,H-2Kd,H-2d,CLASS-I,MOUSE,HUMAN,P04222,EURO.JOURNAL OF IMMUNOLOGY 1993 23 1118-1124
5441,RYLRDQQL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
5442,RYLRDQQLL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
5443,RYLRDQQLLGI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
5444,RYPLTFGWCF,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03405,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
5445,RYQYNVLPQGW,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P04589,HUMAN IMMUNOLOGY 2003 64 245-255
5446,RYRPGTVAL,2.0,Cw*0401,HLA-Cw4,CLASS-I,HUMAN,SELF PEPTIDE,P06351,JOURNAL OF IMMUNOLOGY 1995 154 247-259
5447,,,Cw*0702,HLA-Cw7,CLASS-I,HUMAN,SELF PEPTIDE,P06351,JOURNAL OF IMMUNOLOGY 1995 154 247-259
5448,RYWAIRTRS,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P15663,JOURNAL OF IMMUNOLOGY 1994 152 163-175
5449,SAAFEDLRVLSFIRGY,12.0,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P26062,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
5450,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P26062,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
5451,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P26062,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
5452,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P26062,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
5453,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P26062,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
5454,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P26062,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
5455,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P26062,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
5456,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P26062,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
5457,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P26062,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
5458,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P26062,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
5459,,,n/a,HLA-DR13,CLASS-2,HUMAN,VIRAL,P26062,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
5460,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26062,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
5461,SAANDPIFV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
5462,SAEQNKNHI,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
5463,SAICSVVRR,7.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
5464,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
5465,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
5466,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
5467,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
5468,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
5469,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
5470,SAIENLEYM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5471,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5472,SAINNYAQKL,3.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P03070,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5473,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P03070,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5474,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P03070,VIROLOGY 1999 256 246-257
5475,SAIPSAEYI,1.0,n/a,I-Kd,CLASS-I,MOUSE,PARASITE,P06915,FEBS 1996 387 42-46
5476,SAIRERMRR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20867,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
5477,SAPDFRPA,3.0,H-2Kb,H-2b,CLASS-I,MOUSE,CANCER,P15941,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
5478,,,H-2Kb,H-2b,CLASS-I,MOUSE,CANCER,P15941,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
5479,,,H-2Kb,H-2b,CLASS-I,MOUSE,CANCER,P15941,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
5480,SAPDFRPL,3.0,H-2Kb,H-2b,CLASS-I,MOUSE,CANCER,P15941,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
5481,,,H-2Kb,H-2b,CLASS-I,MOUSE,CANCER,P15941,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
5482,,,H-2Kb,H-2b,CLASS-I,MOUSE,CANCER,P15941,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
5483,SAPDTRPA,3.0,H-2Kb,H-2b,CLASS-I,MOUSE,CANCER,P15941,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
5484,,,H-2Kb,H-2b,CLASS-I,MOUSE,CANCER,P15941,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
5485,,,H-2Kb,H-2b,CLASS-I,MOUSE,CANCER,P15941,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
5486,SAPDTRPAP,3.0,H-2Kb,H-2b,CLASS-I,MOUSE,CANCER,P15941,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
5487,,,H-2Kb,H-2b,CLASS-I,MOUSE,CANCER,P15941,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
5488,,,H-2Kb,H-2b,CLASS-I,MOUSE,CANCER,P15941,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
5489,SAPDTRPL,3.0,H-2Kb,H-2b,CLASS-I,MOUSE,CANCER,P15941,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
5490,,,H-2Kb,H-2b,CLASS-I,MOUSE,CANCER,P15941,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
5491,,,H-2Kb,H-2b,CLASS-I,MOUSE,CANCER,P15941,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
5492,SATGFKQSSK,2.0,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P11274,BLOOD 1995 85 2680-2684
5493,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P11274,BLOOD 1995 85 2680-2684
5494,SCDFNNGITI,3.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
5495,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5496,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5497,SDYEGRLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P26065,JOURNAL OF IMMUNOLOGY 1994 153 3079-3092
5498,SEIWRDIDF,1.0,n/a,Mamu-A*11,CLASS-I,RHESUS,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 2000 164 283-291
5499,SERSQPRGRRQPIP,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
5500,SESTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
5501,SEVENPGGYCL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5502,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5503,SEVSNVQRI,5.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
5504,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
5505,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5506,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5507,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1999 256 246-257
5508,SEVSNVQRIM,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
5509,SFLFVEALF,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,BACTERIAL,P19597,IMMUNOGENETICS 2003 54 830-841
5510,SFLPSDFFPSV,2.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P17391,JOURNAL OF IMMUNOLOGY 2003 170 2977-2984
5511,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24023,MOLECULAR IMMUNOLOGY 1994 31 813-822
5512,SFSIFLLALLSCLT,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27954,JOURNAL OF HEPATOLOGY 2001 34 321-329
5513,SFSTTINYTL,1.0,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P43356,CLINICAL CANCER RESEARCH 1999 5 2236-2241
5514,SFYRNLLWL,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P03452,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
5515,SGGDPEIV,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20871,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
5516,SGPKTNIIV,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27973,JOURNAL OF VIROLOGY 2001 75 738-749
5517,SGPSNTPPEI,4.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P03254,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
5518,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P03254,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5519,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P03254,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5520,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P03254,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
5521,SGVENPGG,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
5522,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
5523,SGVENPGGY,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
5524,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
5525,SGVENPGGYC,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
5526,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
5527,SGVENPGGYCL,12.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
5528,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
5529,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
5530,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5531,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5532,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5533,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5534,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
5535,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1998 161 5087-5096
5536,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1999 256 246-257
5537,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
5538,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1998 161 5087-5096
5539,SGVENPGGYCLT,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
5540,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
5541,SGVENPGGYCLTK,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
5542,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
5543,SHIGDAVV,1.0,B*3901,HLA-B39,CLASS-I,HUMAN,CANCER,P12004,ARTHRITIS & RHEUMATISM 1999 42 175-181
5544,SHLEVQGYW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05902,JOURNAL OF IMMUNOLOGY 2002 168 210-219
5545,SHYAFSPMFEVL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9RB65,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
5546,SIADTTNQK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03383,TISSUE ANTIGENS 2000 55 296-302
5547,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03383,TISSUE ANTIGENS 2000 55 296-302
5548,SIEDLEVTC,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5549,SIEDLEVTCT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5550,SIFEQWLRR,2.0,n/a,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
5551,,,n/a,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
5552,SIFQSSMTK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
5553,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
5554,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
5555,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
5556,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
5557,SIIDPLIYA,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
5558,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
5559,SIILFLPL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z6X9,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
5560,SIINFCKL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,CHICKEN,P01012,JOURNAL OF IMMUNOLOGICAL METHODS 1995 183 77-94
5561,SIINFEKL,11.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,P01012,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
5562,,,H-2Kb,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,P01012,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
5563,,,H-2Kb,H-2b,CLASS-I,MOUSE,CHICKEN,P01012,IMMUNITY 2001 14 231-242
5564,,,H-2Kb,H-2b,CLASS-I,MOUSE,CHICKEN,P01012,IMMUNITY 2001 14 231-242
5565,,,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,P01012,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
5566,,,H-2Kb,H-2b,CLASS-I,MOUSE,CHICKEN,P01012,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
5567,,,H-2Kb,H-2b,CLASS-I,MOUSE,CHICKEN,P01012,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
5568,,,H-2Kb,H-2b,CLASS-I,MOUSE,CHICKEN,P01012,JOURNAL OF MOLECULAR BIOLOGY 2002 318 1293-1305
5569,,,H-2Kb,H-2b,CLASS-I,MOUSE,CHICKEN,P01012,JOURNAL OF IMMUNOLOGY 1998 160 77-86
5570,,,H-2Kb,H-2b,CLASS-I,MOUSE,CHICKEN,P01012,IMMUNITY 2001 14 231-242
5571,,,H-2Kb,H-2b,CLASS-I,MOUSE,CHICKEN,P01012,JOURNAL OF IMMUNOLOGY 1995 154 567-576
5572,SIIPSAEYI,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,PARASITE,P06915,FEBS 1996 387 42-46
5573,SIIPSGPLK,1.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P21429,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
5574,SIISAVVGI,8.0,n/a,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427
5575,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,INTERNATIONAL JOURNAL OF CANCER 1998 78 202-208
5576,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
5577,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
5578,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
5579,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
5580,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
5581,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
5582,SILDIRQGPK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03350,TISSUE ANTIGENS 2000 55 296-302
5583,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03350,TISSUE ANTIGENS 2000 55 296-302
5584,SINNETPGIR,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
5585,SIPHAACHK,1.0,A*1102,HLA-A11,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
5586,SIPTATIRRHVDLLV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
5587,SISALQSLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5588,SISISALQSL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5589,SIVIWGKTPK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
5590,SIYPGHVSGHRMAWD,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01403,JOURNAL OF HEPATOLOGY 2001 34 321-329
5591,SIYVYALPL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
5592,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
5593,SKLQYKII,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,BACTERIAL,Q9Z7P3,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
5594,SLADTNSLA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
5595,SLADTNSLAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802
5596,SLAGFVRML,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q06861,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
5597,SLCADARMYGV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
5598,SLCFLGAIA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
5599,SLDDYNHLV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
5600,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
5601,SLEQRSLHCK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
5602,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
5603,SLFFLRGRL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5604,SLFNTIATL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5605,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5606,SLFNTIAVL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5607,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5608,SLFNTVATL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5609,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5610,SLFNTVAVL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5611,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5612,SLFRAVITK,16.0,n/a,HLA-A3,CLASS-I,HUMAN,HUMAN,P43355,HUMAN IMMUNOLOGY 1996 45 79-93
5613,,,n/a,HLA-A31,CLASS-I,HUMAN,CANCER,P43355,HUMAN IMMUNOLOGY 1996 45 79-93
5614,,,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
5615,,,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355,HUMAN IMMUNOLOGY 1996 45 79-93
5616,,,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
5617,,,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
5618,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
5619,,,A*3101,HLA-A31,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
5620,,,A*3301,HLA-A33,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
5621,,,A*3301,HLA-A33,CLASS-I,HUMAN,CANCER,P43355,HUMAN IMMUNOLOGY 1996 45 79-93
5622,,,A*6801,HLA-A68,CLASS-I,HUMAN,CANCER,P43355,HUMAN IMMUNOLOGY 1996 45 79-93
5623,,,A*6801,HLA-A68,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
5624,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 2000 164 4130-4134
5625,,,B*3501,HLA-B35,CLASS-I,HUMAN,n/a,not applicable,JOURNAL OF IMMUNOLOGY 2000 164 4130-4134
5626,,,B*3503,HLA-B35,CLASS-I,HUMAN,CANCER,P43355,JOURNAL OF IMMUNOLOGY 2000 164 4130-4134
5627,,,B*3503,HLA-B35,CLASS-I,HUMAN,n/a,not applicable,JOURNAL OF IMMUNOLOGY 2000 164 4130-4134
5628,SLFRAVITKK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
5629,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
5630,SLGEQQYSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P19544,IMMUNOGENETICS 2000 51 99-107
5631,SLGQHIYET,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20883,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
5632,SLHCKPEEA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
5633,SLHNLVHSFL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
5634,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
5635,SLHVGTQCA,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
5636,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1995 154 2257-2265
5637,SLHVGTQCAL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
5638,SLIPSAEYI,2.0,H-2Kd,H-2d,CLASS-I,MOUSE,PARASITE,P06915,FEBS 1996 387 42-46
5639,,,n/a,I-Kd,CLASS-I,MOUSE,PARASITE,P06915,FEBS 1996 387 42-46
5640,SLIYRRRLMK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P40967,INTERNATIONAL JOURNAL OF CANCER 1998 78 518-524
5641,SLKIFIAGN,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P13201,JOURNAL OF IMMUNOLOGY 1992 149 3580-3587
5642,SLKLEDLPTV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16790,CANCER RESEARCH 1999 59 5554-5559
5643,SLLEIGEGV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P19993,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
5644,SLLEIGEGVV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P19993,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
5645,SLLGNATAL,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SYNTHETIC,P27455,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
5646,SLLKDEALA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5647,SLLKDEALAI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5648,SLLMWITQC,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78358,JOURNAL OF IMMUNOTHERAPY 2001 24 1-9
5649,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P78358,CANCER RESEARCH 2002 62 3630-3635
5650,SLLMWITQCFL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P78358,CANCER RESEARCH 2002 62 3630-3635
5651,SLLMWITQCFLPVF,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P78358,CANCER RESEARCH 2002 62 3630-3635
5652,SLLMWITQV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78358,JOURNAL OF IMMUNOTHERAPY 2001 24 1-9
5653,SLLNATDIAV,8.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P35961,AIDS RESEARCH HUMAN RETROVIRUSES 1998 14 1669-1678
5654,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20871,JOURNAL OF VIROLOGY 2001 75 1301-1311
5655,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03377,JOURNAL OF IMMUNOLOGY 1995 155 2232-2239
5656,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P20871,JOURNAL OF VIROLOGY 2001 75 1301-1311
5657,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P20871,JOURNAL OF VIROLOGY 2001 75 1301-1311
5658,,,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20871,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
5659,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P20871,JOURNAL OF VIROLOGY 2001 75 1301-1311
5660,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P20871,JOURNAL OF VIROLOGY 2001 75 1301-1311
5661,SLLNNQFGTM,3.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09992,VIROLOGY 1998 240 158-167
5662,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5663,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5664,SLLPAIVEL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P30154,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
5665,SLLQHLIGL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5666,SLLSTNLPY,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
5667,,,A*0301,HLA-A3,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
5668,,,A*3101,HLA-A31,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
5669,,,A*3301,HLA-A33,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
5670,,,A*6801,HLA-A68,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
5671,SLLTFMIAA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
5672,SLLYNLDLM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5673,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5674,SLMAFTAAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
5675,SLNFMGYVI,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
5676,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P12933,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
5677,SLNSTPTAI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
5678,SLPPPGTRV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
5679,,,A*0202,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
5680,,,A*0203,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
5681,,,A*0206,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
5682,,,A*6802,HLA-A68,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
5683,SLQCLQALYV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5684,SLQDIEITC,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
5685,SLQEKNCEPV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
5686,SLQEKNCEPVV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
5687,SLQLVFGIDV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
5688,SLQMNSLRV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
5689,SLQTGFLAA,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
5690,SLSGVMLTDV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5691,SLSHCSQLT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5692,SLSHCSQLTT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5693,SLSRFSWGA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P02686,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
5694,SLSYTNPAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P15941,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
5695,SLTEILKGGV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,INTERNATIONAL JOURNAL OF CANCER 1998 78 202-208
5696,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
5697,SLVDVMPWL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,Q16678,BLOOD 2003 102 3287-3294
5698,SLVENALVV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
5699,SLVKHHMYI,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20877,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
5700,SLVKHHMYV,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20877,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
5701,SLYADSPSV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03159,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 1047-1058
5702,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
5703,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
5704,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
5705,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1997 27 671-678
5706,SLYAVSPSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03159,CELL 1993 74 929-937
5707,SLYDEHIKK,5.0,A*3301,HLA-A33,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
5708,,,A*1101,HLA-A11,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
5709,,,A*0301,HLA-A3,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
5710,,,A*3101,HLA-A31,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
5711,,,A*6801,HLA-A68,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
5712,SLYFGGICV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,O86345,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
5713,SLYFGGICVI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q50097,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
5714,SLYGTTLEQ,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
5715,SLYITVATL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5716,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5717,SLYITVAVL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5718,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5719,SLYNAIATL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5720,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5721,SLYNAVATL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5722,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5723,SLYNLVAVL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5724,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5725,SLYNTIATL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5726,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5727,SLYNTIAVL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5728,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5729,SLYNTISVL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5730,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5731,SLYNTITVL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5732,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5733,SLYNTVATL,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05889,HUMAN IMMUNOLOGY 1995 44 189-198
5734,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
5735,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5736,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5737,,,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20873,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
5738,SLYNTVAVL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5739,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5740,SLYNTVSTL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5741,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF CLINICAL INVESTIGATION 1998 101 2559-2566
5742,SLYSEPEPEA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5743,SMAENLEYM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5744,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5745,SMAGSSAMI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P31952,JOURNAL OF IMMUNOLOGY 2000 165 6463-6471
5746,SMAGSSAMIL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P31952,JOURNAL OF IMMUNOLOGY 2000 165 6463-6471
5747,SMIANLEYM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5748,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5749,SMIEALEYM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5750,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5751,SMIENAEYM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5752,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5753,SMIENLAYM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5754,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5755,SMIENLE,2.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5756,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5757,SMIENLEAM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5758,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5759,SMIENLEY,2.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5760,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5761,SMIENLEYA,2.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5762,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5763,SMIENLEYM,7.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5764,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5765,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,VIROLOGY 1999 256 246-257
5766,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5767,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5768,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
5769,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5770,SMIPSAEYI,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,PARASITE,P06915,FEBS 1996 387 42-46
5771,SMPPPGTRV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
5772,,,A*0202,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
5773,,,A*0203,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
5774,,,A*0206,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
5775,,,A*6802,HLA-A68,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
5776,SMTKILEPFR,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
5777,SMVGNWAKV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
5778,SPAIFQSSM,2.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P05959,IMMUNOGENETICS 1998 47 256-263
5779,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P05959,AIDS 1996 10 1075-1083
5780,SPALNKMFCQL,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P04637,HUMAN IMMUNOLOGY 2003 64 245-255
5781,SPASFFSSW,5.0,n/a,HLA-B51,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5782,,,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5783,,,B*5301,HLA-B53,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5784,,,B*5401,HLA-B54,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5785,,,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5786,SPATLLLVL,5.0,n/a,HLA-B51,CLASS-I,HUMAN,SELF PEPTIDE,P12273,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5787,,,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P12273,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5788,,,B*5301,HLA-B53,CLASS-I,HUMAN,SELF PEPTIDE,P12273,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5789,,,B*5401,HLA-B54,CLASS-I,HUMAN,SELF PEPTIDE,P12273,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5790,,,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P12273,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5791,SPISNVANA,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P04014,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5792,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P04014,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5793,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P04014,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5794,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P04014,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5795,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P04014,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5796,SPLGERLEV,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P06789,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5797,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P06789,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5798,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P06789,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5799,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P06789,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5800,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P06789,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5801,SPLTTQNTL,2.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 1998 47 256-263
5802,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
5803,SPNQARAQAAL,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P26599,JOURNAL OF IMMUNOLOGY 2003 171 22-26
5804,SPPAVPQTF,4.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 1999 49 819-822
5805,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
5806,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26662,IMMUNOGENETICS 1998 47 256-263
5807,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 1999 49 819-822
5808,SPPITWPLL,6.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5809,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5810,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03409,IMMUNOGENETICS 1998 47 256-263
5811,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5812,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5813,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5814,SPPSTPLLY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P14075,IMMUNOGENETICS 1998 47 256-263
5815,SPPSYFQTHT,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05885,JOURNAL OF VIROLOGY 2001 75 738-749
5816,SPQPKKKPL,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P04637,HUMAN IMMUNOLOGY 2003 64 245-255
5817,SPRGSRPSWGPTDP,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
5818,SPRHYSTDL,1.0,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P03189,JOURNAL OF MEDICAL VIROLOGY 2004 72 635-645
5819,SPRLKAICI,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P27220,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5820,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P27220,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5821,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P27220,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5822,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P27220,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5823,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P27220,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5824,SPRTLNAWV,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF IMMUNOLOGY 2003 171 22-26
5825,SPSCPLERF,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5826,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5827,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5828,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5829,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
5830,SPSSTPLLY,3.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P14075,IMMUNOGENETICS 1998 47 256-263
5831,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P14075,IMMUNOGENETICS 1999 49 819-822
5832,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P14075,IMMUNOGENETICS 1999 49 819-822
5833,SPSVDKARAEL,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,Q9BY66,JOURNAL OF IMMUNOLOGY 1997 158 5797-5804
5834,SPTAALVVSQLLRIP,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01404,JOURNAL OF HEPATOLOGY 2001 34 321-329
5835,SQQRNFQLL,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
5836,SQTSYQYL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
5837,SRDKTIIM,2.0,B*3901,HLA-B39,CLASS-I,HUMAN,SELF PEPTIDE,P25388,ARTHRITIS & RHEUMATISM 1999 42 175-181
5838,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P25388,ARTHRITIS & RHEUMATISM 1999 42 175-181
5839,SRDKTIIMW,1.0,n/a,Gogo-B*0101,CLASS-I,GORILLA,SELF PEPTIDE,P25388,JOURNAL OF IMMUNOLOGY 2001 166 3334-3344
5840,SRFAFVVAK,1.0,n/a,HLA-B27,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF EXPERIMENTAL MEDICINE 1995 182 1883-1895
5841,SRFAKKFAK,1.0,n/a,HLA-B27,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF EXPERIMENTAL MEDICINE 1995 182 1883-1895
5842,SRFASFKAK,1.0,n/a,HLA-B27,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF EXPERIMENTAL MEDICINE 1995 182 1883-1895
5843,SRIGDPAL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P17397,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
5844,SRIRKLFNL,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P10660,JOURNAL OF IMMUNOLOGY 2001 166 1016-1027
5845,SRKAKSSAK,1.0,n/a,HLA-B27,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF EXPERIMENTAL MEDICINE 1995 182 1883-1895
5846,SRKAVSFAK,1.0,n/a,HLA-B27,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF EXPERIMENTAL MEDICINE 1995 182 1883-1895
5847,SRLTNHTKF,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q9Y3U8,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
5848,,,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,Q9Y3U8,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
5849,SRQKSGGGSGGF,2.0,,,,,,,
5850,,,,,,,,,
5851,SRQKSGGSGGGF,2.0,,,,,,,
5852,,,,,,,,,
5853,SRRFFPYY,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 164 329-337
5854,SRRFFPYYV,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 164 329-337
5855,SRRFFPYYVY,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 164 329-337
5856,SRRFFPYYVYN,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P20618,JOURNAL OF IMMUNOLOGY 2000 164 329-337
5857,SRSAFFKAK,1.0,n/a,HLA-B27,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF EXPERIMENTAL MEDICINE 1995 182 1883-1895
5858,SRSAKFVAK,1.0,n/a,HLA-B27,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF EXPERIMENTAL MEDICINE 1995 182 1883-1895
5859,SRVASVFAK,1.0,n/a,HLA-B27,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF EXPERIMENTAL MEDICINE 1995 182 1883-1895
5860,SRVAVKSAK,1.0,n/a,HLA-B27,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF EXPERIMENTAL MEDICINE 1995 182 1883-1895
5861,SRWAVVWAK,1.0,n/a,HLA-B27,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF EXPERIMENTAL MEDICINE 1995 182 1883-1895
5862,SRYWAIRTR,15.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03467,JOURNAL OF IMMUNOLOGY 1995 154 247-259
5863,,,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P26089,MOLECULAR IMMUNOLOGY 1994 31 813-822
5864,,,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
5865,,,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P03467,JOURNAL OF IMMUNOLOGY 1995 154 247-259
5866,,,n/a,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,IMMUNOGENETICS 1998 48 98-107
5867,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26089,MOLECULAR IMMUNOLOGY 1994 31 813-822
5868,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03467,JOURNAL OF IMMUNOLOGY 1995 154 247-259
5869,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P26089,MOLECULAR IMMUNOLOGY 1994 31 813-822
5870,,,A*2401,HLA-A24,CLASS-I,HUMAN,VIRAL,P26089,MOLECULAR IMMUNOLOGY 1994 31 813-822
5871,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P26089,MOLECULAR IMMUNOLOGY 1994 31 813-822
5872,,,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P03467,JOURNAL OF IMMUNOLOGY 1995 154 247-259
5873,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P03467,JOURNAL OF IMMUNOLOGY 1995 154 247-259
5874,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
5875,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P03467,JOURNAL OF IMMUNOLOGY 2001 166 1016-1027
5876,,,B*0801,HLA-B8,CLASS-I,HUMAN,VIRAL,P03467,JOURNAL OF IMMUNOLOGY 1995 154 247-259
5877,SSEGNNEPIL,1.0,H-2Db,H-2b,CLASS-I,MOUSE,BACTERIAL,Q9Z7P3,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
5878,SSEQTFMYY,1.0,n/a,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P11926,JOURNAL OF IMMUNOLOGY 1994 152 620-631
5879,SSFSTTINY,1.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43356,PROC.NATL.ACAD.SCI. USA 1994 91 2105-2109
5880,SSGVENPGGYCL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
5881,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
5882,SSIEFARL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P06437,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
5883,SSISFCGV,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P03468,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
5884,SSLENFRAYV,1.0,n/a,H-2b,CLASS-I,MOUSE,VIRAL,P13166,JOURNAL OF BIOLOGICAL CHEMISTRY 2003 278 46 45135-45144
5885,SSLGLPVSY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P36919,IMMUNOGENETICS 1997 45 249-258
5886,SSLLNNQFGTM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5887,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
5888,SSLPFQNI,2.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P03452,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
5889,,,n/a,H-2b,CLASS-I,MOUSE,VIRAL,P03458,JOURNAL OF BIOLOGICAL CHEMISTRY 2003 278 46 45135-45144
5890,SSLPTTMNY,1.0,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P43357,PROC.NATL.ACAD.SCI. USA 1994 91 2105-2109
5891,SSPPSYFQT,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05885,JOURNAL OF VIROLOGY 2001 75 738-749
5892,SSSHWLRLPR,1.0,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
5893,SSVIGVWYL,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,Q9D8V0,JOURNAL OF IMMUNOLOGY 2002 168 283-289
5894,SSVVGVWYL,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,Q9D8V0,JOURNAL OF IMMUNOLOGY 2002 168 283-289
5895,SSVVNVWYL,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,Q9D8V0,JOURNAL OF IMMUNOLOGY 2002 168 283-289
5896,SSWPWQIEY,1.0,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
5897,SSYRRPVGI,1.0,n/a,H-2b,CLASS-I,MOUSE,VIRAL,P26144,JOURNAL OF BIOLOGICAL CHEMISTRY 2003 278 46 45135-45144
5898,STAPPAHGV,6.0,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P15941,JOURNAL OF IMMUNOLOGY 1995 155 4766-4774
5899,,,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P15941,JOURNAL OF IMMUNOLOGY 1995 155 4766-4774
5900,,,n/a,HLA-A1,CLASS-I,HUMAN,CANCER,P15941,JOURNAL OF IMMUNOLOGY 1995 155 4766-4774
5901,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P15941,JOURNAL OF IMMUNOLOGY 1995 155 4766-4774
5902,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P15941,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
5903,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P15941,JOURNAL OF IMMUNOLOGY 1995 155 4766-4774
5904,STAPPVHNV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P15941,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
5905,STDHIPILY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,Q06210,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
5906,STEAEQPFI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5907,STEINQPFITM,2.0,H-2Db,H-2b,CLASS-I,MOUSE,BACTERIAL,P27542,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
5908,,,H-2Kb,H-2b,CLASS-I,MOUSE,BACTERIAL,P27542,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
5909,STEPVNILY,1.0,n/a,HLA-A3,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 620-631
5910,STFSFRNAL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
5911,STGVSFFFL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P15941,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
5912,STLELRSRY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P21433,IMMUNOGENETICS 1997 45 249-258
5913,STLPETTVVR,5.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P17392,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
5914,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P17392,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
5915,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P17392,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
5916,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P17392,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
5917,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P17392,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
5918,STLPETTVVRR,12.0,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF IMMUNOLOGY 1995 154 685-693
5919,,,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
5920,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
5921,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03146,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
5922,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF IMMUNOLOGY 1999 162 3915-3925
5923,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
5924,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF IMMUNOLOGY 1995 154 685-693
5925,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF IMMUNOLOGY 1995 154 685-693
5926,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
5927,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
5928,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
5929,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,Q05495,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
5930,STPESANL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
5931,STPPLVRL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27973,JOURNAL OF VIROLOGY 2001 75 738-749
5932,STPPLVRLV,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27973,JOURNAL OF VIROLOGY 2001 75 738-749
5933,STPPPGTRV,4.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
5934,,,A*0202,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
5935,,,A*0203,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
5936,,,A*6802,HLA-A68,CLASS-I,HUMAN,SELF PEPTIDE,P04637,JOURNAL OF IMMUNOLOGY 2001 167 787-796
5937,STTAGPNEY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P01558,IMMUNOGENETICS 1997 45 249-258
5938,STTAICATGL,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,Q9Y6I4,JOURNAL OF IMMUNOLOGY 2003 171 22-26
5939,SVIDPLIYA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
5940,SVLEVFEGR,5.0,n/a,HLA-A3,CLASS-I,HUMAN,CANCER,P43357,HUMAN IMMUNOLOGY 1996 45 79-93
5941,,,n/a,HLA-A31,CLASS-I,HUMAN,CANCER,P43357,HUMAN IMMUNOLOGY 1996 45 79-93
5942,,,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43357,HUMAN IMMUNOLOGY 1996 45 79-93
5943,,,A*3301,HLA-A33,CLASS-I,HUMAN,CANCER,P43357,HUMAN IMMUNOLOGY 1996 45 79-93
5944,,,A*6801,HLA-A68,CLASS-I,HUMAN,CANCER,P43357,HUMAN IMMUNOLOGY 1996 45 79-93
5945,SVLNLVIVK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,P10660,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
5946,,,A*0301,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P10660,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
5947,SVLSGGELDK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P05889,TISSUE ANTIGENS 2000 55 296-302
5948,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P05889,TISSUE ANTIGENS 2000 55 296-302
5949,SVMDPLIYA,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P33032,CANCER RESEARCH 1997 57 4348-4355
5950,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
5951,SVMEVYDGR,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
5952,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
5953,SVPAEILRK,1.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
5954,SVPLDEDFRK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
5955,SVWGQGTLV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
5956,SVWTSPRRL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5957,SVWTSPRRLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
5958,SVYDFFVWL,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 2000 60 6995-7001
5959,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
5960,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
5961,SVYGDTLEK,2.0,A*1102,HLA-A11,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
5962,,,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
5963,SVYVDAKLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,not applicable,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
5964,SWHINRTALNCNDSL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27953,JOURNAL OF HEPATOLOGY 2001 34 321-329
5965,SWPWQIEYI,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05885,JOURNAL OF VIROLOGY 2001 75 738-749
5966,SYFPEITHI,5.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P52332,PROTEIN SCIENCE 1997 6 1771-1773
5967,,,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P52332,PROTEIN SCIENCE 1997 6 1771-1773
5968,,,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P52332,PROTEIN SCIENCE 1997 6 1771-1773
5969,,,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,P52332,IMMUNOGENETICS 2003 54 830-841
5970,,,A*2402,HLA-A24,CLASS-I,HUMAN,SELF PEPTIDE,P23458,IMMUNOGENETICS 2003 54 830-841
5971,SYGVTVWEL,1.0,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P04626,BRITISH JOURNAL OF CANCER 2001 84 94-99
5972,SYIPSAEKI,4.0,H-2Kd,H-2d,CLASS-I,MOUSE,PARASITE,P23093,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
5973,,,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,P06915,IMMUNOGENETICS 2003 54 830-841
5974,,,n/a,H-2Kd,CLASS-I,MOUSE,VIRAL,P18277,BIOCHEMISTRY 1994 33 8149-8158
5975,,,A*2402,HLA-A24,CLASS-I,HUMAN,BACTERIAL,P06915,IMMUNOGENETICS 2003 54 830-841
5976,SYIPSAEYI,1.0,n/a,I-Kd,CLASS-I,MOUSE,PARASITE,P06915,FEBS 1996 387 42-46
5977,SYKGRPGNF,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
5978,SYKGRPGNFL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P05888,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
5979,SYRRLRDL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03383,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
5980,SYRRLRDLL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
5981,SYRRLRDLLL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
5982,SYRRLRDLLLI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
5983,SYVKVLEYVI,1.0,A*2401,HLA-A24,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
5984,SYVKVLHHTL,1.0,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P43356,CLINICAL CANCER RESEARCH 1999 5 2236-2241
5985,SYVPSAEQI,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,PARASITE,P06914,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
5986,SYVPSAEQIL,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,PARASITE,P06914,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
5987,TAEEAAGI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
5988,TAEEAAGIGI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
5989,TAFTIPSI,2.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,HUMAN IMMUNOLOGY 1999 60 177-186
5990,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03366,IMMUNOGENETICS 1999 49 819-822
5991,TAGANPMDL,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SYNTHETIC,P31681,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
5992,TALANTIEV,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P21426,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
5993,TAQRTRALV,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,FEBS LETTERS 1993 317 49-52
5994,TAVQMAVFI,3.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 43 268-276
5995,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 43 268-276
5996,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 43 268-276
5997,TAYFLLKLAGR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
5998,TCGFADLMGYIPLV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27954,JOURNAL OF HEPATOLOGY 2001 34 321-329
5999,TCGIFALI,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
6000,TCPGYRWM,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P17397,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
6001,TDRFGAPTYRWGENE,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
6002,TDVLLLNNTRPPRGN,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27960,JOURNAL OF HEPATOLOGY 2001 34 321-329
6003,TESTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
6004,TEVFEFAFK,1.0,A*1102,HLA-A11,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
6005,TFDHTLMSI,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
6006,TFPDLESEF,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,CANCER,P43357,INTERNATIONAL JOURNAL OF CANCER 1999 81 387-394
6007,TFQRTRALV,3.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,PROTEIN SCIENCE 1997 6 1771-1773
6008,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,PROTEIN SCIENCE 1997 6 1771-1773
6009,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,PROTEIN SCIENCE 1997 6 1771-1773
6010,TFSPRRHQTVQDCNC,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
6011,TFYVDGAANR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
6012,TGFKQSSK,2.0,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P11274,BLOOD 1995 85 2680-2684
6013,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P11274,BLOOD 1995 85 2680-2684
6014,TGICNQNII,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P03468,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
6015,TGKLNLENL,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z6X8,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
6016,TGLRNIPSI,1.0,n/a,H-2b,CLASS-I,MOUSE,VIRAL,P28730,JOURNAL OF BIOLOGICAL CHEMISTRY 2003 278 46 45135-45144
6017,TGPCRTCMT,1.0,H-2Dd,H-2d,CLASS-I,MOUSE,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
6018,TGPCRTCMTT,1.0,H-2Dd,H-2d,CLASS-I,MOUSE,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
6019,TGVKFVPM,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
6020,THRFNASGCSERMAS,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26662,JOURNAL OF HEPATOLOGY 2001 34 321-329
6021,TIFKVRMYV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,p27961,JOURNAL OF HEPATOLOGY 2001 34 321-329
6022,TIHDIILECV,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
6023,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1995 154 5934-5943
6024,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
6025,TIILPCRIK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P19551,TISSUE ANTIGENS 2000 55 296-302
6026,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P19551,TISSUE ANTIGENS 2000 55 296-302
6027,TILIGVFVV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
6028,TILLGIFFL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
6029,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
6030,TILLGVFIF,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01718,CANCER RESEARCH 1997 57 4348-4355
6031,TINKEEAL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P00519,BLOOD 1995 85 2680-2684
6032,TINKEEALQR,2.0,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P00519,BLOOD 1995 85 2680-2684
6033,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P00519,BLOOD 1995 85 2680-2684
6034,TIRRHVDLLVGAAAF,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
6035,TITDQVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1995 154 3961-3968
6036,TKALTEVIPL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
6037,TKRNTNRRPQDVKF,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
6038,TLAAKDASI,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q68173,JOURNAL OF HEPATOLOGY 2001 34 321-329
6039,TLADFTSL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P22777,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
6040,TLAGAWGDLW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2002 168 210-219
6041,TLAKFSPYL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6042,TLAPATERA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P15941,INTERNATIONAL JOURNAL OF CANCER 2001 91 385-392
6043,TLDSQVMSL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
6044,TLESFCEDV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P18139,IMMUNOGENETICS 1998 48 98-107
6045,TLFLQMNSL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
6046,TLGFGAYMSK,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
6047,TLGIVCPI,13.0,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
6048,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,HUMAN IMMUNOLOGY 1995 44 189-198
6049,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
6050,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
6051,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
6052,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
6053,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
6054,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1995 154 5934-5943
6055,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
6056,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
6057,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
6058,,,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
6059,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
6060,TLGIVCPIC,4.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,HUMAN IMMUNOLOGY 1995 44 189-198
6061,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
6062,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1995 154 5934-5943
6063,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
6064,TLHCDCEIL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,not applicable,CANCER RESEARCH 2000 60 6448-6456
6065,TLHEYMLDL,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
6066,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
6067,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
6068,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1995 154 5934-5943
6069,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
6070,TLHGPTPLLY,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
6071,TLHLERLAYL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6072,TLKDIRDCL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
6073,TLLQAAPTL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P06806,EURO.JOURNAL OF IMMUNOLOGY 2001 31 3602-3611
6074,TLLVVMGTL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
6075,TLLVVMGTLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
6076,TLNFPISPI,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
6077,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
6078,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
6079,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
6080,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
6081,TLPETTVVRR,5.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P17392,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6082,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P17392,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6083,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P17392,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6084,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P17392,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6085,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P17392,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6086,TLPPGLEMA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16790,CANCER RESEARCH 1999 59 5554-5559
6087,TLPRARRRV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
6088,TLQDIVLHL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06788,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
6089,TLQDLVFDEC,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6090,TLQEQIGWM,4.0,A*2601,HLA-A26,CLASS-I,HUMAN,VIRAL,P05888,TISSUE ANTIGENS 1999 54 325-332
6091,,,A*2602,HLA-A26,CLASS-I,HUMAN,VIRAL,P05888,TISSUE ANTIGENS 1999 54 325-332
6092,,,A*2603,HLA-A26,CLASS-I,HUMAN,VIRAL,P05888,TISSUE ANTIGENS 1999 54 325-332
6093,,,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20873,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
6094,TLSFYGNSI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6095,TLSITNCRL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6096,TLSKIFKL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P02686,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
6097,TLTDTTNQKT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
6098,TLVALVGLFV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
6099,TLVSLLTFMI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
6100,TLWGPGDSRL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16790,CANCER RESEARCH 1999 59 5554-5559
6101,TLWKAGILY,5.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6102,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6103,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6104,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6105,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6106,TLWKAGILYK,11.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6107,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6108,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P12933,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
6109,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
6110,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
6111,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
6112,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6113,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
6114,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6115,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6116,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
6117,TLWQRPLVTIR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
6118,TLYCVHQR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
6119,TMGAASITL,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20871,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
6120,TMLLGVFTV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P33032,CANCER RESEARCH 1997 57 4348-4355
6121,TMSYKLAIDM,1.0,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
6122,TNRRPQDVKFPGGG,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
6123,TPAETTVRL,2.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 1998 47 256-263
6124,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
6125,TPAEVSIVV,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6126,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6127,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6128,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6129,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6130,TPARVTGGV,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P12933,IMMUNOGENETICS 2003 54 830-841
6131,TPARVTGGVF,8.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6132,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6133,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6134,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6135,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P12933,HUMAN IMMUNOLOGY 2003 64 211-223
6136,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P12933,IMMUNOGENETICS 2003 54 830-841
6137,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6138,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
6139,TPCTCGSSDLY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
6140,TPEGIIPSM,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26664,IMMUNOGENETICS 1998 47 256-263
6141,TPGIRYQYNI,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P04589,HUMAN IMMUNOLOGY 2003 64 211-223
6142,TPGPAQKIQLVNTNG,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01404,JOURNAL OF HEPATOLOGY 2001 34 321-329
6143,TPGQEITQY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P10274,IMMUNOGENETICS 1998 47 256-263
6144,TPHPARIGL,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,BACTERIAL,P00722,MOLECULAR IMMUNOLOGY 1997 34 273-281
6145,TPIPAASQL,4.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 1998 47 256-263
6146,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 1999 49 819-822
6147,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
6148,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 1999 49 819-822
6149,TPITIPMEY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P06756,IMMUNOGENETICS 1998 47 256-263
6150,TPKKNCIAI,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P03113,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6151,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03113,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6152,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03113,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6153,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03113,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6154,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03113,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6155,TPLKNTSVL,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P10274,IMMUNOGENETICS 1998 47 256-263
6156,TPMFNDINI,5.0,B*5101,HLA-B51,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6157,,,B*5301,HLA-B53,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6158,,,B*5301,HLA-B53,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6159,,,B*5401,HLA-B54,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6160,,,B*0702,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6161,TPQDLNTML,3.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P03350,JOURNAL OF IMMUNOLOGY 1994 152 163-175
6162,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03350,IMMUNOGENETICS 1998 47 256-263
6163,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF IMMUNOLOGY 2003 171 22-26
6164,TPQSNRPVM,1.0,,,,,,,
6165,TPRCIVDY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,Q00269http://us.expasy.org/cgi-bin/get-sprot-entry,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
6166,TPRCIVDYPY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
6167,TPRLPSSADVEF,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 2003 171 6283-6289
6168,TPRPVSRFL,1.0,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,Q07284,JOURNAL OF MEDICAL VIROLOGY 2004 72 635-645
6169,TPWPTSQGL,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,IMMUNOGENETICS 1998 47 256-263
6170,TPYAGEPAPF,7.0,n/a,HLA-B7,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
6171,,,B*3501,HLA-B35,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
6172,,,B*5101,HLA-B51,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
6173,,,B*5301,HLA-B53,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
6174,,,B*5401,HLA-B54,CLASS-I,HUMAN,BACTERIAL,P16893,IMMUNITY 1997 7 97-112
6175,,,B*0702,HLA-B7,CLASS-I,HUMAN,BACTERIAL,P16893,HUMAN IMMUNOLOGY 2003 64 211-223
6176,,,B*0702,HLA-B7,CLASS-I,HUMAN,BACTERIAL,P16893,HUMAN IMMUNOLOGY 2003 64 211-223
6177,TPYDINQM,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
6178,TPYDINQML,7.0,B*3502,HLA-B35,CLASS-I,HUMAN,VIRAL,P18041,JOURNAL OF IMMUNOLOGY 1995 154 247-259
6179,,,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF IMMUNOLOGY 1998 160 6062-6071
6180,,,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P18041,JOURNAL OF IMMUNOLOGY 1995 154 247-259
6181,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P18041,JOURNAL OF IMMUNOLOGY 1995 154 247-259
6182,,,B*3503,HLA-B35,CLASS-I,HUMAN,VIRAL,P18041,JOURNAL OF IMMUNOLOGY 1995 154 247-259
6183,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P18041,IMMUNOGENETICS 1999 49 819-822
6184,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P18041,JOURNAL OF IMMUNOLOGY 1995 154 247-259
6185,TQDLVQEKY,2.0,A*0101,HLA-A1,CLASS-I,HUMAN,CANCER,P43355,IMMUNOGENETICS 1997 45 249-258
6186,,,A*0101,HLA-A1,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
6187,TQNHRALDL,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,CANCER,P14685,MOLECULAR IMMUNOLOGY 1997 34 273-281
6188,TRMMETQTSTW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05884,JOURNAL OF IMMUNOLOGY 2002 168 210-219
6189,TRWIILGLNK,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
6190,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P05889,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
6191,TRYPILAGH,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
6192,,,B*2705,HLA-B27,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
6193,TRYWAIRTR,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
6194,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
6195,TSAPDTRPA,2.0,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P15941,JOURNAL OF IMMUNOLOGY 1995 155 4766-4774
6196,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P15941,JOURNAL OF IMMUNOLOGY 1995 155 4766-4774
6197,TSCILESLFR,1.0,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
6198,TSGPGIRY,1.0,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
6199,TSIPFLHEY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,not applicable,IMMUNOGENETICS 1997 45 249-258
6200,TSKKNVLKV,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
6201,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
6202,TSPIFQWL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P49183,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
6203,TSPYELSLY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P46082,IMMUNOGENETICS 1997 45 249-258
6204,TSYQYLII,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09992,VIROLOGY 1998 240 158-167
6205,TSYVKVLEY,3.0,A*0101,HLA-A1,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
6206,,,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
6207,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
6208,TTAEEAAGI,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
6209,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1995 154 2257-2265
6210,TTDLEAYFY,1.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P20975,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
6211,TTDLYCYEQ,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
6212,TTINFTRQR,12.0,n/a,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,HUMAN IMMUNOLOGY 1996 45 79-93
6213,,,n/a,HLA-A31,CLASS-I,HUMAN,CANCER,P43355,HUMAN IMMUNOLOGY 1996 45 79-93
6214,,,n/a,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,HUMAN IMMUNOLOGY 1996 45 79-93
6215,,,n/a,HLA-A31,CLASS-I,HUMAN,CANCER,P43355,HUMAN IMMUNOLOGY 1996 45 79-93
6216,,,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355,HUMAN IMMUNOLOGY 1996 45 79-93
6217,,,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355,HUMAN IMMUNOLOGY 1996 45 79-93
6218,,,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
6219,,,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
6220,,,A*3301,HLA-A33,CLASS-I,HUMAN,CANCER,P43355,HUMAN IMMUNOLOGY 1996 45 79-93
6221,,,A*3301,HLA-A33,CLASS-I,HUMAN,CANCER,P43355,HUMAN IMMUNOLOGY 1996 45 79-93
6222,,,A*6801,HLA-A68,CLASS-I,HUMAN,CANCER,P43355,HUMAN IMMUNOLOGY 1996 45 79-93
6223,,,A*6801,HLA-A68,CLASS-I,HUMAN,CANCER,P43355,HUMAN IMMUNOLOGY 1996 45 79-93
6224,TTINYTLWR,6.0,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
6225,,,n/a,HLA-A3,CLASS-I,HUMAN,CANCER,P43356,HUMAN IMMUNOLOGY 1996 45 79-93
6226,,,n/a,HLA-A31,CLASS-I,HUMAN,CANCER,P43356,HUMAN IMMUNOLOGY 1996 45 79-93
6227,,,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P43356,HUMAN IMMUNOLOGY 1996 45 79-93
6228,,,A*3301,HLA-A33,CLASS-I,HUMAN,CANCER,P43356,HUMAN IMMUNOLOGY 1996 45 79-93
6229,,,A*6801,HLA-A68,CLASS-I,HUMAN,CANCER,P43356,HUMAN IMMUNOLOGY 1996 45 79-93
6230,TTLEQQYNK,3.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
6231,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03126,HUMAN IMMUNOLOGY 1995 44 189-198
6232,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
6233,TTLFCASDAK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6234,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6235,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6236,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6237,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6238,TTLSFYGNSI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6239,TTPESANL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27975,JOURNAL OF VIROLOGY 2001 75 738-749
6240,TTQHWLGLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
6241,TTRPGLAGY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,not applicable,IMMUNOGENETICS 1997 45 249-258
6242,TVATLYCVHQR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
6243,TVFDAKRLIGR,1.0,n/a,HLA-A68,CLASS-I,HUMAN,VIRAL,P21433,JOURNAL OF IMMUNOLOGY 1999 162 331-337
6244,TVILGVLLL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
6245,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1995 154 2257-2265
6246,TVLDVGDAY,3.0,A*2601,HLA-A26,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 1999 54 325-332
6247,,,A*2602,HLA-A26,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 1999 54 325-332
6248,,,A*2603,HLA-A26,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 1999 54 325-332
6249,TVLDVGDAYF,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
6250,TVLEYLVSFGV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
6251,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P29178,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
6252,TVLRFVPPL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P22487,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
6253,TVNFTIFKV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27961,JOURNAL OF HEPATOLOGY 2001 34 321-329
6254,TVPVKLKPGM,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
6255,TVPWPNASL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05885,JOURNAL OF VIROLOGY 2001 75 738-749
6256,TVQPIVLPEK,2.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
6257,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
6258,TVWSGNRASL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6259,TVYYGVPVWK,11.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
6260,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
6261,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6262,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6263,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
6264,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
6265,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6266,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6267,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
6268,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6269,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6270,TYACFVSNL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,CANCER,P06731,INTERNATIONAL JOURNAL OF CANCER 1999 80 92-97
6271,TYARTRALV,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,FEBS LETTERS 1993 317 49-52
6272,TYCRTRALV,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,BIOCHEMISTRY 1996 35 14841-14848
6273,TYGGGGGLV,3.0,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,PP75132,PROTEIN SCIENCE 1997 6 1771-1773
6274,,,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,PP75132,PROTEIN SCIENCE 1997 6 1771-1773
6275,,,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,PP75132,PROTEIN SCIENCE 1997 6 1771-1773
6276,TYKAALDI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03407,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
6277,TYKAALDISHF,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03405,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
6278,TYLKNAQFV,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,P75125,JOURNAL OF IMMUNOLOGY 2001 167 655-666
6279,TYQATRALV,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,FEBS LETTERS 1993 317 49-52
6280,TYQCTRALV,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,BIOCHEMISTRY 1996 35 14841-14848
6281,TYQIYQEPF,2.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P04589,IMMUNOGENETICS 2003 54 830-841
6282,,,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
6283,TYQIYQEPFK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03366,TISSUE ANTIGENS 2000 55 296-302
6284,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03366,TISSUE ANTIGENS 2000 55 296-302
6285,TYQRARALV,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,FEBS LETTERS 1993 317 49-52
6286,TYQRCRALV,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,BIOCHEMISTRY 1996 35 14841-14848
6287,TYQRTAALV,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,FEBS LETTERS 1993 317 49-52
6288,TYQRTCALV,3.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,BIOCHEMISTRY 1996 35 14841-14848
6289,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,PROTEIN SCIENCE 1997 6 1771-1773
6290,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,PROTEIN SCIENCE 1997 6 1771-1773
6291,TYQRTRAAV,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,FEBS LETTERS 1993 317 49-52
6292,TYQRTRALK,3.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,PROTEIN SCIENCE 1997 6 1771-1773
6293,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,PROTEIN SCIENCE 1997 6 1771-1773
6294,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,PROTEIN SCIENCE 1997 6 1771-1773
6295,TYQRTRALS,3.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,PROTEIN SCIENCE 1997 6 1771-1773
6296,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,PROTEIN SCIENCE 1997 6 1771-1773
6297,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,PROTEIN SCIENCE 1997 6 1771-1773
6298,TYQRTRALV,23.0,H-2Dd,H-2d,CLASS-I,MOUSE,VIRAL,P06826,VACCINE 1999 17 675-685
6299,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P06826,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
6300,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P26065,VACCINE 1999 17 675-685
6301,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,EURO.JOURNAL OF IMMUNOLOGY 1993 23 1118-1124
6302,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,EURO.JOURNAL OF IMMUNOLOGY 1993 23 1118-1124
6303,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,FEBS LETTERS 1993 317 49-52
6304,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,PROTEIN SCIENCE 1997 6 1771-1773
6305,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,PROTEIN SCIENCE 1997 6 1771-1773
6306,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,PROTEIN SCIENCE 1997 6 1771-1773
6307,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,FEBS LETTERS 1993 317 49-52
6308,,,n/a,I-Ad,CLASS-2,MOUSE,VIRAL,P06826,VACCINE 1999 17 675-685
6309,,,n/a,I-Ed,CLASS-2,MOUSE,VIRAL,P06826,VACCINE 1999 17 675-685
6310,,,n/a,I-Ab,CLASS-2,MOUSE,VIRAL,P06826,VACCINE 1999 17 675-685
6311,,,n/a,H-2Kd,CLASS-I,MOUSE,VIRAL,P18277,BIOCHEMISTRY 1994 33 8149-8158
6312,,,n/a,H-2Kd,CLASS-I,MOUSE,VIRAL,P18277,BIOCHEMISTRY 1994 33 8149-8158
6313,,,n/a,H-2Kd,CLASS-I,MOUSE,VIRAL,P18277,BIOCHEMISTRY 1994 33 8149-8158
6314,,,n/a,H-2Kd,CLASS-I,MOUSE,VIRAL,P18277,BIOCHEMISTRY 1994 33 8149-8158
6315,,,n/a,H-2Kd,CLASS-I,MOUSE,VIRAL,P18277,BIOCHEMISTRY 1994 33 8149-8158
6316,,,n/a,H-2Kd,CLASS-I,MOUSE,VIRAL,P18277,BIOCHEMISTRY 1994 33 8149-8158
6317,,,n/a,H-2Kd,CLASS-I,MOUSE,VIRAL,P18277,BIOCHEMISTRY 1994 33 8149-8158
6318,,,n/a,H-2Kd,CLASS-I,MOUSE,VIRAL,P18277,BIOCHEMISTRY 1994 33 8149-8158
6319,,,n/a,H-2Kd,CLASS-I,MOUSE,VIRAL,P18277,BIOCHEMISTRY 1994 33 8149-8158
6320,,,n/a,H-2Kd,CLASS-I,MOUSE,VIRAL,P18277,BIOCHEMISTRY 1994 33 8149-8158
6321,TYQRTRCLV,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P18277,BIOCHEMISTRY 1996 35 14841-14848
6322,TYSVSFDSL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,Q04609,CLINICAL CANCER RESEARCH 2002 8 3885-3892
6323,TYSVSFDSLF,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,Q04609,CLINICAL CANCER RESEARCH 2002 8 3885-3892
6324,VADKVHLMY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,Q14258,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
6325,VADLVGFLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
6326,VAEGDTVIY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P15020,IMMUNOGENETICS 1997 45 249-258
6327,VAELVHFLL,1.0,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P43357,CANCER RESEARCH 1997 57 4465-4468
6328,VAGALVAFK,10.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
6329,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6330,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
6331,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6332,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6333,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
6334,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6335,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
6336,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 1156-1164
6337,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6338,VAITRIEQLSPFPFDL,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,Q60597,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
6339,VALVGLFVL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
6340,VAQRAYRAI,4.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P03383,IMMUNOGENETICS 1996 43 268-276
6341,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P03383,IMMUNOGENETICS 1996 43 268-276
6342,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03383,HUMAN IMMUNOLOGY 1999 60 177-186
6343,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03383,IMMUNOGENETICS 1996 43 268-276
6344,VASGYIEAEV,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03383,HUMAN IMMUNOLOGY 1999 60 177-186
6345,VATLYCVHQR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
6346,VCDKCLKFY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03126,IMMUNOGENETICS 1997 45 249-258
6347,VCMTVDSLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
6348,VDLLVGAAAFCSAMY,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
6349,VDYNFTIV,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
6350,VENPGGYCL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
6351,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF VIROLOGY 1995 69 2297-2305
6352,VESTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
6353,VFEGREDSI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,CANCER,P43357,INTERNATIONAL JOURNAL OF CANCER 1999 81 387-394
6354,VFIHNFKR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
6355,VFIHNFKRK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 2000 55 296-302
6356,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 2000 55 296-302
6357,VFLNGQETL,2.0,H-2Kd,H-2d,CLASS-I,MOUSE,PARASITE,Q01443,IMMUNOGENETICS 2003 54 830-841
6358,,,A*2402,HLA-A24,CLASS-I,HUMAN,PARASITE,Q01443,IMMUNOGENETICS 2003 54 830-841
6359,VFNVVNSSI,2.0,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,P19597,IMMUNOGENETICS 2003 54 830-841
6360,,,A*2402,HLA-A24,CLASS-I,HUMAN,BACTERIAL,P19597,IMMUNOGENETICS 2003 54 830-841
6361,VGDLCDSVFLVSQLF,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
6362,VGDRNPYENI,3.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
6363,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
6364,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
6365,VGDRNPYENIL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
6366,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
6367,VGFLLLKYR,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
6368,VGGLVGLRI,4.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P03383,IMMUNOGENETICS 1996 43 268-276
6369,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P03383,IMMUNOGENETICS 1996 43 268-276
6370,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03383,HUMAN IMMUNOLOGY 1999 60 177-186
6371,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03383,IMMUNOGENETICS 1996 43 268-276
6372,VGLSYSQTM,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09992,VIROLOGY 1998 240 158-167
6373,VGNNTLICPTDCFRK,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
6374,VGNWAKVLV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
6375,VHSQFNSL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,Q07235,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
6376,VIDPYNIKY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
6377,VIHAFQYVI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
6378,VILGVLLLI,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
6379,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q16655,JOURNAL OF IMMUNOLOGY 1995 154 2257-2265
6380,VIPLTEEAEL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
6381,VIRQNIHSL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
6382,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,INTERNATIONAL JOURNAL OF CANCER 2000 87 241-246
6383,VIWGKTPKFK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
6384,VIYQYMDDL,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20875,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
6385,VIYQYMDDLY,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
6386,VKHHMYVSGKARGWFY,2.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q70623,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
6387,,,n/a,HLA-DR13,CLASS-I,HUMAN,VIRAL,Q70623,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
6388,VKYPNLNDL,3.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
6389,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
6390,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
6391,VLAALAAYCL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
6392,VLAEAMSQA,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20873,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
6393,VLAEAMSQV,10.0,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03407,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6394,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03407,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6395,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF VIROLOGY 2001 75 1301-1311
6396,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03407,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6397,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF VIROLOGY 2001 75 1301-1311
6398,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03407,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6399,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF VIROLOGY 2001 75 1301-1311
6400,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF VIROLOGY 2001 75 1301-1311
6401,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF VIROLOGY 2001 75 1301-1311
6402,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P03407,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6403,VLAEMSQV,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20873,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
6404,VLAGLAYYS,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
6405,VLAGLLGNV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
6406,,,A*0202,HLA-A2,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
6407,,,A*0203,HLA-A2,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
6408,,,A*0206,HLA-A2,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
6409,,,A*6802,HLA-A68,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
6410,VLAKDGTEV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,not applicable,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
6411,VLCPKNMII,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
6412,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
6413,VLDGLDVLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6414,VLDGLDVLLA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6415,VLDPYNIKY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
6416,VLDPYNLKY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
6417,VLDVGDAYFSV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
6418,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
6419,VLETAVGLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
6420,VLGPISGHV,3.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P18139,IMMUNOGENETICS 1998 48 98-107
6421,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
6422,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
6423,VLHSFTDAI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
6424,VLIAFGRFPI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q02251,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
6425,VLIQRNPQL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,INTERNATIONAL JOURNAL OF CANCER 1998 78 202-208
6426,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
6427,VLLDYQGM,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
6428,VLLDYQGML,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
6429,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
6430,VLLEDGGVEV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P41514,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
6431,,,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P41514,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
6432,VLLGGVGLVL,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
6433,,,A*0203,HLA-A2,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
6434,,,A*0206,HLA-A2,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
6435,VLLGVVFGV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6436,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6437,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6438,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6439,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6440,VLLLDVTPL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P19993,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
6441,VLLPSLFLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,P18269,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
6442,VLLPSLFLLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,P18269,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
6443,VLMAVVLASL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802
6444,VLMKGQHLHL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6445,VLPEKDSWTV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
6446,VLPHETRLL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
6447,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
6448,VLPSPACQLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802
6449,VLPWIAFPGKV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
6450,VLQAGFFLL,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,Q02317,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
6451,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03140,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
6452,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
6453,VLQQSTYQL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,ALLERGEN,P04721,JOURNAL OF IMMUNOLOGY 2003 170 2719-2726
6454,VLRENTSPK,7.0,n/a,HLA-A3,CLASS-I,HUMAN,CANCER,P04626,HUMAN IMMUNOLOGY 1996 45 79-93
6455,,,n/a,HLA-A31,CLASS-I,HUMAN,CANCER,P04626,HUMAN IMMUNOLOGY 1996 45 79-93
6456,,,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P04626,HUMAN IMMUNOLOGY 1996 45 79-93
6457,,,A*0301,HLA-A3,CLASS-I,HUMAN,CANCER,P04626,CANCER RESEARCH 1999 59 431-435
6458,,,A*3301,HLA-A33,CLASS-I,HUMAN,CANCER,P04626,HUMAN IMMUNOLOGY 1996 45 79-93
6459,,,A*6801,HLA-A68,CLASS-I,HUMAN,CANCER,P04626,HUMAN IMMUNOLOGY 1996 45 79-93
6460,,,A*6801,HLA-A68,CLASS-I,HUMAN,CANCER,P04626,CANCER RESEARCH 1999 59 431-435
6461,VLRLCCKKL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6462,VLSFNLGDM,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SYNTHETIC,P23700,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
6463,VLSHNSYEK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
6464,,,A*0301,HLA-A3,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
6465,,,A*3301,HLA-A33,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
6466,,,A*3101,HLA-A31,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
6467,,,A*6801,HLA-A68,CLASS-I,HUMAN,PARASITE,not applicable,IMMUNITY 1997 7 97-112
6468,VLSLSGVML,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6469,VLSLSGVMLT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6470,VLSTNGDTL,1.0,H-2Db,H-2b,CLASS-I,MOUSE,BACTERIAL,P27542,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
6471,VLTALLAGL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
6472,VLVGGVLAA,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6473,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6474,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6475,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6476,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6477,VLVKSPNHV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,CELL 1993 74 929-937
6478,VLYGPDAPTI,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6479,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6480,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6481,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6482,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6483,VLYGPDAPTV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6484,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6485,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6486,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6487,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6488,VLYGPDTPI,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6489,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6490,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6491,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6492,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6493,VLYGPDTPV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6494,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6495,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6496,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6497,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6498,VLYNTEKGR,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
6499,,,A*0301,HLA-A3,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
6500,,,A*3101,HLA-A31,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
6501,,,A*3301,HLA-A33,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
6502,,,A*6801,HLA-A68,CLASS-I,HUMAN,PARASITE,P04926,IMMUNITY 1997 7 97-112
6503,VLYRYGSFSV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,CELLULAR IMMUNOLOGY 2000 204 29-37
6504,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,IMMUNOLOGICAL REVIEWS 2002 188 136-146
6505,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1995 154 3961-3968
6506,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802
6507,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 2000 164 2354-2361
6508,VMAGVGSPYV,6.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6509,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
6510,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6511,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6512,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6513,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6514,VMGSSYGF,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 2003 54 830-841
6515,VMGTLVALV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
6516,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
6517,VMHLSQSPSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6518,VMIAMEGGHA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
6519,VMNPLETLSI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6520,VMPKTGLLI,1.0,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P43356,CLINICAL CANCER RESEARCH 1999 5 2236-2241
6521,VMPKTGLLII,1.0,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P43356,CLINICAL CANCER RESEARCH 1999 5 2236-2241
6522,VNPTLEEMLT,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF VIROLOGY 2001 75 738-749
6523,VNTNGSQHINRTALN,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27953,JOURNAL OF HEPATOLOGY 2001 34 321-329
6524,VPAAYAAQGY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
6525,VPASQVCGPVY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
6526,VPCRIKQII,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1997 46 245-248
6527,VPCVREGNSSRCWVA,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
6528,VPDSDPARY,2.0,A*0101,HLA-A1,CLASS-I,HUMAN,CANCER,P43355,IMMUNOGENETICS 1997 45 249-258
6529,,,A*0101,HLA-A1,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
6530,VPFFSCQRGY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663http://us.expasy.org/cgi-bin/get-sprot-entry,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
6531,VPFVQWFV,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P31873,IMMUNOGENETICS 2003 54 830-841
6532,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P31873,IMMUNOGENETICS 2003 54 830-841
6533,VPFVQWFVGL,2.0,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P31873,IMMUNOGENETICS 2003 54 830-841
6534,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P31873,IMMUNOGENETICS 2003 54 830-841
6535,VPGAAYALY,4.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 1998 47 256-263
6536,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 1999 49 819-822
6537,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
6538,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P26663http://www.expasy.ch/cgi-bin/get-sprot-entry,IMMUNOGENETICS 1999 49 819-822
6539,VPGTVVRTL,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P03113,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6540,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03113,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6541,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03113,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6542,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03113,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6543,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03113,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6544,VPHFKVGWAW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05902,JOURNAL OF IMMUNOLOGY 2002 168 210-219
6545,VPISHLYIL,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6546,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6547,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6548,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6549,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P43356,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6550,VPKVSGLQY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P27232,IMMUNOGENETICS 1998 47 256-263
6551,VPLAHSSSA,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6552,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6553,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6554,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6555,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6556,VPLDCVLYRY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P40967,JOURNAL OF IMMUNOLOGY 2003 171 6283-6289
6557,VPLDKDFRKY,2.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03369,IMMUNOGENETICS 1999 49 819-822
6558,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03369,AIDS 1996 10 1075-1083
6559,VPLKRLEEL,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03410,IMMUNOGENETICS 1998 47 256-263
6560,VPLQLPPL,6.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P04623,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6561,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P04623,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6562,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P04623,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6563,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P04623,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6564,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P05866,HUMAN IMMUNOLOGY 2003 64 211-223
6565,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P04623,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6566,VPLSEDQLL,5.0,n/a,HLA-B51,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6567,,,B*3501,HLA-B35,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6568,,,B*5301,HLA-B53,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6569,,,B*5401,HLA-B54,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6570,,,B*0702,HLA-B7,CLASS-I,HUMAN,CANCER,P15309,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6571,VPRPRFSAL,1.0,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P03210,JOURNAL OF MEDICAL VIROLOGY 2004 72 635-645
6572,VPRRKAKII,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,HUMAN IMMUNOLOGY 1999 60 177-186
6573,VPTSTIVQY,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03363,IMMUNOGENETICS 1998 47 256-263
6574,VPVKLKPGM,4.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 43 268-276
6575,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 43 268-276
6576,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,IMMUNOGENETICS 1996 43 268-276
6577,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03368,HUMAN IMMUNOLOGY 1999 60 177-186
6578,VQDCNCSIY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P29846,IMMUNOGENETICS 1997 45 249-258
6579,VREFPEDQY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P48371,IMMUNOGENETICS 1997 45 249-258
6580,VRVLEDGVNYATGN,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27954,JOURNAL OF HEPATOLOGY 2001 34 321-329
6581,VRYWAIRTR,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
6582,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
6583,VSAINNYAQKL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P03070,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
6584,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P03070,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
6585,VSDGGPNLY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P16504,IMMUNOGENETICS 1997 45 249-258
6586,VSEIFVEL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,Q62348,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
6587,VSGIYHVTNDCSNSS,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01404,JOURNAL OF HEPATOLOGY 2001 34 321-329
6588,VSQLFTFSPRRHQTV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
6589,VTCGNGIQVR,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,PARASITE,P05691,IMMUNITY 1997 7 97-112
6590,,,A*0301,HLA-A3,CLASS-I,HUMAN,PARASITE,P05691,IMMUNITY 1997 7 97-112
6591,,,A*3101,HLA-A31,CLASS-I,HUMAN,PARASITE,P05691,IMMUNITY 1997 7 97-112
6592,,,A*3301,HLA-A33,CLASS-I,HUMAN,PARASITE,P05691,IMMUNITY 1997 7 97-112
6593,,,A*6801,HLA-A68,CLASS-I,HUMAN,PARASITE,P05691,IMMUNITY 1997 7 97-112
6594,VTCTWKLPT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6595,VTCTWKLPTL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6596,VTDSQYALGI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
6597,VTGGVFLVDK,5.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6598,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6599,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6600,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6601,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6602,VTGLIGSI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,PARASITE,P13664,INFECTION AND IMMUNITY 1999 67 6358-6363
6603,VTIKIGGQLK,5.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6604,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6605,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6606,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6607,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6608,VTNPANIMM,3.0,A*2601,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
6609,,,A*2602,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
6610,,,A*2603,HLA-A26,CLASS-I,HUMAN,VIRAL,P03349,TISSUE ANTIGENS 1999 54 325-332
6611,VTNRGRQKVV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
6612,VTPDYADI,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27974,JOURNAL OF VIROLOGY 2001 75 738-749
6613,VTPEQRPLY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,Q02251,IMMUNOGENETICS 1997 45 249-258
6614,VTPNYADI,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
6615,VTPNYADIL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
6616,VTPNYADILL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
6617,VTVYYGVPV,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20871,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
6618,VTVYYGVPVWK,11.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
6619,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
6620,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6621,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6622,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
6623,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
6624,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6625,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6626,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
6627,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03378,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
6628,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 1648-1657
6629,VTWHRYHLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
6630,VVAAIIAIV,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20882,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
6631,VVDFSQFSR,5.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6632,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6633,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6634,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6635,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6636,VVESMNNELK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03368,TISSUE ANTIGENS 2000 55 296-302
6637,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20892,TISSUE ANTIGENS 2000 55 296-302
6638,VVFGILIKR,5.0,n/a,HLA-A3,CLASS-I,HUMAN,CANCER,P04626,HUMAN IMMUNOLOGY 1996 45 79-93
6639,,,n/a,HLA-A31,CLASS-I,HUMAN,CANCER,P04626,HUMAN IMMUNOLOGY 1996 45 79-93
6640,,,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P04626,HUMAN IMMUNOLOGY 1996 45 79-93
6641,,,A*3301,HLA-A33,CLASS-I,HUMAN,CANCER,P04626,HUMAN IMMUNOLOGY 1996 45 79-93
6642,,,A*6801,HLA-A68,CLASS-I,HUMAN,CANCER,P04626,HUMAN IMMUNOLOGY 1996 45 79-93
6643,VVHFFKNIV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P02686,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
6644,VVIQDNSDIK,2.0,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P03383,TISSUE ANTIGENS 2000 55 296-302
6645,,,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P03383,TISSUE ANTIGENS 2000 55 296-302
6646,VVLASLIYR,2.0,n/a,HLA-A3,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
6647,,,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
6648,VVLASLIYRR,2.0,n/a,HLA-A3,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
6649,,,n/a,HLA-A11,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
6650,VVLGVVFGI,7.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,INTERNATIONAL JOURNAL OF CANCER 1998 78 202-208
6651,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6652,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
6653,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6654,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6655,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6656,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6657,VVMGTLVAL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
6658,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
6659,VVPGFQAL,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P31634,JOURNAL OF VIROLOGY 2001 75 738-749
6660,VVTLTDTTNQ,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
6661,VVVGTTDRFGAPTYR,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
6662,VVYRDSIPH,1.0,A*1102,HLA-A11,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
6663,VWDKYGWL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
6664,VWEQWWTDYW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05897,JOURNAL OF IMMUNOLOGY 2002 168 210-219
6665,VYAEPPKPF,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,CANCER,P06731,INTERNATIONAL JOURNAL OF CANCER 1999 80 92-97
6666,VYAKECTGL,2.0,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,P13128http://us.expasy.org/cgi-bin/get-sprot-entry,IMMUNOGENETICS 2003 54 830-841
6667,,,A*2402,HLA-A24,CLASS-I,HUMAN,BACTERIAL,P13128http://us.expasy.org/cgi-bin/get-sprot-entry,IMMUNOGENETICS 2003 54 830-841
6668,VYCKTVLEL,2.0,A*1102,HLA-A11,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
6669,,,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
6670,VYDFAFRD,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03126,IMMUNOLOGY LETTERS 1995 47 1-8
6671,VYDFAFRDL,2.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03126,IMMUNOLOGY LETTERS 1995 47 1-8
6672,,,A*2401,HLA-A24,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
6673,VYDFAFRDLA,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03126,IMMUNOLOGY LETTERS 1995 47 1-8
6674,VYDFFVWL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 2000 60 6995-7001
6675,VYGDTLEKL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
6676,VYIEVLHL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P21428,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
6677,VYIKHPVSI,1.0,A*2401,HLA-A24,CLASS-I,HUMAN,SELF PEPTIDE,P48556,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
6678,VYINTALL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P21427,JOURNAL OF IMMUNOLOGY 1996 157 5555-5562
6679,VYLKHPVSI,1.0,A*2401,HLA-A24,CLASS-I,HUMAN,SELF PEPTIDE,P48556,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
6680,VYLKHPVSL,1.0,A*2401,HLA-A24,CLASS-I,HUMAN,SELF PEPTIDE,P48556,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
6681,VYMGNLTTQQL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
6682,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
6683,VYMIMVKCW,1.0,n/a,HLA-A24,CLASS-I,HUMAN,CANCER,P04626,BRITISH JOURNAL OF CANCER 2001 84 94-99
6684,VYNFATCGI,5.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1997 234 62-73
6685,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
6686,,,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1997 234 62-73
6687,,,H-2Kd,H-2d,CLASS-I,MOUSE,BACTERIAL,P09991,IMMUNOGENETICS 2003 54 830-841
6688,,,A*2402,HLA-A24,CLASS-I,HUMAN,BACTERIAL,P09991,IMMUNOGENETICS 2003 54 830-841
6689,VYVKTSSFI,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,FLY,Q24019,JOURNAL OF IMMUNOLOGY 2001 167 655-666
6690,VYYDPSKDL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
6691,VYYRDNKDPL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
6692,WAQPGYPWPLYGNE,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
6693,WCFKLVPV,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20867,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
6694,WESTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
6695,WFGCTWMNSTGFTKT,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
6696,WGENETDVLLLNNTR,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
6697,WGPITYNESHGLDQR,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q00269,JOURNAL OF HEPATOLOGY 2001 34 321-329
6698,WGPSLYSIL,1.0,H-2Dd,H-2d,CLASS-I,MOUSE,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
6699,WILRGTSFV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P17394,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
6700,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P17394,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
6701,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03159,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 1047-1058
6702,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
6703,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P12933,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
6704,WIPEWEFVNT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
6705,WITQCFLPV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P78358,CANCER RESEARCH 2002 62 3630-3635
6706,WIYHTQGYFPDWQNYT,4.0,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P19545,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
6707,,,B*3701,HLA-B37,CLASS-I,HUMAN,VIRAL,P19545,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
6708,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P19545,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
6709,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P19545,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
6710,WKGPGELLW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05897,JOURNAL OF IMMUNOLOGY 2002 168 210-219
6711,WLDQVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
6712,WLEPGPVTA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
6713,WLGHPDKFV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
6714,WLGHPDKFVGI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
6715,WLGLLGPNG,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
6716,WLLGAAMVGA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
6717,WLLIDTSNA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q02251,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
6718,WLLVFACSA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
6719,WLLVFACSAV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
6720,WLPKILGEV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,not applicable,CANCER RESEARCH 2000 60 6448-6456
6721,WLSANPCPHC,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6722,WLSLLVPFV,21.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P24025,MOLECULAR IMMUNOLOGY 1994 31 813-822
6723,,,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P12934,JOURNAL OF IMMUNOLOGY 1995 154 685-693
6724,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,MOLECULAR IMMUNOLOGY 1994 31 813-822
6725,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P31869,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
6726,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P12934,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 1047-1058
6727,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P17101,CELL 1993 74 929-937
6728,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P12934,JOURNAL OF IMMUNOLOGY 1995 154 685-693
6729,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6730,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1999 162 3915-3925
6731,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
6732,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
6733,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
6734,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6735,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P12934,JOURNAL OF IMMUNOLOGY 1995 154 685-693
6736,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6737,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P24025,MOLECULAR IMMUNOLOGY 1994 31 813-822
6738,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6739,,,A*2401,HLA-A24,CLASS-I,HUMAN,VIRAL,P24025,MOLECULAR IMMUNOLOGY 1994 31 813-822
6740,,,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P24025,MOLECULAR IMMUNOLOGY 1994 31 813-822
6741,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
6742,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P12934,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
6743,WLVTNGSYL,3.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,VIROLOGY 1998 240 158-167
6744,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
6745,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
6746,WLWYIKIFI,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P35961,AIDS RESEARCH HUMAN RETROVIRUSES 1998 14 1669-1678
6747,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03377,JOURNAL OF IMMUNOLOGY 1995 155 2232-2239
6748,WMAETTLGRV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P47769,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
6749,WMGYELHPPK,1.0,A*0301,HLA-A3,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
6750,WMMWYWGPSL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P24025,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
6751,WMNRLIAFA,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6752,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6753,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6754,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6755,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6756,WMNSTGFTK,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
6757,WMNSTGFTKTCGGPP,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
6758,WPLLPHVIF,5.0,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6759,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6760,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6761,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6762,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03409,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
6763,WPLTEEKIKI,1.0,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P04589,HUMAN IMMUNOLOGY 2003 64 211-223
6764,WPLYGNEGL,4.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 1999 49 819-822
6765,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P26663,IMMUNOGENETICS 1998 47 256-263
6766,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
6767,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,Q01404,IMMUNOGENETICS 1999 49 819-822
6768,WPRTTPTFL,1.0,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P03184,JOURNAL OF MEDICAL VIROLOGY 2004 72 635-645
6769,WPTLIGLAM,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,BACTERIAL,P31953,JOURNAL OF INFECTIOUS DISEASES 2001 183 928-934
6770,WQVTWIPEW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05897,JOURNAL OF IMMUNOLOGY 2002 168 210-219
6771,WRIPERLERW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05902,JOURNAL OF IMMUNOLOGY 2002 168 210-219
6772,WRYWAIRTR,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
6773,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
6774,WTDQVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
6775,WTDVTPNY,1.0,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
6776,WTEYWQATWI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
6777,WTSPRRLVEL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6778,WTVNDIQKLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF IMMUNOLOGICAL METHODS 1997 205 201-209
6779,WTVWSGNRA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6780,WVFPESISPV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,PARASITE,not applicable,JOURNAL OF CLINICAL INVESTIGATION 1998 102 1062-1071
6781,WVSIIYGDGK,2.0,n/a,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
6782,,,n/a,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
6783,WYIKIFIMI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P19551,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
6784,WYQLEKEPI,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
6785,WYWGPSLYSI,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
6786,YAAVVPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591 ,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
6787,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591 ,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
6788,YADILLHSTY,1.0,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05903 ,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
6789,YAIDLPVSV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126 ,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
6790,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126 ,CANCER RESEARCH 1998 58 4895-4901
6791,YAIENAEAL,4.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
6792,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
6793,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
6794,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
6795,YAIENAKAL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
6796,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
6797,YAIKNAEAL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
6798,,,H-2Db,H-2b,CLASS-I,MOUSE,MISCELLANEOUS,not applicable,MOLECULAR IMMUNOLOGY 1995 32 895-907
6799,YALTVVWLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905 ,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
6800,YALTVVWLLV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P06905 ,JOURNAL OF IMMUNOLOGY 1997 159 4943-4951
6801,YAPPIGGQI,5.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888 ,IMMUNOGENETICS 1996 43 268-276
6802,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888 ,IMMUNOGENETICS 1996 43 268-276
6803,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888 ,IMMUNOGENETICS 1997 46 245-248
6804,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888 ,HUMAN IMMUNOLOGY 1999 60 177-186
6805,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888 ,IMMUNOGENETICS 1996 43 268-276
6806,YAPPISGQI,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P04579 ,JOURNAL OF VIROLOGY 2001 75 2462-2467
6807,YAPQPCGIVPALQVC,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26662 ,JOURNAL OF HEPATOLOGY 2001 34 321-329
6808,YARAYDTEV,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551 ,IMMUNOGENETICS 1997 46 245-248
6809,YASDNQAIL,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z7H7 ,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
6810,YAYTFWTYM,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P28352 ,SCAND.JOURNAL OF IMMUNOLOGY 2003 57 21-27
6811,YDAVVPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591 ,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
6812,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591 ,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
6813,YDEDDYSYY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,BACTERIAL,P09790 ,IMMUNOGENETICS 1997 45 249-258
6814,YDFAFRDL,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03126 ,IMMUNOLOGY LETTERS 1995 47 1-8
6815,YDFAFRDLA,1.0,n/a,n/a,CLASS-I,HUMAN,VIRAL,P03126 ,IMMUNOLOGY LETTERS 1995 47 1-8
6816,YESTGNLI,1.0,H-2Kk,H-2k,CLASS-I,MOUSE,VIRAL,P03451 ,PROC.NATL.ACAD.SCI. USA 1996 93 10338-10342
6817,YEVRNVSGIYHVTND,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,Q01404 ,JOURNAL OF HEPATOLOGY 2001 34 321-329
6818,YFAVVPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591 ,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
6819,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591 ,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
6820,YFHEAVQAVW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05884 ,JOURNAL OF IMMUNOLOGY 2002 168 210-219
6821,YFILVNLLI,2.0,H-2Kd,H-2d,CLASS-I,MOUSE,n/a,not applicable,IMMUNOGENETICS 2003 54 830-841
6822,,,A*2402,HLA-A24,CLASS-I,HUMAN,n/a,not applicable,IMMUNOGENETICS 2003 54 830-841
6823,YFLLKLAGR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875 ,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
6824,YFLPSDFFPSV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P17391 ,JOURNAL OF IMMUNOLOGY 2003 170 2977-2984
6825,YFPCFTAGEV,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903 ,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
6826,YFSVPLDKDFR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875 ,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
6827,YGIENEVFL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P16125 ,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
6828,,,H-2Db,H-2b,CLASS-I,MOUSE,SELF PEPTIDE,P16125 ,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 19396-19403
6829,YHLPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
6830,YHRPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
6831,YIAQFTSQFL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395 ,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6832,YIASNENMDAM,3.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P22435 ,EURO.JOURNAL OF IMMUNOLOGY 1991 21 2069-2075
6833,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P22435 ,EURO.JOURNAL OF IMMUNOLOGY 1991 21 2069-2075
6834,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P22435 ,EURO.JOURNAL OF IMMUNOLOGY 1991 21 2069-2075
6835,YIAVVPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591 ,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
6836,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591 ,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
6837,YIGEVLVSM,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,O00159 ,JOURNAL OF IMMUNOLOGY 2001 167 3223-3230
6838,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,O00159 ,JOURNAL OF IMMUNOLOGY 2001 167 3223-3230
6839,YIGEVLVSV,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,O00159 ,JOURNAL OF IMMUNOLOGY 2001 167 3223-3230
6840,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,O00159 ,JOURNAL OF IMMUNOLOGY 2001 167 3223-3230
6841,,,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1997 158 5797-5804
6842,YIGSVLISV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,O00160 ,JOURNAL OF IMMUNOLOGY 2001 167 3223-3230
6843,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,O00159 ,JOURNAL OF IMMUNOLOGY 2001 167 3223-3230
6844,YIKIFIMIV,1.0,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20871 ,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
6845,YIPSAEKI,2.0,H-2Kd,H-2d,CLASS-I,MOUSE,PARASITE,P06915 ,EURO.JOURNAL OF IMMUNOLOGY 1993 23 1118-1124
6846,,,n/a,H-2Kd,CLASS-I,MOUSE,VIRAL,P18277 ,BIOCHEMISTRY 1994 33 8149-8158
6847,YISAWPDSL,1.0,n/a,HLA-A2,CLASS-I,HUMAN,CANCER,P04626 ,JOURNAL OF BIOLOGICAL CHEMISTRY 1999 274 36422-36427
6848,YKAVVPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591 ,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
6849,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591 ,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
6850,YKFSGFTQK,1.0,B*2705,HLA-B27,CLASS-I,HUMAN,SELF PEPTIDE,P04637 ,JOURNAL OF BIOLOGICAL CHEMISTRY 2001 276 48740-48747
6851,YKKGILGFVFTLTV,12.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429 ,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
6852,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429 ,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
6853,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429 ,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
6854,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429 ,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
6855,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429 ,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
6856,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429 ,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
6857,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429 ,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
6858,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429 ,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
6859,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429 ,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
6860,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429 ,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
6861,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429 ,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
6862,,,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P21429 ,JOURNAL OF EXPERIMENTAL MEDICINE 1990 172 889-899
6863,YKVAYQATV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663 ,HUMAN IMMUNOLOGY 2001 62 1200-1216
6864,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663 ,HUMAN IMMUNOLOGY 2001 62 1200-1216
6865,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663 ,HUMAN IMMUNOLOGY 2001 62 1200-1216
6866,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663 ,HUMAN IMMUNOLOGY 2001 62 1200-1216
6867,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P26663 ,HUMAN IMMUNOLOGY 2001 62 1200-1216
6868,YLAEADLSYT,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
6869,YLAPGPVTA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
6870,YLAPGPVTV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
6871,YLAVVPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591 ,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
6872,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591 ,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
6873,YLAWVPAHK,7.0,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03368 ,JOURNAL OF IMMUNOLOGY 1997 159 4753-4761
6874,,,n/a,HLA-A31,CLASS-I,HUMAN,VIRAL,P12499 ,HUMAN IMMUNOLOGY 1996 45 79-93
6875,,,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P12499 ,HUMAN IMMUNOLOGY 1996 45 79-93
6876,,,A*1101,HLA-A11,CLASS-I,HUMAN,VIRAL,P12499 ,HUMAN IMMUNOLOGY 1996 45 79-93
6877,,,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P20875 ,JOURNAL OF GENERAL VIROLOGY 2003 84 2409-2421
6878,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P12499 ,HUMAN IMMUNOLOGY 1996 45 79-93
6879,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P12499 ,HUMAN IMMUNOLOGY 1996 45 79-93
6880,YLDDPDLKY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P26358 ,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
6881,YLDLALMSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q02251 ,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
6882,YLDPAQQNL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1997 158 5797-5804
6883,YLDQVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
6884,YLEPAIAKY,6.0,A*0205,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
6885,,,A*0201,HLA-A2,CLASS-I,HUMAN,SYNTHETIC,not applicable,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
6886,,,A*0202,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
6887,,,A*0203,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
6888,,,A*0204,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
6889,,,A*0206,HLA-A2,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
6890,YLEPGPVTA,8.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
6891,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967 ,CELLULAR IMMUNOLOGY 2000 204 29-37
6892,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967 ,IMMUNOLOGICAL REVIEWS 2002 188 136-146
6893,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967 ,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
6894,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 1995 154 3961-3968
6895,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 1997 158 1796-1802
6896,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 2000 164 2354-2361
6897,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
6898,YLEPGPVTI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
6899,YLEPGPVTL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
6900,YLEPGPVTV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
6901,YLESFCEDV,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725 ,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
6902,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P06725 ,JOURNAL OF IMMUNOLOGY 1999 163 5512-5518
6903,YLESGSVTA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,MOUSE,Q60696 ,IMMUNOLOGICAL REVIEWS 2002 188 136-146
6904,YLFPGPVTA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
6905,YLFPGPVTV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
6906,YLGSYGFRL,2.0,n/a,HLA-A,CLASS-I,HUMAN,SELF PEPTIDE,P04637 ,SCAND.JOURNAL OF IMMUNOLOGY 2001 53 357-364
6907,,,n/a,HLA-A,CLASS-I,HUMAN,SELF PEPTIDE,P04637 ,SCAND.JOURNAL OF IMMUNOLOGY 2001 53 357-364
6908,YLHARLREL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395 ,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6909,YLHARLRELL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P78395 ,JOURNAL OF EXPERIMENTAL MEDICINE 2001 193 73-88
6910,YLHTLWKAGI,6.0,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P03159 ,JOURNAL OF IMMUNOLOGY 1995 154 685-693
6911,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03159 ,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 1047-1058
6912,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156 ,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
6913,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P04484 ,JOURNAL OF IMMUNOLOGY 1995 154 685-693
6914,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P04484 ,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
6915,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P17100 ,JOURNAL OF IMMUNOLOGY 1995 154 685-693
6916,YLILIMCNS,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726 ,CANCER RESEARCH 1997 57 4348-4355
6917,YLIMVKBWMV,5.0,,,,,,,
6918,,,,,,,,,
6919,,,,,,,,,
6920,,,,,,,,,
6921,,,,,,,,,
6922,YLKAYQATV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663 ,HUMAN IMMUNOLOGY 2001 62 1200-1216
6923,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663 ,HUMAN IMMUNOLOGY 2001 62 1200-1216
6924,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663 ,HUMAN IMMUNOLOGY 2001 62 1200-1216
6925,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663 ,HUMAN IMMUNOLOGY 2001 62 1200-1216
6926,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P26663 ,HUMAN IMMUNOLOGY 2001 62 1200-1216
6927,YLKDQQLL,6.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P04578 ,JOURNAL OF IMMUNOLOGY 1995 154 247-259
6928,,,n/a,HLA-B7,CLASS-I,HUMAN,VIRAL,P04578 ,JOURNAL OF IMMUNOLOGY 1995 154 247-259
6929,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P04578 ,JOURNAL OF IMMUNOLOGY 1995 154 247-259
6930,,,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P04578 ,JOURNAL OF IMMUNOLOGY 1995 154 247-259
6931,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P04578 ,JOURNAL OF IMMUNOLOGY 1995 154 247-259
6932,,,B*0801,HLA-B8,CLASS-I,HUMAN,VIRAL,P04578 ,JOURNAL OF IMMUNOLOGY 1995 154 247-259
6933,YLLALRYLA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P36918 ,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
6934,YLLDGLRA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P31952 ,JOURNAL OF IMMUNOLOGY 2000 165 6463-6471
6935,YLLPAIVHI,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P17844 ,JOURNAL OF IMMUNOLOGY 1994 152 2874-2881
6936,YLLPRRGPRL,8.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958 ,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6937,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958 ,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
6938,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958 ,JOURNAL OF VIROLOGY 1995 69 2462-2470
6939,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958 ,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
6940,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958 ,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6941,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958 ,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6942,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958 ,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6943,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958 ,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6944,YLMPGPVTA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
6945,YLMPGPVTV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967 ,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
6946,YLQLFFGIEV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43356 ,JOURNAL OF EXPERIMENTAL MEDICINE 2001 194 833-846
6947,YLQLIFGIEV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43356 ,JOURNAL OF EXPERIMENTAL MEDICINE 2001 194 833-846
6948,YLQLVFGIEV,6.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43356 ,JOURNAL OF EXPERIMENTAL MEDICINE 2001 194 833-846
6949,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43356 ,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6950,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P43356 ,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6951,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P43356 ,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6952,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P43356 ,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6953,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P43356 ,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6954,YLSEGDMAA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P15712,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
6955,YLSGANLNL,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6956,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6957,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6958,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6959,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6960,YLSGANLNV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6961,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6962,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6963,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6964,,,*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
6965,YLSPGPVTA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
6966,YLSPGPVTV,1.0,*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
6967,YLSQIAVLL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q06861,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
6968,YLVAKQATV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6969,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6970,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6971,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6972,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6973,YLVAYKATV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6974,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6975,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6976,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6977,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6978,YLVAYQAKV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6979,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6980,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6981,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6982,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6983,YLVAYQATK,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6984,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6985,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6986,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6987,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6988,YLVAYQATV,11.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6989,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,INTERNATIONAL IMMUNOLOGY 1996 8 651-659
6990,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
6991,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF VIROLOGY 1995 69 2462-2470
6992,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26664,CELL 1993 74 929-937
6993,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
6994,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26664,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
6995,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6996,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6997,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6998,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
6999,YLVAYQKTV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
7000,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
7001,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
7002,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
7003,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
7004,YLVKYQATV,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
7005,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
7006,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
7007,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
7008,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P26663,HUMAN IMMUNOLOGY 2001 62 1200-1216
7009,YLVLINCNS,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,Q01726,CANCER RESEARCH 1997 57 4348-4355
7010,YLVSFGVWI,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03146,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
7011,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P17392,JOURNAL OF IMMUNOLOGY 1994 153 5586-5592
7012,YLVTRHADV,6.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
7013,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,CELL 1993 74 929-937
7014,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
7015,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
7016,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
7017,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1999 162 6681-6689
7018,YLWPGPVTA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
7019,YLWPGPVTV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
7020,YLWWVNNQSL,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
7021,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
7022,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
7023,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
7024,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P06731,JOURNAL OF IMMUNOLOGY 2001 167 787-796
7025,YLYGVGSAV,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P26663,JOURNAL OF HEPATOLOGY 2001 34 321-329
7026,YLYLQMNSL,3.0,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
7027,,,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
7028,,,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
7029,YLYPGPVTA,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
7030,YLYPGPVTV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
7031,YLYVHSPAL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,Q06861,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
7032,YMAVVPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7033,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7034,YMDDLYVGSDL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03368,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
7035,YMDDVVLGA,8.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03159,JOURNAL OF EXPERIMENTAL MEDICINE 1995 181 1047-1058
7036,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
7037,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1999 162 3915-3925
7038,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
7039,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
7040,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
7041,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
7042,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
7043,YMDDVVLGAK,5.0,n/a,HLA-A3,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
7044,,,n/a,HLA-A11,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
7045,,,A*3101,HLA-A31,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
7046,,,A*3301,HLA-A33,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
7047,,,A*6801,HLA-A68,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
7048,YMDDVVLGV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1999 162 3915-3925
7049,YMDGTMSQV,5.0,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,CANCER RESEARCH 1999 59 6230-6238
7050,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,IMMUNOLOGICAL REVIEWS 2002 188 136-146
7051,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
7052,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF EXPERIMENTAL MEDICINE 2000 191 1221-1231
7053,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 2000 164 2354-2361
7054,YMIMVKCWM,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
7055,YMIMVKCWMI,7.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
7056,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,INTERNATIONAL JOURNAL OF CANCER 1998 78 202-208
7057,,,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 1999 163 1037-1044
7058,,,A*0202,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
7059,,,A*6802,HLA-A68,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
7060,,,A*0203,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
7061,,,A*0206,HLA-A2,CLASS-I,HUMAN,CANCER,P04626,JOURNAL OF IMMUNOLOGY 2001 167 787-796
7062,YMLDLQPET,3.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
7063,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1995 154 5934-5943
7064,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
7065,YMLDLQPETT,13.0,A*0205,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
7066,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,HUMAN IMMUNOLOGY 1995 44 189-198
7067,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,HUMAN IMMUNOLOGY 1995 44 189-198
7068,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
7069,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
7070,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
7071,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
7072,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,JOURNAL OF IMMUNOLOGY 1995 154 5934-5943
7073,,,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P03129,EURO.JOURNAL OF IMMUNOLOGY 1996 26 97-101
7074,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
7075,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
7076,,,A*0204,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
7077,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P03126,EURO.JOURNAL OF IMMUNOLOGY 1999 29 1292-1303
7078,YMNGTMSQV,5.0,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,CANCER RESEARCH 1999 59 6230-6238
7079,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,HUMAN IMMUNOLOGY 1995 44 189-198
7080,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1996 156 3308-3314
7081,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,EURO.JOURNAL OF IMMUNOLOGY 1996 26 1683-1689
7082,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGY 1995 154 3961-3968
7083,YMVPFIPLYR,2.0,n/a,HLA-A3,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
7084,,,n/a,HLA-A11,CLASS-I,HUMAN,SELF PEPTIDE,P14679,JOURNAL OF IMMUNOLOGICAL METHODS 2000 244 59-67
7085,YNAVVPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7086,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7087,YNLLIRCLR,3.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
7088,,,A*1102,HLA-A11,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
7089,,,A*0302,HLA-A3,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
7090,YNLTMKCR,1.0,n/a,Mamu-A*02,CLASS-I,RHESUS,VIRAL,P11267,JOURNAL OF VIROLOGY 2002 76 11623-11636
7091,YPAEITLTW,5.0,B*3502,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P10319,JOURNAL OF IMMUNOLOGY 1995 154 247-259
7092,,,n/a,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,P10319,JOURNAL OF IMMUNOLOGY 1995 154 247-259
7093,,,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P10319,JOURNAL OF IMMUNOLOGY 1995 154 247-259
7094,,,B*3503,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,P10319,JOURNAL OF IMMUNOLOGY 1995 154 247-259
7095,,,B*5401,HLA-B54,CLASS-I,HUMAN,SELF PEPTIDE,P10319,JOURNAL OF IMMUNOLOGY 1995 154 247-259
7096,YPALGLHEF,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P04851,MOLECULAR IMMUNOLOGY 1997 34 273-281
7097,YPALMPLY,2.0,B*1301,HLA-B13,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7098,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7099,YPALMPLYA,9.0,B*1301,HLA-B13,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7100,,,n/a,HLA-B35,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
7101,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
7102,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
7103,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
7104,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 1998 161 4447-4455
7105,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P12933,IMMUNOGENETICS 2003 54 830-841
7106,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7107,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF CLINICAL INVESTIGATION 1997 100 503-513
7108,YPALMPLYACI,2.0,B*1301,HLA-B13,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7109,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03156,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7110,YPCRIKQII,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P19551,IMMUNOGENETICS 1997 46 245-248
7111,YPCTVNFTI,12.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P27958,IMMUNOGENETICS 1996 43 268-276
7112,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P27958,IMMUNOGENETICS 1996 43 268-276
7113,,,n/a,HLA-B51,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
7114,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P27958,IMMUNOGENETICS 1998 47 256-263
7115,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P27958,IMMUNOGENETICS 1999 49 819-822
7116,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
7117,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF GENERAL VIROLOGY 1998 79 1735-1744
7118,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P27958,IMMUNOGENETICS 1996 43 268-276
7119,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P27958,IMMUNOGENETICS 1999 49 819-822
7120,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
7121,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
7122,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P27958,JOURNAL OF IMMUNOLOGY 1996 157 3480-3490
7123,YPFQPPKV,5.0,B*3502,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
7124,,,n/a,HLA-B7,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
7125,,,B*3501,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
7126,,,B*3503,HLA-B35,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
7127,,,B*5401,HLA-B54,CLASS-I,HUMAN,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
7128,YPHFMPCNL,1.0,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,JOURNAL OF IMMUNOLOGICAL METHODS 1995 183 77-94
7129,YPHFMPTNL,25.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P11210,JOURNAL OF IMMUNOLOGY 1995 154 567-576
7130,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,JOURNAL OF IMMUNOLOGY 1996 157 5543-5554
7131,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,PROC.NATL.ACAD.SCI. USA 1992 89 2242-2246
7132,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,PROC.NATL.ACAD.SCI. USA 1992 89 2242-2246
7133,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,PROC.NATL.ACAD.SCI. USA 1992 89 2242-2246
7134,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,PROC.NATL.ACAD.SCI. USA 1992 89 2242-2246
7135,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,PROC.NATL.ACAD.SCI. USA 1992 89 2242-2246
7136,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,PROC.NATL.ACAD.SCI. USA 1992 89 2242-2246
7137,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,PROC.NATL.ACAD.SCI. USA 1992 89 2242-2246
7138,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,PROC.NATL.ACAD.SCI. USA 1992 89 2242-2246
7139,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,PROC.NATL.ACAD.SCI. USA 1992 89 2242-2246
7140,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,PROC.NATL.ACAD.SCI. USA 1992 89 2242-2246
7141,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,PROC.NATL.ACAD.SCI. USA 1992 89 2242-2246
7142,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,PROC.NATL.ACAD.SCI. USA 1992 89 2242-2246
7143,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,PROC.NATL.ACAD.SCI. USA 1992 89 2242-2246
7144,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,PROC.NATL.ACAD.SCI. USA 1992 89 2242-2246
7145,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,PROC.NATL.ACAD.SCI. USA 1992 89 2242-2246
7146,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,PROC.NATL.ACAD.SCI. USA 1992 89 2242-2246
7147,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,PROC.NATL.ACAD.SCI. USA 1992 89 2242-2246
7148,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,JOURNAL OF IMMUNOLOGY 1997 158 3244-3251
7149,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,JOURNAL OF IMMUNOLOGY 1998 160 77-86
7150,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,MOLECULAR IMMUNOLOGY 1997 34 273-281
7151,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,JOURNAL OF IMMUNOLOGY 2001 166 3028-3034
7152,,,H-2Ld,H-2d,CLASS-I,MOUSE,VIRAL,P11210,JOURNAL OF IMMUNOLOGY 1995 154 567-576
7153,,,n/a,Qa-1b,CLASS-Ib,MOUSE,VIRAL,P11210,JOURNAL OF IMMUNOLOGY 1997 158 3244-3251
7154,YPLASLKSL,5.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1996 43 268-276
7155,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1996 43 268-276
7156,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1998 47 256-263
7157,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1996 43 268-276
7158,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,HUMAN IMMUNOLOGY 1999 60 177-186
7159,YPLASLRSLF,6.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
7160,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
7161,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
7162,,,B*5401,HLA-B54,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
7163,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P03349,JOURNAL OF IMMUNOLOGY 2003 171 5611-5623
7164,,,B*0702,HLA-B7,CLASS-I,HUMAN,VIRAL,P05887,HUMAN IMMUNOLOGY 2003 64 211-223
7165,YPLTFGWCF,1.0,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P24741,IMMUNOGENETICS 1998 47 256-263
7166,YPLTSLRSL,7.0,B*5102,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1996 43 268-276
7167,,,B*5103,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1996 43 268-276
7168,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1998 47 256-263
7169,,,B*3501,HLA-B35,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1999 49 819-822
7170,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1996 43 268-276
7171,,,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,HUMAN IMMUNOLOGY 1999 60 177-186
7172,,,B*5301,HLA-B53,CLASS-I,HUMAN,VIRAL,P05888http://www.expasy.ch/cgi-bin/get-sprot-entry,IMMUNOGENETICS 1999 49 819-822
7173,YPLTSLRSLF,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,HUMAN IMMUNOLOGY 1999 60 177-186
7174,YPNLNDLERL,2.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
7175,,,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P09991,JOURNAL OF BIOLOGICAL CHEMISTRY 1996 271 17829-17836
7176,YPPIPVGEI,1.0,B*5101,HLA-B51,CLASS-I,HUMAN,VIRAL,P05888,IMMUNOGENETICS 1997 46 245-248
7177,YPWPLYGNEGCGWA,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27961,JOURNAL OF HEPATOLOGY 2001 34 321-329
7178,YPYRLWHY,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27961,JOURNAL OF HEPATOLOGY 2001 34 321-329
7179,YQFTGIKKY,3.0,Cw*0401,HLA-Cw4,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
7180,,,Cw*0602,HLA-Cw6,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
7181,,,Cw*0702,HLA-Cw7,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
7182,YQGSYGFRL,2.0,n/a,HLA-A,CLASS-I,HUMAN,SELF PEPTIDE,P04637,SCAND.JOURNAL OF IMMUNOLOGY 2001 53 357-364
7183,,,n/a,HLA-A,CLASS-I,HUMAN,SELF PEPTIDE,P04637,SCAND.JOURNAL OF IMMUNOLOGY 2001 53 357-364
7184,YREGRDQLW,1.0,n/a,Mamu-B*17,CLASS-I,CHIMPANZEE,VIRAL,P05897,JOURNAL OF IMMUNOLOGY 2002 168 210-219
7185,YRHDGGNVL,3.0,Cw*0401,HLA-Cw4,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
7186,,,Cw*0602,HLA-Cw6,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
7187,,,Cw*0702,HLA-Cw7,CLASS-I,HUMAN,MISCELLANEOUS,not applicable,JOURNAL OF IMMUNOLOGY 1995 154 247-259
7188,YRYWAIRTR,2.0,B*2703,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
7189,,,B*2705,HLA-B27,CLASS-I,HUMAN,VIRAL,P18277,JOURNAL OF IMMUNOLOGY 1997 159 4887-4897
7190,YSAMDISCWI,1.0,A*3101,HLA-A31,CLASS-I,HUMAN,CANCER,not applicable,JOURNAL OF IMMUNOLOGY 1999 163 2783-2791
7191,YSAVVPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7192,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7193,YSDSVYGDT,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P06463,CLINICAL CANCER RESEARCH 2001 7 SUPP. 788-795
7194,YSFRNVLSI,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P26121,MOLECULAR IMMUNOLOGY 1996 33 1323-1333
7195,YSILSPFL,1.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P03140,JOURNAL OF IMMUNOLOGY 2001 166 1389-1397
7196,YSKISEYRHY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,VIRAL,P03126,JOURNAL OF IMMUNOLOGY 1994 152 3904-3912
7197,YSMVGNWAKVLVVML,1.0,n/a,HLA-A2,CLASS-I,HUMAN,VIRAL,P27959,JOURNAL OF HEPATOLOGY 2001 34 321-329
7198,YSNENMDAM,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P22435,BIOCHEMISTRY 1998 37 3001-3012
7199,YSNENMDAMSSTL,1.0,H-2Db,H-2b,CLASS-I,MOUSE,VIRAL,P22435,BIOCHEMISTRY 1998 37 3001-3012
7200,YSPCFTAGEV,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05903,JOURNAL OF IMMUNOLOGY 2000 165 6387-6399
7201,YSQGNSGLM,1.0,H-2Db,H-2b,CLASS-I,MOUSE,SYNTHETIC,Q9Z6X9,JOURNAL OF IMMUNOLOGY 2002 169 2524-2535
7202,YSWMDASCWI,1.0,A*3101,HLA-A31,CLASS-I,HUMAN,CANCER,not applicable,JOURNAL OF IMMUNOLOGY 1999 163 2783-2791
7203,YSWMDIS,1.0,A*3101,HLA-A31,CLASS-I,HUMAN,CANCER,not applicable,JOURNAL OF IMMUNOLOGY 1999 163 2783-2791
7204,YSWMDISC,1.0,A*3101,HLA-A31,CLASS-I,HUMAN,CANCER,not applicable,JOURNAL OF IMMUNOLOGY 1999 163 2783-2791
7205,YSWMDISCAI,1.0,A*3101,HLA-A31,CLASS-I,HUMAN,CANCER,not applicable,JOURNAL OF IMMUNOLOGY 1999 163 2783-2791
7206,YSWMDISCRI,1.0,A*3101,HLA-A31,CLASS-I,HUMAN,CANCER,not applicable,JOURNAL OF IMMUNOLOGY 1999 163 2783-2791
7207,YSWMDISCW,1.0,A*3101,HLA-A31,CLASS-I,HUMAN,CANCER,not applicable,JOURNAL OF IMMUNOLOGY 1999 163 2783-2791
7208,YSWMDISCWI,1.0,A*3101,HLA-A31,CLASS-I,HUMAN,CANCER,not applicable,JOURNAL OF IMMUNOLOGY 1999 163 2783-2791
7209,YTAFTIPSI,5.0,A*0201,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
7210,,,A*0202,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
7211,,,A*0203,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
7212,,,A*0206,HLA-A2,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
7213,,,A*6802,HLA-A68,CLASS-I,HUMAN,VIRAL,P20892,JOURNAL OF VIROLOGY 2001 75 1301-1311
7214,YTAKVPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7215,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7216,YTAVKPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7217,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7218,YTAVVALVY,1.0,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7219,YTAVVDLVY,1.0,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7220,YTAVVFLVY,1.0,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7221,YTAVVKLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7222,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7223,YTAVVLLVY,1.0,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7224,YTAVVNLVY,1.0,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7225,YTAVVPAVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7226,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7227,YTAVVPDVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7228,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7229,YTAVVPFVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7230,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7231,YTAVVPKVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7232,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7233,YTAVVPLAY,1.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7234,YTAVVPLDY,1.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7235,YTAVVPLFY,1.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7236,YTAVVPLKY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7237,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7238,YTAVVPLLY,1.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7239,YTAVVPLNY,1.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7240,YTAVVPLVA,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7241,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7242,YTAVVPLVD,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7243,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7244,YTAVVPLVF,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7245,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7246,YTAVVPLVK,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7247,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7248,YTAVVPLVL,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7249,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7250,YTAVVPLVN,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7251,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7252,YTAVVPLVW,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7253,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7254,YTAVVPLVY,4.0,A*0101,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
7255,,,A*0101,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P01591,IMMUNOGENETICS 1997 45 249-258
7256,,,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7257,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7258,YTAVVPNVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7259,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7260,YTDQVPFSV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P40967,JOURNAL OF IMMUNOLOGY 1996 157 2539-2548
7261,YTDVVPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7262,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7263,YTDYGGLIFNSY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P00403,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
7264,YTEVVPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7265,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7266,YTFGPGIRY,1.0,n/a,Mamu-A*02,CLASS-I,RHESUS,VIRAL,P05861,JOURNAL OF VIROLOGY 2002 76 11623-11636
7267,YTFVVPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7268,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7269,YTKVVHYRK,5.0,n/a,HLA-A3,CLASS-I,HUMAN,CANCER,P07288,HUMAN IMMUNOLOGY 1996 45 79-93
7270,,,n/a,HLA-A31,CLASS-I,HUMAN,CANCER,P07288,HUMAN IMMUNOLOGY 1996 45 79-93
7271,,,A*1101,HLA-A11,CLASS-I,HUMAN,CANCER,P07288,HUMAN IMMUNOLOGY 1996 45 79-93
7272,,,A*3301,HLA-A33,CLASS-I,HUMAN,CANCER,P07288,HUMAN IMMUNOLOGY 1996 45 79-93
7273,,,A*6801,HLA-A68,CLASS-I,HUMAN,CANCER,P07288,HUMAN IMMUNOLOGY 1996 45 79-93
7274,YTKVVPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7275,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7276,YTLGPGIRF,1.0,n/a,Mamu-A*02,CLASS-I,RHESUS,VIRAL,P19501,JOURNAL OF VIROLOGY 2002 76 11623-11636
7277,YTLGPGIRY,1.0,n/a,Mamu-A*02,CLASS-I,RHESUS,VIRAL,P19501,JOURNAL OF VIROLOGY 2002 76 11623-11636
7278,YTLPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
7279,YTLVVPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7280,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7281,YTNPQFNVY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SYNTHETIC,not applicable,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
7282,YTNVVPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7283,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7284,YTPKIVGGI,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P27973,JOURNAL OF VIROLOGY 2001 75 738-749
7285,YTPLMETHL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
7286,YTQVVPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7287,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7288,YTRPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
7289,YTSDYFISY,1.0,A*0101,HLA-A1,CLASS-I,HUMAN,SELF PEPTIDE,P41156,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
7290,YTSGPGIRF,1.0,n/a,Mamu-A*02,CLASS-I,RHESUS,VIRAL,P05861,JOURNAL OF VIROLOGY 2002 76 11623-11636
7291,YTSGPGIRS,1.0,n/a,Mamu-A*02,CLASS-I,RHESUS,VIRAL,P05861,JOURNAL OF VIROLOGY 2002 76 11623-11636
7292,YTSGPGIRY,2.0,n/a,Mamu-A*02,CLASS-I,RHESUS,VIRAL,P05861,JOURNAL OF VIROLOGY 2002 76 11623-11636
7293,,,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
7294,YTSVVPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7295,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7296,YTVKYPNL,2.0,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09992,VIROLOGY 1998 240 158-167
7297,,,H-2Kb,H-2b,CLASS-I,MOUSE,VIRAL,P09992,NATURE IMMUNOLOGY 2000 1 145-150
7298,YTYEAYVRY,1.0,n/a,Mamu-A*02,CLASS-I,MONKEY,VIRAL,P05861,JOURNAL OF IMMUNOLOGY 2004 173 5064-5076
7299,YTYKWETFL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,BACTERIAL,P31953,PROC.NATL.ACAD.SCI. USA 2000 97 12210-12215
7300,YVAVVPLVY,2.0,n/a,Patr-B*0901,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7301,,,n/a,Patr-A*0602,CLASS-I,CHIMPANZEE,SELF PEPTIDE,P01591,JOURNAL OF IMMUNOLOGY 2000 165 4414-4422
7302,YVDGAANR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20875,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
7303,YVDRFYKTLR,1.0,A*3303,HLA-A33,CLASS-I,HUMAN,VIRAL,P20873,AIDS RESEARCH AND HUMAN RETROVIRUSES 2003 19 503-510
7304,YVIKVSARV,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
7305,YVIKVSARVR,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
7306,YVITTQHWL,2.0,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,JOURNAL OF IMMUNOLOGY 1998 161 6970-6976
7307,,,A*0201,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P40126,CANCER RESEARCH 1998 58 4895-4901
7308,YVKVLEYVIK,1.0,A*0302,HLA-A3,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
7309,YVLPLWGRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
7310,YVLVTCLGL,1.0,A*0201,HLA-A2,CLASS-I,HUMAN,CANCER,P43355,MOLECULAR IMMUNOLOGY 1994 31 1423-1430
7311,YVMSWVRQV,3.0,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
7312,,,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
7313,,,n/a,HLA-A2,CLASS-I,HUMAN,SELF PEPTIDE,P01781,CANCER RESEARCH 2001 61 5145-5152
7314,YVPCHIRQI,1.0,n/a,Mamu-A*01,CLASS-I,RHESUS,VIRAL,P05885,JOURNAL OF VIROLOGY 2001 75 738-749
7315,YVRPLWGRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
7316,YVRPLWVRME,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,SELF PEPTIDE,not applicable,JOURNAL OF IMMUNOLOGY 2001 166 908-917
7317,YYDPSKDL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03369,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
7318,YYEEQHPEL,1.0,A*2401,HLA-A24,CLASS-I,HUMAN,SELF PEPTIDE,P24001,JOURNAL OF IMMUNOLOGY 1994 152 3913-3924
7319,YYIPHQSSL,2.0,H-2Kd,H-2d,CLASS-I,MOUSE,n/a,not applicable,IMMUNOGENETICS 2003 54 830-841
7320,,,A*2402,HLA-A24,CLASS-I,HUMAN,n/a,not applicable,IMMUNOGENETICS 2003 54 830-841
7321,YYNKALSFI,1.0,H-2Kd,H-2d,CLASS-I,MOUSE,VIRAL,P19692,JOURNAL OF IMMUNOLOGY 2001 167 655-666
7322,YYRDNKDPL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,VIRAL,P03368 ,JOURNAL OF IMMUNOLOGY 1997 159 6242-6252
7323,YYRPGVNLSL,1.0,A*2402,HLA-A24,CLASS-I,HUMAN,CANCER,P06731 ,INTERNATIONAL JOURNAL OF CANCER 1999 80 92-97
